Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Dermatology

  Free Subscription


Articles published in J Dermatol

Retrieve available abstracts of 862 articles:
HTML format



Single Articles


    April 2024
  1. BABA A, Yamada K, Kanekura T
    Cutaneous adverse events following COVID-19 vaccination: A case series of 30 Japanese patients and a review of 93 Japanese studies.
    J Dermatol. 2024 Apr 11. doi: 10.1111/1346-8138.17188.
    PubMed     Abstract available


  2. LIU Q, Su H, Hong C, Han J, et al
    Toxic epidermal necrolysis complicated with primary cutaneous aspergillosis: A report of four cases.
    J Dermatol. 2024 Apr 11. doi: 10.1111/1346-8138.17226.
    PubMed     Abstract available


  3. HAYAKAWA K, Irisawa R, Umefune R, Mae K, et al
    Marked effect of larotrectinib on primary cutaneous secretory carcinoma: A case report.
    J Dermatol. 2024 Apr 11. doi: 10.1111/1346-8138.17218.
    PubMed    


  4. SITTIWATTANAWONG P, Kantikosum K, Charoenchaipiyakul K, Pootongkam S, et al
    In-vivo and ex-vivo tests for culprit drugs identification in severe cutaneous adverse drugs reactions.
    J Dermatol. 2024 Apr 11. doi: 10.1111/1346-8138.17207.
    PubMed     Abstract available


  5. SUGIURA R, Hashimoto T, Okuno S, Satoh T, et al
    Expression of phosphorylated-Janus kinase 1 and IL-4Ralpha by dermal basophils and epidermal keratinocytes in atopic dermatitis-associated prurigo nodules: A case report.
    J Dermatol. 2024 Apr 11. doi: 10.1111/1346-8138.17229.
    PubMed    


  6. HANAMI Y, Yamamoto T
    Erythema nodosum of the extremities following dupilumab treatment in a patient with atopic dermatitis.
    J Dermatol. 2024 Apr 8. doi: 10.1111/1346-8138.17199.
    PubMed    


  7. UHARA H, Kiyohara Y, Isei T, Nagase K, et al
    Safety and effectiveness of avelumab in patients with Merkel cell carcinoma in general clinical practice in Japan: Post-marketing surveillance.
    J Dermatol. 2024;51:475-483.
    PubMed     Abstract available


  8. LIM S, Sidky L, Eliott E, Cobos G, et al
    A gyrate pattern of discoid lupus erythematosus.
    J Dermatol. 2024;51:e106-e107.
    PubMed    


  9. HAMADA R, Funasaka Y, Saeki H, Serizawa N, et al
    Dietary habits in adult Japanese patients with vitiligo.
    J Dermatol. 2024;51:491-508.
    PubMed     Abstract available


  10. PAN X, Dong Z
    Yellow urticaria following plasma transfusion.
    J Dermatol. 2024;51:e108-e109.
    PubMed    


  11. KIM KH, Kwon SH, Sim WY, Lew BL, et al
    Therapeutic maintenance effect of finasteride 1 mg every other month regimen in androgenetic alopecia and study on the difference in response to finasteride treatment: A prospective cohort study.
    J Dermatol. 2024;51:552-557.
    PubMed     Abstract available


  12. TSUNEMI Y, Otsuka A, Nonaka Y
    Receipt survey of prescription continuation rates for patients with onychomycosis and web-based survey of dermatologists on prescribing policies for onychomycosis therapeutics.
    J Dermatol. 2024;51:526-531.
    PubMed     Abstract available


  13. FAJUYIGBE D, Sewraj P, Connetable S, Molamodi K, et al
    Weekly hair washing: The recommended solution for women with afro-textured hair to alleviate dandruff and scalp discomfort.
    J Dermatol. 2024;51:518-525.
    PubMed     Abstract available


  14. CHATPROEDPRAI S, Tiasiri N, Chantawarangkul K, Wananukul S, et al
    Pediatric drug reaction with eosinophilia and systemic symptoms: A 12-year retrospective study in a tertiary center.
    J Dermatol. 2024;51:509-517.
    PubMed     Abstract available


  15. AO S, Huang G, Tang X, Zhu Z, et al
    Anti-immunoglobulin E provides an additional therapy to conventional steroids for Kimura's disease.
    J Dermatol. 2024;51:602-606.
    PubMed     Abstract available


  16. SUN X, Zhang J, Yang Q, Lin J, et al
    Treatment of epidermolysis bullosa simplex with dupilumab.
    J Dermatol. 2024;51:e131-e132.
    PubMed    


  17. SAKAMOTO K, Fujihiro M, Sakamoto A, Yamada C, et al
    A case of nonpigmented fixed-drug eruption with eosinophilic intraepidermal vesicle formation.
    J Dermatol. 2024;51:e120-e122.
    PubMed    


  18. USUI-TANIGUCHI M, Kawakami Y, Toi Y, Kaji T, et al
    Pruritic folliculitis of pregnancy with granular deposition of immunoglobulin G along the basement membrane zone.
    J Dermatol. 2024;51:e125-e126.
    PubMed    


  19. LEE SG, Kim SC, Kim JH
    Risk factors of rituximab-induced thrombocytopenia in patients with autoimmune bullous diseases.
    J Dermatol. 2024;51:597-601.
    PubMed     Abstract available


    March 2024
  20. YOKOTA K, Takenouchi T, Fujisawa Y, Fukushima S, et al
    Long-term follow-up results from KEYNOTE-041: Phase 1b study of pembrolizumab in Japanese patients with advanced melanoma.
    J Dermatol. 2024 Mar 26. doi: 10.1111/1346-8138.17002.
    PubMed     Abstract available


  21. IKUMI N, Hayama K, Kitamura N, Terui T, et al
    Higher prevalence of nail psoriasis in patients with psoriatic arthritis receiving biologic therapy: A single center cross sectional study.
    J Dermatol. 2024 Mar 20. doi: 10.1111/1346-8138.17196.
    PubMed    


  22. FUJIMOTO A, Hayashi R, Iguchi S, Abe R, et al
    Can dermatologists reach their full potential in teledermatology? A validation study of diagnostic performance of skin diseases in live video conferencing teledermatology.
    J Dermatol. 2024 Mar 20. doi: 10.1111/1346-8138.17197.
    PubMed     Abstract available


  23. XIE L, Lopes Almeida Gomes L, Stone CJ, Faden DF, et al
    An update on clinical trials for cutaneous lupus erythematosus.
    J Dermatol. 2024 Mar 15. doi: 10.1111/1346-8138.17161.
    PubMed     Abstract available


  24. TEBOUL A, Arnaud L, Chasset F
    Recent findings about antimalarials in cutaneous lupus erythematosus: What dermatologists should know.
    J Dermatol. 2024 Mar 14. doi: 10.1111/1346-8138.17177.
    PubMed     Abstract available


  25. HAGINO T, Saeki H, Fujimoto E, Kanda N, et al
    Real-world effectiveness and safety of bimekizumab in Japanese patients with psoriasis: A single-center retrospective study.
    J Dermatol. 2024 Mar 14. doi: 10.1111/1346-8138.17186.
    PubMed     Abstract available


  26. HEMMI A, Okamura K, Nikaido M, Saito T, et al
    Post-COVID-19 vaccination diffuse cutaneous sarcoidosis.
    J Dermatol. 2024 Mar 14. doi: 10.1111/1346-8138.17194.
    PubMed    


  27. CHIU YJ, Li CY, Wang TH, Ma H, et al
    Comparative transcriptomic analysis reveals differences in gene expression and regulatory pathways between nonacral and acral melanoma in Asian individuals.
    J Dermatol. 2024 Mar 12. doi: 10.1111/1346-8138.17187.
    PubMed     Abstract available


  28. HASEGAWA M, Chasset F, Chong BF, Fiorentino DF, et al
    International exchange on the clinical practice and research of rheumatic skin diseases: A report of the 5th International Conference of Cutaneous Lupus Erythematosus.
    J Dermatol. 2024 Mar 7. doi: 10.1111/1346-8138.17153.
    PubMed     Abstract available


  29. TAKADA M, Kikuchi N, Yamamoto T
    Umbilical psoriasis is not relevant to psoriatic arthritis.
    J Dermatol. 2024 Mar 5. doi: 10.1111/1346-8138.17189.
    PubMed     Abstract available


  30. TAKAYAMA E, Takai T, Fujimoto M, Yoshioka A, et al
    Bowen disease with sebaceous differentiation arising from clonal seborrheic keratosis.
    J Dermatol. 2024 Mar 5. doi: 10.1111/1346-8138.17180.
    PubMed     Abstract available


  31. KITAYAMA S, Katsuumi K, Takatsuka S, Shimizu T, et al
    Clinical features of skin metastasis from breast cancer: A retrospective observational study in Japan.
    J Dermatol. 2024 Mar 3. doi: 10.1111/1346-8138.17176.
    PubMed    


  32. UCHIYAMA A, Kosaka K, Ishikawa M, Inoue Y, et al
    Real-world effectiveness and safety of abrocitinib in 12 Japanese patients with atopic dermatitis and transcriptome analysis with peripheral blood.
    J Dermatol. 2024 Mar 3. doi: 10.1111/1346-8138.17173.
    PubMed     Abstract available


  33. OYA K, Nakamura Y, Shen LT, Ishizuki S, et al
    Soluble PD-L1 predicts tumor response and immune-related adverse events in patients with advanced melanoma treated with anti-PD-1 antibodies.
    J Dermatol. 2024 Mar 3. doi: 10.1111/1346-8138.17183.
    PubMed     Abstract available


  34. KIRCHLER CA, Fritz A, Spiegelfeld C, Mullegger RR, et al
    19-month follow-up survey on women with atopic eruption of pregnancy postpartum: An encouraging outlook.
    J Dermatol. 2024;51:467-469.
    PubMed    


  35. ODAWARA M, Mezaki M, Yoshimura T, Takaoka A, et al
    Epidermal turnover and iron metabolism in senile lentigo.
    J Dermatol. 2024;51:453-457.
    PubMed     Abstract available


  36. HE MJ, Wang YJ, Ran DL, Fu DS, et al
    Relationship between bullous pemphigoid and malignancy: A Mendelian randomization study.
    J Dermatol. 2024;51:403-408.
    PubMed     Abstract available


  37. KWON IJ, Kim SE, Kim SC, Lee SE, et al
    Efficacy of oral JAK1 or JAK1/2 inhibitor for treating refractory pruritus in dystrophic epidermolysis bullosa: A retrospective case series.
    J Dermatol. 2024;51:441-447.
    PubMed     Abstract available


  38. YU DA, Kim SR, Cho SI, Kwon O, et al
    Endocrine and metabolic comorbidities in primary cicatricial alopecia: A nationwide population-based study.
    J Dermatol. 2024;51:429-440.
    PubMed     Abstract available


  39. RAO L, Yang M, Chen H, Feng YY, et al
    Monkeypox 2023 in China: Dermatologist in the frontline with dermoscopic and reflectance confocal microscopy findings.
    J Dermatol. 2024;51:e81-e82.
    PubMed    


  40. ZHOU Y, Xiao Y, Wang Y, Li W, et al
    Refractory atypical IgA pemphigus successfully treated with apremilast.
    J Dermatol. 2024;51:e86-e87.
    PubMed    


  41. AKASAKA E, Rokunohe D, Nakano H, Yamatani S, et al
    A case of adult-onset localized recessive dystrophic epidermolysis bullosa, harboring the novel COL7A1 mutation p.G2754E and the previously reported mutation p.R1763.
    J Dermatol. 2024;51:e74-e76.
    PubMed    


  42. SUGIOKA K, Kondo M, Yamanaka K
    Elephantiasis verrucous lesions on psoriatic plaque improved with anti-IL-23p19 antibody therapy.
    J Dermatol. 2024;51:e77-e78.
    PubMed    


  43. KOBAYASHI A, Terui H, Takahashi T, Mizuashi M, et al
    A case of lymphangiectatic variant of giant pilomatricoma with bullous appearance: evaluation through magnetic resonance imaging.
    J Dermatol. 2024;51:e79-e80.
    PubMed    


  44. TSUJI H, Ichiki N, Niwa H, Iwata H, et al
    Bullous pemphigoid following hand, foot, and mouth disease.
    J Dermatol. 2024;51:e68-e69.
    PubMed    


    February 2024
  45. HASHIZUME H, Ishikawa Y, Hata A
    Increased Demodex mites after dupilumab therapy in facial skin: A case report.
    J Dermatol. 2024 Feb 29. doi: 10.1111/1346-8138.17150.
    PubMed    


  46. KOJIMA R, Miyake K, Shinohara R, Kushima M, et al
    Association between filaggrin gene mutations and the clinical features of molluscum contagiosum: The Yamanashi Adjunct Study of the Japan Environment and Children's Study.
    J Dermatol. 2024 Feb 27. doi: 10.1111/1346-8138.17157.
    PubMed     Abstract available


  47. KAMEDA E, Matsuzawa T, Togawa Y, Hashimoto R, et al
    Amelanotic melanoma in oculocutaneous albinism type 4 detected using violet-light dermoscopy.
    J Dermatol. 2024 Feb 27. doi: 10.1111/1346-8138.17164.
    PubMed    


  48. KWON SH, Choi S, Kim JS, Kim SS, et al
    Incidence and survival rates of primary cutaneous malignancies in Korea, 1999-2019: A nationwide population-based study.
    J Dermatol. 2024 Feb 17. doi: 10.1111/1346-8138.17118.
    PubMed     Abstract available


  49. ASAI J, Ohta R, Maruyama A, Katoh N, et al
    Lichen planus pigmentosus successfully treated with topical delgocitinib.
    J Dermatol. 2024 Feb 17. doi: 10.1111/1346-8138.17151.
    PubMed    


  50. OGAYA A, Yamamoto K, Okada E, Sawada Y, et al
    Sclerosing cholangitis exacerbated by widespread pustular psoriasis.
    J Dermatol. 2024 Feb 17. doi: 10.1111/1346-8138.17122.
    PubMed    


  51. YAO Y, Zhu Y, Luo Z, Zhu Y, et al
    Reactive cutaneous capillary endothelial proliferation treated successfully by oral itraconazole: A case report.
    J Dermatol. 2024 Feb 16. doi: 10.1111/1346-8138.17154.
    PubMed    


  52. TAGO M, Koizumi H, Kamiya S, Akashi N, et al
    Panniculitis on the trunk as a possible characteristic feature of anti-SAE1/2 antibody-positive dermatomyositis: A possible cutaneous manifestation of treatment resistance.
    J Dermatol. 2024 Feb 16. doi: 10.1111/1346-8138.17128.
    PubMed    


  53. NAMIKAWA K, Nakano E, Ogata D, Yamazaki N, et al
    Long-term survival with systemic therapy in the last decade: Can melanoma be cured?
    J Dermatol. 2024 Feb 15. doi: 10.1111/1346-8138.17147.
    PubMed     Abstract available


  54. FUJISAWA Y
    Preface to the Journal of Dermatology special issue: The changing landscape of melanoma treatment.
    J Dermatol. 2024 Feb 15. doi: 10.1111/1346-8138.17146.
    PubMed    


  55. XU X, Yu B, Lv Y, Cai Q, et al
    Efficacy and safety of epidural block with lidocaine for refractory severe plaque psoriasis: An open-label pilot study in real world setting.
    J Dermatol. 2024 Feb 13. doi: 10.1111/1346-8138.17145.
    PubMed     Abstract available


  56. YAZDANPARAST T, Nassiri Kashani M, Shamsipour M, Izadi Heidari F, et al
    Contact allergens responsible for eyelid dermatitis in adults.
    J Dermatol. 2024 Feb 13. doi: 10.1111/1346-8138.17140.
    PubMed     Abstract available


  57. YAMAMOTO M, Watanabe Y, Mori T, Iwatsuki K, et al
    Coexistence of pyoderma gangrenosum and cutaneous arteritis without systemic diseases.
    J Dermatol. 2024 Feb 12. doi: 10.1111/1346-8138.17144.
    PubMed    


  58. FURUDATE K, Kato J, Horimoto K, Sato S, et al
    Melanoma incidence on the non-weight-bearing areas of the sole.
    J Dermatol. 2024 Feb 12. doi: 10.1111/1346-8138.17149.
    PubMed    


  59. TSIOGKAS SG, Tsimourtou V, Chaidaki K, Dardiotis E, et al
    Risk of multiple sclerosis in patients with psoriasis receiving anti-IL-17 agents: A case-based review.
    J Dermatol. 2024 Feb 12. doi: 10.1111/1346-8138.17143.
    PubMed     Abstract available


  60. KIM BR, Lee KH, Paik K, Kim M, et al
    Automated mass screening and association rules analysis for comorbidities of psoriasis: A population-based case-control study.
    J Dermatol. 2024 Feb 12. doi: 10.1111/1346-8138.17121.
    PubMed     Abstract available


  61. TOKUYAMA M, Fan P, Wang G, Choe YB, et al
    Epidemiological analysis of the patients with psoriasis in Asian countries and region using the same clinical case cards between 2020 and 2022.
    J Dermatol. 2024 Feb 12. doi: 10.1111/1346-8138.17132.
    PubMed     Abstract available


  62. YAMAMOTO T
    Preface to Journal of Dermatology special issue: Neutrophilic dermatoses and autoinflammation.
    J Dermatol. 2024;51:149.
    PubMed    


  63. LAN X, Qiao R, Sun J, Song H, et al
    Clinicopathologic and trichoscopic features of keratosis follicularis spinulosa decalvans: A case series study.
    J Dermatol. 2024;51:253-260.
    PubMed     Abstract available


  64. KURIMOTO T, Mitsui Y
    Pathergy in a patient with pyoderma gangrenosum.
    J Dermatol. 2024;51:e29-e30.
    PubMed    


  65. TERVONEN T, Whichello C, Law E, Mauer J, et al
    Treatment preferences of adults and adolescents with alopecia areata: A discrete choice experiment.
    J Dermatol. 2024;51:243-252.
    PubMed     Abstract available


  66. FUKAE S, Aozasa N, Tarumoto N, Nakamura K, et al
    Secondary syphilis presenting with widespread psoriasiform lesions.
    J Dermatol. 2024;51:e27-e28.
    PubMed    


  67. ASAHINA A, Minami Y, Kameda H
    A cross-sectional questionnaire survey involving physicians for the clarification of the diagnosis and current status of therapeutic intervention of psoriatic arthritis in Japan.
    J Dermatol. 2024;51:261-270.
    PubMed     Abstract available


  68. DAINICHI T, Iwata M, Kaku Y
    Alopecia areata: What's new in the diagnosis and treatment with JAK inhibitors?
    J Dermatol. 2024;51:196-209.
    PubMed     Abstract available


  69. MUROTA H, Arima K, Yoshida T, Fujita H, et al
    Disease burden and treatment satisfaction in patients with prurigo nodularis in Japan.
    J Dermatol. 2024;51:223-233.
    PubMed     Abstract available


  70. SATOH TK
    Genetic mutations in pyoderma gangrenosum, hidradenitis suppurativa, and associated autoinflammatory syndromes: Insights into pathogenic mechanisms and shared pathways.
    J Dermatol. 2024;51:160-171.
    PubMed     Abstract available


  71. YAMANAKA K
    New treatment of pyoderma gangrenosum and hidradenitis suppurativa: A review.
    J Dermatol. 2024;51:172-179.
    PubMed     Abstract available


  72. ANSAI O, Hayashi R, Nakamura A, Sasaki J, et al
    Deep dermatophytosis caused by Trichophyton rubrum in an elderly patient with CARD9 deficiency: A case report and literature review.
    J Dermatol. 2024;51:294-300.
    PubMed     Abstract available


  73. ARAI Y, Okamura K, Saito T, Ito Y, et al
    A case of acute localized exanthematous pustulosis following COVID-19 infection.
    J Dermatol. 2024;51:e37-e38.
    PubMed    


  74. TAKANO A, Oya K, Ishii Y, Maruyama Y, et al
    Amicrobial pustulosis of the folds concurrent with graft-versus-host disease.
    J Dermatol. 2024;51:e35-e36.
    PubMed    


  75. JIANG W, Wang X, Li N, Chen J, et al
    Treating refractory acne conglobata with secukinumab: A case report.
    J Dermatol. 2024;51:e51-e52.
    PubMed    


  76. BI W, Fu H, Huang Y, Zeng X, et al
    The treatment of perianal hidradenitis suppurativa complicated with complex anal fistula by loose combined cutting seton surgery: A case letter.
    J Dermatol. 2024;51:e33-e34.
    PubMed    


  77. KANZAKI M, Honda A, Sawai Y, Suda K, et al
    Lenvatinib-induced pyoderma gangrenosum in a patient with hepatocellular carcinoma: A case report.
    J Dermatol. 2024;51:e31-e32.
    PubMed    


  78. YAMASHITA A, Fukui T, Akasaka E, Nakajima K, et al
    Acquired cutis laxa secondary to acute generalized exanthematous pustulosis: A case report and mini-review of literature.
    J Dermatol. 2024;51:287-293.
    PubMed     Abstract available


    January 2024
  79. PATT YS, Ben-Shabat N, Sharif K, David P, et al
    Unraveling the connection: Uveitis prevalence and risk factors in psoriasis patients - a population-based study.
    J Dermatol. 2024 Jan 31. doi: 10.1111/1346-8138.17123.
    PubMed     Abstract available


  80. KOMATSU S, Horimoto K, Kato J, Sato S, et al
    Disseminated intravascular coagulation induced by the combination therapy of encorafenib and binimetinib in a melanoma case.
    J Dermatol. 2024 Jan 31. doi: 10.1111/1346-8138.17124.
    PubMed    


  81. SHIM J, Noh H, Kim H, Joo B, et al
    Assessment of hair loss and skin changes during treatment in Asian breast cancer patients: A prospective cohort study.
    J Dermatol. 2024 Jan 31. doi: 10.1111/1346-8138.17092.
    PubMed     Abstract available


  82. YOSHIOKA A, Shintani-Domoto Y, Kousuke I, Kubo A, et al
    A case of nodular cutaneous amyloidosis presenting as refractory leg skin ulcers.
    J Dermatol. 2024 Jan 31. doi: 10.1111/1346-8138.17117.
    PubMed    


  83. FUJITA H, Iwasaki R, Tsuboi S, Murashiuma Y, et al
    Regional differences in the prevalence of generalized pustular psoriasis in Japan.
    J Dermatol. 2024 Jan 31. doi: 10.1111/1346-8138.17089.
    PubMed     Abstract available


  84. VALENTI M, Gargiulo L, Ibba L, Cortese A, et al
    Effectiveness of ixekizumab for the treatment of moderate-to-severe plaque psoriasis with involvement of difficult-to-treat areas: A 52-week multicenter retrospective study.
    J Dermatol. 2024 Jan 31. doi: 10.1111/1346-8138.17115.
    PubMed     Abstract available


  85. ZILBERG C, Ferguson AL, Lyons JG, Gupta R, et al
    Cutaneous malignancies in chronic lymphocytic leukemia.
    J Dermatol. 2024 Jan 31. doi: 10.1111/1346-8138.17126.
    PubMed     Abstract available


  86. IMAFUKU S, Okubo Y, Tada Y, Ohtsuki M, et al
    Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 inhibitor, in Japanese patients with moderate to severe plaque, erythrodermic, or generalized pustular psoriasis: Efficacy and safety results from an open-label, phase 3 trial.
    J Dermatol. 2024 Jan 24. doi: 10.1111/1346-8138.17074.
    PubMed     Abstract available


  87. HOASHI T, Ishikawa M, Uehara J, Oashi K, et al
    Japanese Dermatological Association guidelines: Outlines of Japanese clinical guidelines for basal cell carcinoma 2021.
    J Dermatol. 2024 Jan 24. doi: 10.1111/1346-8138.16944.
    PubMed     Abstract available


  88. WEN X, Aoi J, Mijee T, Kajihara I, et al
    SLC39A7 upregulation links to skin fibrosis in systemic sclerosis via TGF-beta/SMAD pathway.
    J Dermatol. 2024 Jan 13. doi: 10.1111/1346-8138.17103.
    PubMed     Abstract available


  89. LONGO R, Mammoud SB, Ribal R, Dadoun A, et al
    A metastatic, cutaneous mucinous carcinoma revealed by the 16alpha-(18) F-fluoroestradiol ((18) F-FES) PET/CT scan and successfully treated by hormonotherapy: Description of a case report.
    J Dermatol. 2024 Jan 12. doi: 10.1111/1346-8138.17111.
    PubMed    


  90. TADA Y, Guan J, Iwasaki R, Morita A, et al
    Treatment patterns and drug survival for generalized pustular psoriasis: A patient journey study using a Japanese claims database.
    J Dermatol. 2024 Jan 12. doi: 10.1111/1346-8138.17097.
    PubMed     Abstract available


  91. HASHIZUME H, Ishikawa Y, Hata A
    Differential immune complex deposition in mild and severe drug-induced cutaneous reactions.
    J Dermatol. 2024 Jan 12. doi: 10.1111/1346-8138.17099.
    PubMed    


  92. FUKUSHIMA S, Miyashita A, Kimura T, Kuriyama H, et al
    Deciphering the role of adjuvant therapy in melanoma and its actual benefits.
    J Dermatol. 2024 Jan 11. doi: 10.1111/1346-8138.17093.
    PubMed     Abstract available


  93. SATOH TK, Neulinger MM, Stadler PC, Aoki R, et al
    Immune checkpoint inhibitor-induced epidermal necrolysis: A narrative review evaluating demographics, clinical features, and culprit medications.
    J Dermatol. 2024;51:3-11.
    PubMed     Abstract available


  94. SAITO M, Ikoma A, Fujikawa A, Tanaka K, et al
    Improvements in pincer nail deformity occur earlier and last longer when acetylcysteine gel is added to an overcurvature-correcting device: Results of a phase 3, multicenter, randomized, vehicle-controlled, investigator-blinded study.
    J Dermatol. 2024;51:23-29.
    PubMed     Abstract available


  95. WOHL Y, Mashiah J, Drutin Y, Vered S, et al
    Incidence rate of alopecia areata in Israel: A 15-year analysis of population-based data and the emergence of young male adults as the most at-risk group.
    J Dermatol. 2024;51:88-94.
    PubMed     Abstract available


  96. CHEN L, Xu Q, Liu J, Li Z, et al
    Severe acute urticaria is associated with elevated plasma levels of D-dimer.
    J Dermatol. 2024;51:81-87.
    PubMed     Abstract available


  97. CHAE K, Cho M, Kim S, Woo YR, et al
    Increased risk of sleep disturbances in patients with rosacea: A nationwide population-based cohort study.
    J Dermatol. 2024;51:70-75.
    PubMed     Abstract available


  98. OGAWA T, Matsuda A, Ogawa Y, Tanaka R, et al
    Risk factors for the development of tinea pedis and onychomycosis: Real-world evidence from a single-podiatry center, large-scale database in Japan.
    J Dermatol. 2024;51:30-39.
    PubMed     Abstract available


  99. HAMAGUCHI Y, Yoshimura Y, Horii M, Fushida N, et al
    Absence of interstitial lung disease at initial visit may predict a favorable outcome for Japanese patients with systemic sclerosis with anti-topoisomerase I antibody.
    J Dermatol. 2024;51:62-69.
    PubMed     Abstract available


  100. FUNATO M, Iwata R, Iimoto M
    Efficacy of 5% sofpironium bromide gel in Duchenne muscular dystrophy with palmoplantar hyperhidrosis: A retrospective case study.
    J Dermatol. 2024;51:135-139.
    PubMed     Abstract available


  101. TAKEI S, Hayashi R, Tomii K, Deguchi T, et al
    Two cases of infancy associated eosinophilic pustular folliculitis (I-EPF) comparing the profile of infiltrating cells with classic EPF by immunohistochemical study.
    J Dermatol. 2024;51:125-129.
    PubMed     Abstract available


  102. TAKEICHI T, Hamada T, Yamamoto M, Ito Y, et al
    Patients with keratinization disorders due to ABCA12 variants showing pityriasis rubra pilaris phenotypes.
    J Dermatol. 2024;51:101-105.
    PubMed     Abstract available


  103. ZHOU X, Geng J, Wang M, Yang J, et al
    Novel compound heterozygous mutations of the COL7A1 gene in a Chinese patient with recessive dystrophic epidermolysis bullosa pruriginosa and digestive symptoms successfully treated with tofacitinib.
    J Dermatol. 2024;51:e8-e10.
    PubMed    


  104. YAMAMOTO S, Koga H, Tsutsumi M, Ishii N, et al
    Bullous pemphigoid associated with prodromal-phase by repeated COVID-19 vaccinations.
    J Dermatol. 2024;51:e6-e7.
    PubMed    


  105. USAMI T, Ohsawa I, Suga Y, Mitsuishi T, et al
    Human papillomavirus type 94-associated flat warts and review of reported cases.
    J Dermatol. 2024;51:95-97.
    PubMed     Abstract available


  106. TERAO K, Kawai K, Takei I
    Nodular amyloidosis presenting as multiple thin yellow plaques on the back.
    J Dermatol. 2024;51:e19-e21.
    PubMed    


  107. YAMAMOTO M, Kokubu H, Yamamoto B, Koga H, et al
    Dipeptidyl peptidase-4 inhibitor-related pemphigus herpetiformis with antibodies against desmocollin 3.
    J Dermatol. 2024;51:e16-e18.
    PubMed    


  108. KAGEYAMA R, Ginoza A, Honda T
    Author reply to "Response to 'A case of acquired idiopathic generalized anhidrosis following severe acute respiratory syndrome coronavirus 2 vaccination'".
    J Dermatol. 2024;51:e24.
    PubMed    


  109. HSIEH CY, Tsai TF
    Response to "a case of acquired idiopathic generalized anhidrosis following severe acute respiratory syndrome coronavirus 2 vaccination".
    J Dermatol. 2024;51:e22-e23.
    PubMed    


  110. NIIYAMA S, Fukuda H, Hirata A, Takenaka S, et al
    Recalcitrant multiple warts in GATA2 deficiency treated with systemic etretinate.
    J Dermatol. 2024;51:e1-e2.
    PubMed    


  111. LEE JM, Lee YJ, Choi YJ, Lee JH, et al
    A case of persistent erythema multiforme treated with upadacitinib.
    J Dermatol. 2024;51:e3-e5.
    PubMed    


    December 2023
  112. KOIZUMI S, Inozume T, Nakamura Y
    Current surgical management for melanoma.
    J Dermatol. 2023 Dec 27. doi: 10.1111/1346-8138.17086.
    PubMed     Abstract available


  113. MASUDA T, Yonekura S, Kataoka K, Mizoguchi K, et al
    Psoriasis-like lesions in an atopic dermatitis patient possibly associated with nemolizumab treatment.
    J Dermatol. 2023 Dec 27. doi: 10.1111/1346-8138.17085.
    PubMed    


  114. SAITO M, Uchiyama A, Kim J, Endo Y, et al
    Case report of anti-survival motor neuron complex antibody-positive overlap syndrome of diffuse cutaneous systemic sclerosis and idiopathic inflammatory myopathies.
    J Dermatol. 2023 Dec 27. doi: 10.1111/1346-8138.17084.
    PubMed    


  115. LIU F, Tang Y, Li X, Wang L, et al
    Successful treatment of recalcitrant subcorneal pustular dermatosis with Secukinumab: A case report.
    J Dermatol. 2023 Dec 19. doi: 10.1111/1346-8138.17077.
    PubMed    


  116. AMAGAI R, Fujimura T, Yamazaki E, Takahashi M, et al
    Vogt-Koyanagi-Harada disease-like uveitis after drug therapy including BRAF/MEK inhibitors in melanoma patients with HLA-DRB1*04.
    J Dermatol. 2023 Dec 19. doi: 10.1111/1346-8138.17082.
    PubMed     Abstract available


  117. AMADEARU A, Kubota N, Ogawa R, Furuta J, et al
    Wells syndrome confined to the back of the hands mimicking contact dermatitis.
    J Dermatol. 2023 Dec 19. doi: 10.1111/1346-8138.17083.
    PubMed    


  118. FUKUMURA E, Tateishi C, Ayano Y, Tsuruta D, et al
    A case of leukoencephalopathy and optic neuritis caused by infliximab for pustular psoriasis.
    J Dermatol. 2023 Dec 17. doi: 10.1111/1346-8138.17078.
    PubMed    


  119. MORITA A, Saeki H
    Pediatric psoriasis: Understanding pathological conditions and advances in treatment.
    J Dermatol. 2023 Dec 17. doi: 10.1111/1346-8138.17049.
    PubMed     Abstract available


  120. OGUZ ID, Oguz U, Usta M, Kulakli S, et al
    Relationship between psoriasis and urolithiasis.
    J Dermatol. 2023 Dec 12. doi: 10.1111/1346-8138.17058.
    PubMed     Abstract available


  121. YAMADA I, Kakuta R, Sato T, Yamazaki K, et al
    A case of cutaneous chromoblastomycosis in a toddler due to Verticillium spp. identified by molecular biological methods from formalin-fixed and paraffin-embedded samples.
    J Dermatol. 2023 Dec 12. doi: 10.1111/1346-8138.17066.
    PubMed    


  122. UCHI H
    Optimal strategy in managing advanced melanoma.
    J Dermatol. 2023 Dec 12. doi: 10.1111/1346-8138.17068.
    PubMed     Abstract available


  123. TABATA K, Ikarashi N, Shinozaki Y, Yoshida R, et al
    Effect of the gut microbiota on the expression of genes that are important for maintaining skin function: Analysis using aged mice.
    J Dermatol. 2023 Dec 12. doi: 10.1111/1346-8138.17062.
    PubMed     Abstract available


  124. CHEN J, Zheng Y, Zhu C, Lin L, et al
    Successful treatment of classic Kaposi sarcoma with Trichophyton rubrum-infected onychomycosis and tinea pedis utilizing combination of oral itraconazole and thalidomide.
    J Dermatol. 2023 Dec 12. doi: 10.1111/1346-8138.17060.
    PubMed     Abstract available


  125. VAN LITH PEA, Schreuder K, Jalving M, Reyners AKL, et al
    Systemic therapy timing and use in patients with advanced melanoma at the end of life: A retrospective cohort study.
    J Dermatol. 2023 Dec 11. doi: 10.1111/1346-8138.17061.
    PubMed     Abstract available


  126. SHOGASE N, Minowa T, Kato J, Horimoto K, et al
    Characterization of CD4 T-cell phenotype in human leukocyte antigen class II-positive acral melanoma.
    J Dermatol. 2023 Dec 11. doi: 10.1111/1346-8138.17070.
    PubMed    


  127. HAYASHI M, Shiraishi K, Yoshida S, Yatsuzuka K, et al
    Cutaneous arteritis combined with antiphospholipid syndrome associated with the use of immune checkpoint inhibitors in a patient with a metastatic lung adenocarcinoma.
    J Dermatol. 2023 Dec 8. doi: 10.1111/1346-8138.17063.
    PubMed    


  128. NAKAIZUMI H, Kambe N, Irie H, Kaku Y, et al
    Neutrophilic epitheliotropism, proposed as an auto-inflammatory condition of neutrophilic urticarial dermatosis including Schnitzler syndrome, is also observed in Japanese cases.
    J Dermatol. 2023 Dec 6. doi: 10.1111/1346-8138.17067.
    PubMed     Abstract available


  129. HIRAYAMA A, Nobeyama Y, Asahina A
    Relationships between severities of dermatological, neurological, and bone manifestations in neurofibromatosis type 1.
    J Dermatol. 2023;50:1647-1649.
    PubMed    


  130. SHI X, Song M, Zhao Y, Tuan H, et al
    The development and validation of the hair shedding visual scale for Asian women (HSVS-A).
    J Dermatol. 2023;50:1644-1646.
    PubMed    


  131. HARADA K, Ohyama M, Niiyama S, Irisawa R, et al
    Efficacy of autologous dermal sheath cup cell transplantation in male and female pattern hair loss: A Single-Arm, Multi-Center, phase III equivalent clinical study.
    J Dermatol. 2023;50:1539-1549.
    PubMed     Abstract available


  132. NAKAMURA K, Takashima S, Nohara T, Watanabe M, et al
    Development of a nutritionally balanced, melt-in-the-mouth chocolate for patients with epidermolysis bullosa.
    J Dermatol. 2023;50:1640-1643.
    PubMed     Abstract available


  133. TANG CH, Sue YM, Chang CL, Wang CC, et al
    Risk of bullous pemphigoid and pemphigus in patients on chronic dialysis: A nationwide population-based cohort study.
    J Dermatol. 2023;50:1568-1575.
    PubMed     Abstract available


  134. TANIZAKI H, Hayashi N, Abe M
    Evaluation of the efficacy of maintenance therapy for acne vulgaris using adapalene 0.1%/benzoyl peroxide 2.5% gel and benzoyl peroxide 2.5% gel for 24 weeks and assessment of atrophic acne scars using three-dimensional image analysis.
    J Dermatol. 2023;50:1513-1522.
    PubMed     Abstract available


  135. MURAO K, Kubo Y
    Podoplanin-positive cells located in the basal layer of Bowen disease include tumor cells with cancer stem cell properties.
    J Dermatol. 2023;50:1560-1567.
    PubMed     Abstract available


  136. CHENG J, Zhao L, Wang Y, Chen Y, et al
    Exon 8 deletion of KRT5 in epidermolysis bullosa simplex with mottled pigmentation: A case report.
    J Dermatol. 2023;50:e415-e417.
    PubMed    


  137. WATAYA-KANEDA M, Maeda S, Nakamura A, Hayashi M, et al
    Verification of the efficacy of topical sirolimus gel for systemic rare vascular malformations: a pilot study.
    J Dermatol. 2023;50:1619-1624.
    PubMed     Abstract available


  138. WANG R, Wang M
    A case of herpetiform pemphigus mimicking bullous pemphigoid after using secukinumab and successfully treated with sulfasalazine.
    J Dermatol. 2023;50:1625-1628.
    PubMed     Abstract available


  139. TAGA F, Anzawa K, Ono H, Futatsuya T, et al
    Possibly the first case of onychomycosis by Fusarium lactis: Case presentation and literature review of onychomycosis by Fusarium species.
    J Dermatol. 2023;50:1550-1559.
    PubMed     Abstract available


  140. NOGUCHI H, Matsumoto T, Mimura Y, Kubo M, et al
    Dermatophyte antigen kit: A useful diagnostic tool for onychomycosis.
    J Dermatol. 2023;50:1614-1618.
    PubMed     Abstract available


  141. INOUE M, Goto H, Hirata C, Tsujino M, et al
    Dermoscopic findings in two cases of keratoacanthoma en plaque.
    J Dermatol. 2023;50:e409-e410.
    PubMed    


  142. WANG T, Zhao P, Shi X, Zhang J, et al
    Efficacy of intralesional corticosteroid injections for scalp vitiligo: An effective therapeutic option.
    J Dermatol. 2023;50:e404-e405.
    PubMed    


  143. NAKANISHI M, Mizutani K, Sugioka K, Nishimura M, et al
    A case of anti-MDA5 antibody-positive dermatomyositis with severe necrosis on limbs after COVID-19 vaccination.
    J Dermatol. 2023;50:e402-e403.
    PubMed    


    November 2023
  144. HU W, Wang Y, Zhang S, Wu X, et al
    Treatment of severely itchy scalp psoriasis and palmoplantar pustulosis with unsatisfied response to secukinumab, adalimumab or ustekinumab using upadacitinib: A report of two cases.
    J Dermatol. 2023 Nov 30. doi: 10.1111/1346-8138.17046.
    PubMed    


  145. TADA Y, Komine M, Okubo Y, Habiro K, et al
    Treatment patterns of systemic drug use in Japanese patients with plaque psoriasis: A retrospective chart review.
    J Dermatol. 2023 Nov 30. doi: 10.1111/1346-8138.17038.
    PubMed     Abstract available


  146. SAITO N, Sagara C, Terada A, Akasaka E, et al
    Pyoderma gangrenosum successfully treated with split-thickness skin grafting in combination with negative pressure wound therapy: A case report.
    J Dermatol. 2023 Nov 27. doi: 10.1111/1346-8138.17048.
    PubMed    


  147. YAMAMOTO T
    Role of neutrophils in cutaneous lupus erythematosus.
    J Dermatol. 2023 Nov 27. doi: 10.1111/1346-8138.17036.
    PubMed     Abstract available


  148. IZUMI T, Teramoto Y, Kamimura A, Doi R, et al
    Favorable efficacy of S-1 treatment for locoregionally advanced cutaneous squamous cell carcinoma in the head and neck region.
    J Dermatol. 2023 Nov 27. doi: 10.1111/1346-8138.17057.
    PubMed     Abstract available


  149. MIKOSHIBA A, Katsuie S, Satake K, Kitamura S, et al
    A case of acquired idiopathic generalized anhidrosis with perspiration maintained at sites of brodalumab injection to treat psoriasis vulgaris.
    J Dermatol. 2023 Nov 27. doi: 10.1111/1346-8138.17052.
    PubMed    


  150. MAEDA R, Minowa T, Kato J, Horimoto K, et al
    Analysis of the immune microenvironment in the indolent form of primary cutaneous extranodal natural killer/T-cell lymphoma: A case report.
    J Dermatol. 2023 Nov 23. doi: 10.1111/1346-8138.17043.
    PubMed    


  151. KAKURAI M, Kubota N, Harada K, Nomura T, et al
    An unusual presentation of sporotrichosis with multiple fixed papulonodular skin lesions.
    J Dermatol. 2023 Nov 22. doi: 10.1111/1346-8138.17040.
    PubMed    


  152. MATSUO M, Niwa H, Onishi H, Iwata H, et al
    A case of generalized pustular psoriasis with discrepant resolution time between pustules and erythema after treatment with spesolimab.
    J Dermatol. 2023 Nov 13. doi: 10.1111/1346-8138.17032.
    PubMed    


  153. CHEN KR
    Cutaneous vasculitis in autoinflammatory diseases.
    J Dermatol. 2023 Nov 13. doi: 10.1111/1346-8138.17030.
    PubMed     Abstract available


  154. TAN S, Hu H, Xin X, Wu D, et al
    A clinical and biologic review of congenital melanocytic nevi.
    J Dermatol. 2023 Nov 13. doi: 10.1111/1346-8138.17025.
    PubMed     Abstract available


  155. KANG DH, Kwon SH, Lew BL
    Four-year long-term drug survival of dupilumab analyzed by treatment period in patients with moderate to severe atopic dermatitis: A real-world retrospective study.
    J Dermatol. 2023 Nov 10. doi: 10.1111/1346-8138.17017.
    PubMed    


  156. SASAOKA Y, Kiyohara E, Nojima S, Kijima N, et al
    A case of Rosai-Dorfman disease of the central nerve system associated with cutaneous lesions.
    J Dermatol. 2023 Nov 10. doi: 10.1111/1346-8138.17035.
    PubMed    


  157. SUEHIRO M, Tanaka A
    A case of atopic dermatitis with self-healing acute diffuse and total alopecia during nemolizumab treatment.
    J Dermatol. 2023 Nov 6. doi: 10.1111/1346-8138.17023.
    PubMed    


  158. LEE SG, Nam KA, Oh BH, Chung KY, et al
    Comparison of full-thickness skin graft and punch grafting in the reconstruction of plantar defects.
    J Dermatol. 2023 Nov 6. doi: 10.1111/1346-8138.17018.
    PubMed     Abstract available


  159. WOLSWIJK T, Nelemans PJ, Adan F, Abdul Hamid M, et al
    'Pitfalls for differentiating basal cell carcinoma from non-basal cell carcinoma on optical coherence tomography: A clinical series'.
    J Dermatol. 2023 Nov 6. doi: 10.1111/1346-8138.17020.
    PubMed     Abstract available


  160. OBARU C, Kimura T, Yamamura M, Kuriyama H, et al
    A case of melanoma complicated with uveitis induced by two types of BRAF/MEK inhibitors and nivolumab treatment.
    J Dermatol. 2023 Nov 6. doi: 10.1111/1346-8138.17015.
    PubMed    


  161. TAKAMURA S, Nakamura K, Fukuda T
    Evaluation of the safety and effectiveness of berotralstat for patients with hereditary angioedema: Report of six cases.
    J Dermatol. 2023;50:1506-1508.
    PubMed    


  162. FUJIMOTO T, Terahara T, Okawa K, Inakura H, et al
    Long-term evaluation of the safety and efficacy of a novel 20% oxybutynin hydrochloride lotion for primary palmar hyperhidrosis: An open-label extension study.
    J Dermatol. 2023;50:1459-1472.
    PubMed     Abstract available


  163. HIDE M, Ohsawa I, Nurse C, Yu M, et al
    Efficacy and safety of lanadelumab in Japanese patients with hereditary angioedema: A phase 3 multicenter, open-label study.
    J Dermatol. 2023;50:1381-1391.
    PubMed     Abstract available


  164. ZHANG JL, Wang SH, Cui SN, Zhang J, et al
    Severe acute respiratory syndrome coronavirus 2 infection in patients with autoimmune bullous diseases in China.
    J Dermatol. 2023;50:1433-1441.
    PubMed     Abstract available


  165. NAKAYAMA Y, Ogata D, Wada S, Tsuruta S, et al
    Treatment of high tumor mutation burden metastatic extramammary Paget disease with an anti-PD-1 antibody.
    J Dermatol. 2023;50:e396-e397.
    PubMed    


  166. BOUQUEREL M, Dequidt L, Jullie ML, Beltzung F, et al
    Wells syndrome and acquired cutis laxa: An atypical association.
    J Dermatol. 2023;50:e394-e395.
    PubMed    


  167. KOTHARI R, Valarmathi T, Kishore K, Kumar R, et al
    Novel intralesional rituximab regimen in recalcitrant oral pemphigus vulgaris.
    J Dermatol. 2023;50:e390-e391.
    PubMed    


  168. KUDOU M, Fukai K, Yamaguchi S, Omine T, et al
    Chronic mucocutaneous candidiasis due to STAT1 gene mutation.
    J Dermatol. 2023;50:e379-e380.
    PubMed    


  169. TAKAHASHI T, Fujimura T, Asano Y
    Eruptive milium-like syringoma: A case report.
    J Dermatol. 2023;50:e377-e378.
    PubMed    


  170. OMI M, Takeichi T, Chiba T, Asano Y, et al
    An in-frame 18 bp deletion in linker domain L1 of KRT9 identified in a Japanese patient with epidermolytic palmoplantar keratoderma.
    J Dermatol. 2023;50:e370-e372.
    PubMed    


  171. HIDE M, Wang Y, Dote N, Miyakawa K, et al
    Safety, efficacy, and pharmacokinetics of icatibant treatment in Japanese pediatric patients with hereditary angioedema: A phase 3, open-label study.
    J Dermatol. 2023;50:1473-1477.
    PubMed     Abstract available


  172. TERUI H, Segawa Y, Otake E, Omori R, et al
    Successful treatment of pustulotic arthro-osteitis with amoxicillin: A case report and review of the literature.
    J Dermatol. 2023;50:1478-1483.
    PubMed     Abstract available


    October 2023
  173. NOGUCHI H, Takeichi T, Hayai S, Yoshikawa M, et al
    Pneumocystis pneumonia in a patient with severe generalized pustular psoriasis treated with biologics.
    J Dermatol. 2023 Oct 31. doi: 10.1111/1346-8138.17014.
    PubMed    


  174. NAITO A, Kogame T, Kambe N, Kabashima K, et al
    A case of post herpes zoster granulomatous dermatitis successfully treated with UVA1 phototherapy.
    J Dermatol. 2023 Oct 31. doi: 10.1111/1346-8138.17016.
    PubMed    


  175. OYA K, Ishizuki S, Yasunaga S, Fujisawa Y, et al
    Metastatic melanoma of the oral cavity showing prompt regression with the use of BRAF/MEK inhibitors.
    J Dermatol. 2023 Oct 30. doi: 10.1111/1346-8138.17019.
    PubMed    


  176. LIN TL, Fan YH, Chang YL, Ho HJ, et al
    The epidemiology of pediatric psoriasis: A nationwide cohort study in Taiwan.
    J Dermatol. 2023 Oct 23. doi: 10.1111/1346-8138.16996.
    PubMed     Abstract available


  177. ALEGRE-BAILO A, Sanchez-Gilo A, Marlene-Mendoza NM, Mateos-Rico JJ, et al
    Tralokinumab treatment in atopic dermatitis: Depicting super-responders.
    J Dermatol. 2023 Oct 23. doi: 10.1111/1346-8138.17009.
    PubMed    


  178. KURIYAMA H, Myangat TM, Kajihara I, Shimada S, et al
    Elevated circulating C-X-C motif chemokine ligand 1 DNA copies in psoriasis.
    J Dermatol. 2023 Oct 23. doi: 10.1111/1346-8138.17013.
    PubMed    


  179. YOKOI K, Watanabe R, Kume M, Tanaka T, et al
    Novel real-time visualization of functional vitiligo skin lymphocytes attracting melanocytes in autologous cultured epidermis.
    J Dermatol. 2023 Oct 13. doi: 10.1111/1346-8138.17011.
    PubMed    


  180. SIMPSON EL, Kircik L, Blauvelt A, Kallender H, et al
    Clinically relevant improvements in adults and adolescents with atopic dermatitis who did not achieve Investigator's Global Assessment treatment success following 8 weeks of ruxolitinib cream monotherapy.
    J Dermatol. 2023 Oct 13. doi: 10.1111/1346-8138.16975.
    PubMed     Abstract available


  181. ITO Y, Takeuchi S, Tozawa T, Hisada S, et al
    Anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis with possible complication of thrombotic microangiopathy.
    J Dermatol. 2023 Oct 13. doi: 10.1111/1346-8138.17004.
    PubMed     Abstract available


  182. FUJISAKI M, Kasamatsu H, Nishimura K, Yoshida Y, et al
    A case of anti-SAE1/2 antibody-positive dermatomyositis with extensive panniculitis: A possible cutaneous manifestation of treatment resistance.
    J Dermatol. 2023 Oct 13. doi: 10.1111/1346-8138.17000.
    PubMed     Abstract available


  183. ZOU Q, Wei R, Yao Z, Li H, et al
    Successful treatment with baricitinib of linear morphea following the lines of Blaschko mimicking lichen striatus.
    J Dermatol. 2023 Oct 13. doi: 10.1111/1346-8138.16980.
    PubMed     Abstract available


  184. GETZLER IE, Vered S, Gavze RP, Adler L, et al
    Unraveling the debate: Can the skin manifestations of SARS-CoV-2 infection and vaccination be explained by the reactivation of herpes virus?
    J Dermatol. 2023 Oct 13. doi: 10.1111/1346-8138.16984.
    PubMed     Abstract available


  185. NAKANISHI Y, Shinkuma S, Mitsui Y, Ogawa K, et al
    Ultrasonographic findings in nevus lipomatosus cutaneous superficialis: What differentiates this tumor from other soft tissue tumors?
    J Dermatol. 2023 Oct 7. doi: 10.1111/1346-8138.16998.
    PubMed     Abstract available


  186. IMURA K, Masuda Y, Sano Y, Yagi H, et al
    Spontaneous remission of actinic lichen nitidus after long-term follow-up in a Japanese pediatric patient.
    J Dermatol. 2023 Oct 5. doi: 10.1111/1346-8138.16973.
    PubMed    


  187. SHIMADA S, Mijiddorj MT, Kajihara I, Maeda-Otsuka S, et al
    Increased circulating interleukin-8 DNA copies in psoriasis.
    J Dermatol. 2023 Oct 5. doi: 10.1111/1346-8138.16988.
    PubMed    


  188. NAGASHIMA N, Ugajin T, Miyake K, Walls AF, et al
    Cutaneous basophil infiltration in atopic dermatitis is associated with abundant epidermal infiltration of helper T cells: A preliminary retrospective study.
    J Dermatol. 2023 Oct 3. doi: 10.1111/1346-8138.16987.
    PubMed     Abstract available


  189. NAKAJIMA M, Watanabe K, Ohara Y, Otsuki M, et al
    Hyperpigmentation with droplets of melanocytes into the dermis in primary localized cutaneous amyloidosis.
    J Dermatol. 2023 Oct 3. doi: 10.1111/1346-8138.16986.
    PubMed    


  190. OSHIMA Y, Fujimoto T, Nomoto M, Fukui J, et al
    Hyperhidrosis: A targeted literature review of the disease burden.
    J Dermatol. 2023;50:1227-1236.
    PubMed     Abstract available


  191. TOWFIGHI P, Huffman SS, Bovill JD, Shan HD, et al
    Financial toxicity of hidradenitis suppurativa: A single-center experience at an urban wound-care clinic.
    J Dermatol. 2023;50:1279-1286.
    PubMed     Abstract available


  192. WANG J, Wu H, Cong W, Zhu H, et al
    Psychological morbidity in patients with pemphigus and its clinicodemographic risk factor: A comparative study.
    J Dermatol. 2023;50:1237-1245.
    PubMed     Abstract available


  193. HOU YL, Lin SH
    Real-world efficacy of adjunctive calcipotriene/betamethasone dipropionate foam for recalcitrant psoriatic lesions on the scalp or lower legs with biologic therapy.
    J Dermatol. 2023;50:1272-1278.
    PubMed     Abstract available


  194. STEADMAN T, O'Reilly S
    Elevated interleukin-11 in systemic sclerosis and role in disease pathogenesis.
    J Dermatol. 2023;50:1255-1261.
    PubMed     Abstract available


  195. FENG Y, Xiong X, Su Z, Su T, et al
    Disseminated Prototheca wickerhamii infection in a patient with CARD9 gene mutation.
    J Dermatol. 2023;50:e342-e343.
    PubMed    


  196. HATANO Y, Nakagawa Y, Tanemura A, Fujimoto M, et al
    A case of thiamazole-induced erythema nodosum.
    J Dermatol. 2023;50:e335-e336.
    PubMed    


  197. CHOI SM, Kang MJ, Kwon SH, Sim WY, et al
    A retrospective study on the clinical characteristics and prognosis of alopecia totalis and universalis: An update on prognosis.
    J Dermatol. 2023;50:1335-1338.
    PubMed     Abstract available


  198. MOE KK, Wang CC
    Pemphigus vegetans overlying an occlusive hemodialysis fistula and involving multiple digits.
    J Dermatol. 2023;50:e333-e334.
    PubMed    


  199. KURIYAMA Y, Yasuda M, Saito S, Nakano H, et al
    Epidermodysplasia verruciformis with squamous cell carcinomas and the identification of a novel TMC8 mutation.
    J Dermatol. 2023;50:e325-e326.
    PubMed    


  200. ZHOU X, Zhou Y, Qian H, Wu F, et al
    Anti-laminin gamma1 (p200) pemphigoid successfully treated with tofacitinib combined with prednisone.
    J Dermatol. 2023;50:e354-e356.
    PubMed    


  201. FUKAURA R, Terashima-Murase C, Tanahashi K, Takeichi T, et al
    Diagnosis of acute generalized pustular bacterid facilitated by point-of-care testing.
    J Dermatol. 2023;50:e347-e348.
    PubMed    


  202. IMAWARI H, Fujimori K, Hiruma JI, Numata T, et al
    Perianal erosion in a patient with sorafenib-induced hand-foot syndrome: A case report.
    J Dermatol. 2023;50:e344-e346.
    PubMed    


  203. FAZELZADEH HAGHIGHI N, Kamal N, Jafari Khamirani H, Fazelzadeh Haghighi M, et al
    Novel insight into the ectodermal dysplasia 11A: Splicing variant of the EDARADD gene in a family with clinical variability and literature review.
    J Dermatol. 2023;50:1357-1362.
    PubMed     Abstract available


  204. WANG M, Li J, Shang P, Chong S, et al
    Evaluation of clinical factors and outcome of systemic glucocorticoid therapy discontinuation in patients with pemphigus achieving complete remission.
    J Dermatol. 2023;50:1347-1352.
    PubMed     Abstract available


    September 2023
  205. NORIMATSU Y, Akatsuka T, Matsuoka A, Hamada T, et al
    Detection of TRAF1-ALK fusion in skin lesions of systemic ALK+ anaplastic large cell lymphoma initially involving the skin and the draining lymph node.
    J Dermatol. 2023 Sep 27. doi: 10.1111/1346-8138.16981.
    PubMed     Abstract available


  206. TANAKA A, Miyazawa H, Yanagi T, Maeda T, et al
    Association between weight loss and death in patients with malignant melanoma: A retrospective study of 28 cases.
    J Dermatol. 2023 Sep 27. doi: 10.1111/1346-8138.16982.
    PubMed     Abstract available


  207. CHEN CH, Lan CE
    Cutaneous cytomegalovirus and herpes simplex virus coinfection presented as refractory buttock ulcer in a patient with anti-interferon-gamma syndrome.
    J Dermatol. 2023 Sep 27. doi: 10.1111/1346-8138.16964.
    PubMed    


  208. MASUDA Y, Imura K, Sano Y, Yagi H, et al
    Methotrexate-associated lymphoproliferative disorder presenting as primary cutaneous anaplastic large cell lymphoma with generalized skin lesions.
    J Dermatol. 2023 Sep 27. doi: 10.1111/1346-8138.16971.
    PubMed    


  209. KATAYAMA S, Koga K, Fujimoto M, Matsuzaki I, et al
    Expression of laminin332 gamma2 at the invasive front is associated with tumor budding and poor prognosis in cutaneous squamous cell carcinoma.
    J Dermatol. 2023 Sep 26. doi: 10.1111/1346-8138.16952.
    PubMed     Abstract available


  210. NAKANE Y, Yoshikawa T, Takeichi T, Kono M, et al
    Dual clinical features of fine and rough scales seen in a combined ichthyosis vulgaris and X-linked recessive ichthyosis patient with atopic dermatitis.
    J Dermatol. 2023 Sep 21. doi: 10.1111/1346-8138.16968.
    PubMed    


  211. YOKOMIZO S, Miyake T, Kawakami Y, Ohashi K, et al
    Cutaneous toxicity with subepidermal blisters and dyskeratosis following administration of pemetrexed in a patient with nivolumab-induced psoriasis and linear IgA bullous dermatosis.
    J Dermatol. 2023 Sep 21. doi: 10.1111/1346-8138.16974.
    PubMed    


  212. KATSUTA M, Nobeyama Y, Hirafuku K, Tashiro K, et al
    Characteristics of mild and severe apalutamide-related cutaneous adverse events in patients with prostate cancer: A review of the literature.
    J Dermatol. 2023 Sep 21. doi: 10.1111/1346-8138.16972.
    PubMed     Abstract available


  213. PARADISI A, Piccerillo A, Bocchino E, Cappilli S, et al
    Surgery after sonidegib treatment achieves complete response in locally advanced basal cell carcinoma of the face.
    J Dermatol. 2023 Sep 21. doi: 10.1111/1346-8138.16970.
    PubMed     Abstract available


  214. HAYAMA K, Iwasaki R, Tian Y, Fujita H, et al
    Factors associated with generalized pustular psoriasis progression among patients with psoriasis vulgaris in Japan: Results from a claims database study.
    J Dermatol. 2023 Sep 18. doi: 10.1111/1346-8138.16949.
    PubMed     Abstract available


  215. REN X, Tan D, Deng J, Wang Z, et al
    Skin biopsy and neuronal intranuclear inclusion disease.
    J Dermatol. 2023 Sep 18. doi: 10.1111/1346-8138.16966.
    PubMed     Abstract available


  216. NOZAKI H, Honma M, Tanino H, Ishida-Yamamoto A, et al
    Characteristics of osteonecrosis of the femoral head complicated by psoriasis.
    J Dermatol. 2023 Sep 12. doi: 10.1111/1346-8138.16959.
    PubMed    


  217. LI Z, Shan Y, Dong J, Mei H, et al
    Disseminated cryptococcosis presenting with generalized cutaneous involvement in a rheumatoid arthritis patient receiving tofacitinib: A case report.
    J Dermatol. 2023 Sep 12. doi: 10.1111/1346-8138.16960.
    PubMed    


  218. ARIYOSHI A, Fukumoto T, Imamura S, Ohnuma K, et al
    Cutaneous cryptococcosis due to Cryptococcus neoformans with the formation of a giant subcutaneous nodule.
    J Dermatol. 2023 Sep 12. doi: 10.1111/1346-8138.16961.
    PubMed    


  219. CHU M, Shen S, Zhu Z, Li Z, et al
    Association of psoriasis with depression, anxiety, and suicidality: A bidirectional two-sample Mendelian randomization study.
    J Dermatol. 2023 Sep 12. doi: 10.1111/1346-8138.16941.
    PubMed     Abstract available


  220. OYA K, Kakurai M, Ishii Y, Nomura T, et al
    Atypical radiation recall dermatitis induced by radiotherapy targeting a different site from the previously irradiated site.
    J Dermatol. 2023 Sep 4. doi: 10.1111/1346-8138.16953.
    PubMed    


  221. TRIWATCHARIKORN J, Itthipanichpong Y, Washrawirul C, Chuenboonngarm N, et al
    Skin manifestations and biophysical changes following weight reduction induced by bariatric surgery: A 2-year prospective study.
    J Dermatol. 2023 Sep 4. doi: 10.1111/1346-8138.16951.
    PubMed     Abstract available


  222. HAGINO T, Yoshida M, Hamada R, Fujimoto E, et al
    Therapeutic effectiveness of upadacitinib on individual types of rash in Japanese patients with moderate-to-severe atopic dermatitis.
    J Dermatol. 2023 Sep 4. doi: 10.1111/1346-8138.16950.
    PubMed     Abstract available


  223. SHIMOMURA N, Sugimoto H, Nakayama A, Katsuki K, et al
    Case of mycosis fungoides palmaris et plantaris possibly associated with nail psoriasis.
    J Dermatol. 2023 Sep 4. doi: 10.1111/1346-8138.16954.
    PubMed    


  224. SAWADA M, Hida T, Kamiya T, Minowa T, et al
    Effects of temozolomide on tumor mutation burden and microsatellite instability in melanoma cells.
    J Dermatol. 2023 Sep 2. doi: 10.1111/1346-8138.16925.
    PubMed     Abstract available


  225. YAMAMOTO T, Yamasaki K, Yamanaka K, Komine M, et al
    Clinical guidance of pyoderma gangrenosum 2022.
    J Dermatol. 2023;50:e253-e275.
    PubMed     Abstract available


  226. GEORGE P, Jagun O, Liu Q, Wentworth C, et al
    Prevalence of autoimmune and inflammatory diseases and mental health conditions among an alopecia areata cohort from a US administrative claims database.
    J Dermatol. 2023;50:1121-1128.
    PubMed     Abstract available


  227. ASAKA A, Kyutoku S, Nuri T, Sakuraba M, et al
    Modified trilobed transposition flap for a distal nasal defect.
    J Dermatol. 2023;50:1145-1149.
    PubMed     Abstract available


  228. ONO H, Yamaguchi R, Arai M, Togi S, et al
    Schimmelpenning-Feuerstein-Mims syndrome induced by HRAS Gly12Ser somatic mosaic mutation: Case report and literature review.
    J Dermatol. 2023;50:1213-1215.
    PubMed     Abstract available


  229. HIDA T, Ishikawa A, Okura M, Kishibe M, et al
    A Japanese patient with hereditary angioedema caused by deep intron variation in the SERPING1 gene.
    J Dermatol. 2023;50:e309-e310.
    PubMed    


  230. SANO H, Kase M, Aoyama Y, Sano S, et al
    A case of persistent, confluent maculopapular erythema following a COVID-19 mRNA vaccination is possibly associated with the intralesional spike protein expressed by vascular endothelial cells and eccrine glands in the deep dermis.
    J Dermatol. 2023;50:1208-1212.
    PubMed     Abstract available


  231. NAKAMIZO S, Murata T, Ishida Y, Aoki S, et al
    A Japanese case of Vorner-type palmoplantar keratoderma caused by a novel KRT1 variant.
    J Dermatol. 2023;50:e307-e308.
    PubMed    


  232. TANAKA A, Fujimura Y, Fuke S, Izumi K, et al
    A case of bullous pemphigoid developing under treatment with benralizumab for bronchial asthma.
    J Dermatol. 2023;50:1199-1202.
    PubMed     Abstract available


  233. USUI-TANIGUCHI M, Kaji T, Taniguchi K, Kawakami Y, et al
    A pediatric case of gradually spreading longitudinal melanonychia initially accompanied by Hutchinson's sign.
    J Dermatol. 2023;50:e297-e298.
    PubMed    


  234. CHOI S, Kim SH, Hwang JH, Jang HW, et al
    Rapidly progressing generalized bullous fixed drug eruption after the first dose of COVID-19 messenger RNA vaccination.
    J Dermatol. 2023;50:1190-1193.
    PubMed     Abstract available


  235. LAN X, Yang X, Jiang Y
    Concurrent acquired cutis laxa and necrobiotic xanthogranuloma without paraproteinemia.
    J Dermatol. 2023;50:e299-e300.
    PubMed    


  236. KITAYAMA S, Makino T, Hayashi M, Mizawa M, et al
    Usefulness of immunofluorescence overlay antigen mapping in the identification of autoantigen in anti-p200 pemphigoid.
    J Dermatol. 2023;50:1194-1198.
    PubMed     Abstract available


  237. SAWA M, Murase C, Yamada N, Fukaura R, et al
    Giant condyloma of Buschke-Lowenstein in a Netherton syndrome patient, successfully treated with cryotherapy and intravenous immunoglobulin.
    J Dermatol. 2023;50:e289-e291.
    PubMed    


  238. YAN C, Zhou T, Geng S
    Chinese nontwin sisters suffer from poikiloderma with neutropenia harboring novel compound heterozygous USB1 gene mutations.
    J Dermatol. 2023;50:e278-e279.
    PubMed    


    August 2023
  239. SAEKI H, Akiyama M, Abe M, Igarashi A, et al
    English version of Japanese guidance for biologics in treating atopic dermatitis.
    J Dermatol. 2023 Aug 31. doi: 10.1111/1346-8138.16932.
    PubMed     Abstract available


  240. ANDERSCH-BJORKMAN Y, Micu E, Seifert O, Lonne-Rahm SB, et al
    Effects of brodalumab on psoriasis and depressive symptoms in patients with insufficient response to TNF-alpha inhibitors.
    J Dermatol. 2023 Aug 31. doi: 10.1111/1346-8138.16917.
    PubMed     Abstract available


  241. SEISHIMA M, Sasaki M, Hachiken H, Furukawa T, et al
    Ulcerative colitis during dupilumab therapy in a patient with atopic dermatitis.
    J Dermatol. 2023 Aug 25. doi: 10.1111/1346-8138.16928.
    PubMed    


  242. KURIYAMA Y, Kosaka M, Kaneko A, Nishioka H, et al
    Skin surface material for detecting human papillomavirus infection of skin warts.
    J Dermatol. 2023 Aug 25. doi: 10.1111/1346-8138.16920.
    PubMed     Abstract available


  243. TADA Y, Morita A, Yamanaka K, Kono M, et al
    Real-world retention rates and effectiveness of secukinumab in psoriasis: Results from a multicenter cohort study (RAILWAY).
    J Dermatol. 2023 Aug 24. doi: 10.1111/1346-8138.16926.
    PubMed     Abstract available


  244. LABRANDERO HOYOS C, Penuelas Leal R, Echevarria AG, Lorca Sprohnle J, et al
    JAK-STAT pathway is involved in cutaneous sclerosis processes: Generalized morphea successfully treated with baricitinib.
    J Dermatol. 2023 Aug 22. doi: 10.1111/1346-8138.16933.
    PubMed    


  245. FUKAURA R, Terashima-Murase C, Ota M, Noda H, et al
    Methicillin-resistant Staphylococcus aureus-induced staphylococcal scalded skin syndrome in a preterm infant, and subsequent toxigenic analysis.
    J Dermatol. 2023 Aug 22. doi: 10.1111/1346-8138.16929.
    PubMed    


  246. KOIZUMI S, Shu J, Okuyama C, Sugiura K, et al
    A case of generalized pustular psoriasis with a "bamboo spine" appearance.
    J Dermatol. 2023 Aug 17. doi: 10.1111/1346-8138.16927.
    PubMed    


  247. SAWAI N, Kawakami Y, Tachibana K, Nomura H, et al
    Successful treatment with secukinumab in a patient with generalized pustular psoriasis preceded by palmoplantar lesions.
    J Dermatol. 2023 Aug 14. doi: 10.1111/1346-8138.16919.
    PubMed    


  248. KOBAYASHI Y, Adachi T, Arakawa H, Minakata Y, et al
    A case of drug-induced hypersensitivity syndrome complicated with fulminant type 1 diabetes and type 2 myocardial infarction.
    J Dermatol. 2023 Aug 10. doi: 10.1111/1346-8138.16916.
    PubMed     Abstract available


  249. CHEN L, Wang Y, Qin B, Fang H, et al
    Reflectance confocal microscopy features of vulvar lichen sclerosus in Chinese juvenile girls.
    J Dermatol. 2023 Aug 2. doi: 10.1111/1346-8138.16884.
    PubMed     Abstract available


  250. NAM KH, Lee GJ, Kim JI, Song KH, et al
    Home-based diphenylcyclopropenone immunotherapy for alopecia areata: A large retrospective study of 94 cases.
    J Dermatol. 2023;50:1093-1095.
    PubMed    


  251. TSAI TF, Ng CY
    COVID-19 vaccine-associated vitiligo: A cross-sectional study in a tertiary referral center and systematic review.
    J Dermatol. 2023;50:982-989.
    PubMed     Abstract available


  252. FANG HY, Lian CH
    The effectiveness and safety of dupilumab in the management of refractory prurigo nodularis in 45 Chinese patients: A real-life observational study.
    J Dermatol. 2023;50:1084-1087.
    PubMed     Abstract available


  253. GINOZA A, Kageyama R, Suzuki N, Shimauchi T, et al
    A case of acquired idiopathic generalized anhidrosis following severe acute respiratory syndrome coronavirus 2 vaccination.
    J Dermatol. 2023;50:e249-e250.
    PubMed    


  254. MIKAMI Y, Fujimura T, Yamazaki E, Shimada-Omori R, et al
    Acquired idiopathic generalized anhidrosis after novel coronavirus (SARS-CoV-2) infection.
    J Dermatol. 2023;50:e245-e246.
    PubMed    


  255. YAMAGUCHI N, Kiniwa Y, Hayashi R, Abe R, et al
    Case of autosomal recessive woolly hair/hypotrichosis with compound heterozygous mutations in the LIPH gene at c.742C > A and c.614A > G: The first Japanese case.
    J Dermatol. 2023;50:e238-e239.
    PubMed    


  256. LIU L, Wang W, Si Y, Li X, et al
    Genetic insights into the risk of metabolic syndrome and its components on psoriasis: A bidirectional Mendelian randomization.
    J Dermatol. 2023 Aug 1. doi: 10.1111/1346-8138.16910.
    PubMed     Abstract available


  257. HAYASHI N, Hayama K, Takahashi K, Kurokawa I, et al
    Real-world safety and effectiveness of adalimumab in patients with hidradenitis suppurativa: A 52-week analysis of a postmarketing surveillance study in Japan.
    J Dermatol. 2023;50:1034-1044.
    PubMed     Abstract available


  258. INOUE T, Watabe D, Tsunemi Y, Amano H, et al
    Outcome of fosravuconazole treatment for onychomycosis refractory to topical antifungal agents.
    J Dermatol. 2023;50:1014-1019.
    PubMed     Abstract available


  259. INOUE E, Hiroumi S, Sato S, Hayashi M, et al
    Palmoplantar pustulosis and pustulotic arthro-osteitis associated with multiple venous occlusion: A case report and literature review.
    J Dermatol. 2023;50:1076-1080.
    PubMed     Abstract available


  260. MERCADE-TORRAS JM, Samaniego C, Saez A, Yebenes M, et al
    Paraneoplastic secretion of antidiuretic hormone in Merkel cell carcinoma: A case report.
    J Dermatol. 2023;50:e247-e248.
    PubMed    


  261. YANG X, Kong M, Wang H, Song Z, et al
    Symptomatic dermographism induced by oral minocycline: A report of four cases.
    J Dermatol. 2023;50:1063-1067.
    PubMed     Abstract available


  262. BAGCI IS, Ergun EZ, Avci P, Aoki R, et al
    Indirect immunofluorescence for bullous pemphigoid using ex vivo confocal laser scanning microscopy.
    J Dermatol. 2023;50:e236-e237.
    PubMed    


  263. UEDA-HAYAKAWA I, Tonomura K, Maekawa A, Kaneda E, et al
    Age distribution and prevalence in different age groups of four myositis-specific autoantibodies, including anti-ARS, anti-MDA5, anti-Mi-2, and anti-TIF1gamma antibodies.
    J Dermatol. 2023;50:1058-1062.
    PubMed     Abstract available


  264. SHIMIZU K, Fujita H, Fujisawa D, Hayama K, et al
    Case of type 1 segmental Darier's disease with a novel mosaic mutation in the ATP2A2 gene.
    J Dermatol. 2023;50:e240-e242.
    PubMed    


  265. KAKURAI M, Kubota N, Ishii Y, Izumi K, et al
    Brunsting-Perry type pemphigoid with IgG antibody against full-length BP180 mimicking squamous cell carcinoma.
    J Dermatol. 2023;50:e234-e235.
    PubMed    


  266. KAKURAI M, Oya K, Ishii Y, Nomura T, et al
    Multiple subepidermal calcified nodule confined to cafe-au-lait spots.
    J Dermatol. 2023;50:e232-e233.
    PubMed    


  267. ZHANG F, Chen Y, Song D, Wang S, et al
    One recurrent heterozygous mutation of the PLCD1 gene in a Chinese family with hereditary leukonychia: A case report and genotype-phenotype correlation analysis.
    J Dermatol. 2023;50:e230-e231.
    PubMed    


    July 2023
  268. MIZUKAWA I, Kamata M, Shimizu T, Ito M, et al
    Expression of interleukin-36 receptor antagonist in a patient with generalized pustular psoriasis harboring the p.Pro82Leu variant in the IL36RN gene.
    J Dermatol. 2023 Jul 31. doi: 10.1111/1346-8138.16914.
    PubMed     Abstract available


  269. KIM BR, Lee KH, Kim J, Kim JW, et al
    Association between cardio-cerebrovascular disease and systemic antipsoriatic therapy in psoriasis patients using population-based data: A nested case-control study.
    J Dermatol. 2023 Jul 30. doi: 10.1111/1346-8138.16904.
    PubMed     Abstract available


  270. MUTO Y, Kambayashi Y, Kato H, Fukushima S, et al
    Adverse events associated with postoperative outcomes of adjuvant anti-PD-1 antibody therapy in both acral and non-acral cutaneous melanomas: A multicenter, observational, post hoc analysis study.
    J Dermatol. 2023 Jul 30. doi: 10.1111/1346-8138.16912.
    PubMed     Abstract available


  271. BAR-ILAN E, Bar J, Baniel A, Slodownik D, et al
    Intralesional human papillomavirus vaccine for the treatment of recalcitrant cutaneous warts.
    J Dermatol. 2023 Jul 27. doi: 10.1111/1346-8138.16905.
    PubMed     Abstract available


  272. UCHIDA H, Kamata M, Watanabe A, Ito M, et al
    Improvement of severe alopecia areata after 9-month baricitinib treatment followed by subsequent use of upadacitinib in a patient with atopic dermatitis.
    J Dermatol. 2023 Jul 23. doi: 10.1111/1346-8138.16893.
    PubMed    


  273. TERADA A, Akasaka E, Nakano H, Sawamura D, et al
    Two cases of cutaneous-type pemphigus vulgaris and a case of pemphigus foliaceus without mucosal involvement despite high anti-desmoglein 3 autoantibody levels.
    J Dermatol. 2023 Jul 23. doi: 10.1111/1346-8138.16907.
    PubMed     Abstract available


  274. ISHIKAWA Y, Ajima S, Hashizume H
    Pityriasis rubra pilaris with simultaneous emergence of human herpesvirus-6 reactivation in a patient with drug-induced hypersensitivity syndrome.
    J Dermatol. 2023 Jul 19. doi: 10.1111/1346-8138.16877.
    PubMed    


  275. SU Z, Slivka P, Paulsboe S, Chu K, et al
    Importance of PLD2 in an IL-23 driven psoriasiform dermatitis model and potential link to human psoriasis.
    J Dermatol. 2023 Jul 16. doi: 10.1111/1346-8138.16899.
    PubMed     Abstract available


  276. IKUMI N, Fujita H, Wada TT
    Generalized pustular psoriasis occurred immediately after the withdrawal of upadacitinib in a patient with plaque psoriasis with inflammatory arthritis.
    J Dermatol. 2023 Jul 14. doi: 10.1111/1346-8138.16901.
    PubMed    


  277. KUROKAMI Y, Yamashita C, Yokoi K, Tonomura K, et al
    Successful hepatic arterial chemoembolization for metastatic melanoma resistant to immune checkpoint inhibitors in an extremely aged patient.
    J Dermatol. 2023 Jul 12. doi: 10.1111/1346-8138.16894.
    PubMed    


  278. IKUNO Y, Takahashi T, Yamaguchi A, Kato T, et al
    Cutaneous infection by Mycobacterium lentiflavum diagnosed by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS).
    J Dermatol. 2023 Jul 12. doi: 10.1111/1346-8138.16881.
    PubMed    


  279. REYES S, Vazquez-Lopez F, Galache C, Diaz-Louzao C, et al
    Premature chondrodermatitis nodularis (<61 years): Another acquired perforating dermatosis with a potential association with diabetes mellitus in a two-centre, case-control, retrospective, 22-year study.
    J Dermatol. 2023 Jul 9. doi: 10.1111/1346-8138.16886.
    PubMed    


  280. SHIMIZU T, Sawamura M, Kondoh A, Yarita K, et al
    A rare case of deep cutaneous fungal infection caused by a Didymellaceae species.
    J Dermatol. 2023 Jul 9. doi: 10.1111/1346-8138.16882.
    PubMed    


  281. MORIMOTO H, Oba M, Shirahama S, Tokura Y, et al
    Docetaxel-induced psoriasis with positive scratch patch test.
    J Dermatol. 2023 Jul 6. doi: 10.1111/1346-8138.16885.
    PubMed    


  282. HAGINO T, Saeki H, Fujimoto E, Kanda N, et al
    Background factors predicting the occurrence of herpes zoster in atopic dermatitis patients treated with upadacitinib.
    J Dermatol. 2023 Jul 3. doi: 10.1111/1346-8138.16879.
    PubMed     Abstract available


  283. YONEKURA S, Endo Y, Fujii H, Ishikawa M, et al
    Clinical benefit of switching from paclitaxel to docetaxel or vice versa in cutaneous angiosarcoma patients resistant to first taxane chemotherapy.
    J Dermatol. 2023 Jul 3. doi: 10.1111/1346-8138.16873.
    PubMed     Abstract available


  284. JIANG Y, Huang Y, Ma G, Liu T, et al
    Granulomatous rosacea in Chinese patients: Clinical-histopathological analysis and pathogenesis exploration.
    J Dermatol. 2023;50:856-868.
    PubMed     Abstract available


  285. WANG J, Gao P, Cao Q, Chen F, et al
    Haplotype-based non-invasive prenatal diagnosis of recessive dystrophic epidermolysis bullosa via targeted capture sequencing of maternal plasma.
    J Dermatol. 2023;50:946-950.
    PubMed     Abstract available


  286. FUKUMOTO T, Horita N, Yoshioka A
    Recurrent palmoplantar pustulosis at the site of insertion of therapeutic titanium.
    J Dermatol. 2023;50:e223-e225.
    PubMed    


  287. ZHAN J, Chen F, Jin Y, Yan L, et al
    Blaschko linear lupus erythematosus treated with baricitinib: A case report.
    J Dermatol. 2023;50:e213-e215.
    PubMed    


  288. MATSUSHITA T, Fushida N, Horii M, Mizumaki K, et al
    Authors' reply to "a case of juvenile amyopathic dermatomyositis with anti-transcription intermediary factor 1-alpha antibody showing negative anti-TIF1-gamma ELISA results: Comment on the article by Mizumaki et al.".
    J Dermatol. 2023;50:e228-e229.
    PubMed    


  289. OKUNO S, Hashimoto T, Yamazaki Y, Okuzawa M, et al
    IL-31 and IL-31 receptor alpha in pemphigus: Contributors to more than just itch?
    J Dermatol. 2023;50:927-930.
    PubMed     Abstract available


  290. ZHOU J, Bian H, Wu N
    Protein inhibitor of activated STAT3 (PIAS3) attenuates psoriasis and associated inflammation.
    J Dermatol. 2023 Jul 1. doi: 10.1111/1346-8138.16874.
    PubMed     Abstract available


    June 2023
  291. MA J, Chen YH, Chiang CP, Wang WM, et al
    Hormone replacement therapy did not increase risk of melanoma in Chinese female with menopausal and postmenopausal disorders: A population-based retrospective cohort study in Taiwan.
    J Dermatol. 2023 Jun 27. doi: 10.1111/1346-8138.16859.
    PubMed     Abstract available


  292. YAMAZAKI N, Kiyohara Y, Uhara H, Tsuchida T, et al
    Postmarketing surveillance of nivolumab plus ipilimumab combination therapy in Japanese patients with unresectable malignant melanoma.
    J Dermatol. 2023 Jun 22. doi: 10.1111/1346-8138.16820.
    PubMed     Abstract available


  293. CHEN C, Che K, Guo Y, Huang Q, et al
    Effect of the age of onset on epidemiology, clinical features, and comorbidity of geriatric psoriasis.
    J Dermatol. 2023 Jun 22. doi: 10.1111/1346-8138.16856.
    PubMed     Abstract available


  294. JO SJ, Huang YH, Tsai TF, Kim BS, et al
    Efficacy of guselkumab in difficult-to-treat psoriasis regions: Data from VOYAGE 1 and VOYAGE 2 Asian subpopulations.
    J Dermatol. 2023 Jun 21. doi: 10.1111/1346-8138.16865.
    PubMed     Abstract available


  295. INOUE T, Watabe D, Akasaka K, Sasaki T, et al
    Refractory atopic dermatitis in a child with hypomorphic mutation in XIAP gene and low serum IgG.
    J Dermatol. 2023 Jun 19. doi: 10.1111/1346-8138.16869.
    PubMed    


  296. HAGINO T, Saeki H, Kanda N
    Two cases of generalized pustular psoriasis successfully treated with bimekizumab.
    J Dermatol. 2023 Jun 19. doi: 10.1111/1346-8138.16866.
    PubMed    


  297. HAYAKAWA M, Baba Y, Kouno M, Ishii K, et al
    Dermoscopy in the diagnosis and treatment of childhood granulomatous periorificial dermatitis.
    J Dermatol. 2023 Jun 13. doi: 10.1111/1346-8138.16858.
    PubMed    


  298. SAKASHITA C, Matsushima Y, Yokota N, Kitagawa H, et al
    Exacerbation of generalized pustular psoriasis after administration of granulocyte colony-stimulating factor in a patient with intravascular large B-cell lymphoma.
    J Dermatol. 2023 Jun 13. doi: 10.1111/1346-8138.16862.
    PubMed    


  299. KISHIMOTO M, Komine M, Okada H, Sato A, et al
    Three cases of subcorneal pustular dermatosis with immunohistochemical examinations.
    J Dermatol. 2023 Jun 8. doi: 10.1111/1346-8138.16850.
    PubMed     Abstract available


  300. O'CONNOR C, Byrne B, Roche D, O'Connell G, et al
    Biological and JAK inhibitor therapy outcomes for severe psoriasis in trisomy 21.
    J Dermatol. 2023 Jun 8. doi: 10.1111/1346-8138.16851.
    PubMed     Abstract available


  301. NWIKUE G, Olsson-Brown A, Aboheimed N, Yip V, et al
    TNF-alpha induced extracellular release of keratinocyte high-mobility group box 1 in Stevens-Johnson syndrome/toxic epidermal necrolysis: Biomarker and putative mechanism of pathogenesis.
    J Dermatol. 2023 Jun 2. doi: 10.1111/1346-8138.16847.
    PubMed     Abstract available


  302. LINDEMANN H, Bonetzki T, Frank J
    Diagnostic spectrum and therapeutic efficiency in teledermatology-Results of the largest cohort study to date.
    J Dermatol. 2023;50:800-803.
    PubMed     Abstract available


  303. KOYANAGI S, Koizumi J, Nakase K, Hayashi N, et al
    Increased frequency of clindamycin-resistant Cutibacterium acnes strains isolated from Japanese patients with acne vulgaris caused by the prevalence of exogenous resistance genes.
    J Dermatol. 2023;50:793-799.
    PubMed     Abstract available


  304. PAIK K, Kim BR, Youn SW
    Evaluation of the area subscore of the Palmoplantar Pustulosis Area and Severity Index using an attention U-net deep learning algorithm.
    J Dermatol. 2023;50:787-792.
    PubMed     Abstract available


  305. WASHRAWIRUL C, Puaratana-Arunkon T, Chongpison Y, Noppakun N, et al
    The role of the topical nasal decongestant oxymetazoline as a novel therapeutic option for post-acne erythema: A split-face, double-blind, randomized, placebo-controlled trial.
    J Dermatol. 2023;50:739-745.
    PubMed     Abstract available


  306. LEE JW, Heo YW, Lee JH, Lee S, et al
    Epidemiology and comorbidity of hidradenitis suppurativa in Korea for 17 years: A nationwide population-based cohort study.
    J Dermatol. 2023;50:778-786.
    PubMed     Abstract available


  307. WU XG, Yan S, Jiang JQ, Zhou TT, et al
    Successful treatment of epidermolysis bullosa pruriginosa by dupilumab.
    J Dermatol. 2023;50:837-842.
    PubMed     Abstract available


  308. FUKAURA R, Takeichi T, Ebata A, Muro Y, et al
    COVID-19 infection- and vaccination-related exacerbation of Darier's disease in a single patient.
    J Dermatol. 2023;50:833-836.
    PubMed     Abstract available


  309. SUNAGAWA K, Manabe K, Hamada T
    Dermatofibrosarcoma protuberans coexisting with sarcoid reaction in a patient with sarcoidosis.
    J Dermatol. 2023;50:e194-e195.
    PubMed    


  310. LEE JW, Yu DA, Cho S, Youn SW, et al
    Hair loss after drug reaction with eosinophilia and systemic symptoms (DRESS): A multicentric retrospective case series.
    J Dermatol. 2023;50:814-819.
    PubMed     Abstract available


  311. SUGIHARA N, Kamiya K, Nakano N, Suzuki M, et al
    A case of bullous pemphigoid developing after ixekizumab therapy for pityriasis rubra pilaris.
    J Dermatol. 2023;50:e185-e186.
    PubMed    


  312. ISHIKAWA M, Endo Y, Yamazaki S, Sekiguchi A, et al
    Real-world effectiveness and safety of bosentan in Japanese patients with systemic sclerosis: A single-center retrospective study.
    J Dermatol. 2023;50:828-832.
    PubMed     Abstract available


  313. ISHINO T, Myangat TM, Sawamura S, Kajihara I, et al
    Elevation of cell-free DNA in patients with clinically amyopathic dermatomyositis.
    J Dermatol. 2023;50:e189-e191.
    PubMed    


  314. BARIT JJ, Hiroyasu S, Terashima Y, Ayano Y, et al
    Hereditary angioedema with normal C1 inhibitor with steroid responsiveness in a patient with psychiatric comorbidities.
    J Dermatol. 2023;50:e187-e188.
    PubMed    


  315. TAKEI S, Hayashi R, Katsumi T, Ansai O, et al
    A case of epidermolysis bullosa simplex-Ogna with nail involvement.
    J Dermatol. 2023;50:e177-e178.
    PubMed    


    May 2023
  316. LI D, Chen J, Chen M, Tang Y, et al
    A case of progressive crossed hemiatrophy mistaken as panniculitis.
    J Dermatol. 2023 May 30. doi: 10.1111/1346-8138.16814.
    PubMed     Abstract available


  317. HIRAI Y, Asada H, Hamada T, Kawada JI, et al
    Diagnostic and disease severity determination criteria for hydroa vacciniforme lymphoproliferative disorders and severe mosquito bite allergy.
    J Dermatol. 2023 May 30. doi: 10.1111/1346-8138.16842.
    PubMed     Abstract available


  318. SUGIHARA N, Kamiya K, Kado S, Kishimoto M, et al
    Single-center survey of incidental imaging findings on computed tomography in patients with psoriasis on biologic therapy.
    J Dermatol. 2023 May 29. doi: 10.1111/1346-8138.16843.
    PubMed     Abstract available


  319. KWON IJ, Park JW, Kim SM, Lee KH, et al
    Allergen-specific immunotherapy improves alopecia totalis in a severe atopic dermatitis patient.
    J Dermatol. 2023 May 29. doi: 10.1111/1346-8138.16841.
    PubMed     Abstract available


  320. HAULRIG MB, Loft N, Schwarz CW, Hertz FB, et al
    Urinary tract infections in Danish patients with psoriasis initiating their first biological treatment.
    J Dermatol. 2023 May 24. doi: 10.1111/1346-8138.16846.
    PubMed    


  321. KURIYAMA Y, Endo Y, Oka A, Ishii N, et al
    Two cases of granular C3 dermatosis with IgA antitransglutaminase 2 antibodies showing linear dermatitis-like clinical features.
    J Dermatol. 2023 May 19. doi: 10.1111/1346-8138.16826.
    PubMed    


  322. XU Q, Chi C, Tang Z
    Disseminated molluscum contagiosum after secukinumab: Unreported adverse effect?
    J Dermatol. 2023 May 14. doi: 10.1111/1346-8138.16831.
    PubMed    


  323. OKAMOTO M, Yamamoto T, Sugiyama S, Sunada M, et al
    Positron emission tomography and computed tomography imaging in primary cutaneous nocardiosis with osteomyelitis clinically mimicking soft tissue sarcoma.
    J Dermatol. 2023 May 14. doi: 10.1111/1346-8138.16827.
    PubMed    


  324. KOCHI Y, Miyachi H, Tagashira R, Koga H, et al
    Simultaneous development of generalized pustular psoriasis and pemphigoid with multiple autoantibodies in a complete responder of pembrolizumab for lung cancer.
    J Dermatol. 2023 May 14. doi: 10.1111/1346-8138.16832.
    PubMed     Abstract available


  325. ZHANG Y, Le Y, Guo J, Wu F, et al
    Barrier function and ultrastructure characteristics of epidermis in patients with primary cutaneous amyloidosis.
    J Dermatol. 2023 May 8. doi: 10.1111/1346-8138.16819.
    PubMed     Abstract available


  326. PICCERILLO A, Cappilli S, Costantini A, Peris K, et al
    Sonidegib for the treatment of advanced basal cell carcinoma in a liver transplant recipient.
    J Dermatol. 2023 May 8. doi: 10.1111/1346-8138.16818.
    PubMed    


  327. MA L, Zhang L, Kobayashi M, Tao X, et al
    Efficacy and safety of crisaborole ointment in Chinese and Japanese patients aged >/=2 years with mild-to-moderate atopic dermatitis.
    J Dermatol. 2023 May 8. doi: 10.1111/1346-8138.16792.
    PubMed     Abstract available


  328. SAEKI H, Mabuchi T, Asahina A, Abe M, et al
    English version of Japanese guidance for the use of oral Janus kinase inhibitors (JAK1 and TYK2 inhibitors) in the treatments of psoriasis.
    J Dermatol. 2023;50:e138-e150.
    PubMed     Abstract available


  329. LING X, Shou X, Lou Y, Ling J, et al
    Research progress of omalizumab in the treatment of bullous pemphigoid.
    J Dermatol. 2023;50:575-587.
    PubMed     Abstract available


  330. WEILAND T, Sadoghi B, Pondorfer P, Kiss P, et al
    Trichoblastic carcinosarcoma of the neck: Case report and molecular analysis of a seldom, relapsing entity and a review of the literature.
    J Dermatol. 2023;50:700-704.
    PubMed     Abstract available


  331. LEE H, Choi YW, Kim YC, Choi JW, et al
    Association between the first exposure to general anesthesia and alopecia areata.
    J Dermatol. 2023;50:672-678.
    PubMed     Abstract available


  332. HALASI A, Szegedi A, Torocsik D, Varga J, et al
    Psoriatic arthritis and its special features predispose not only for osteoporosis but also for fractures and falls.
    J Dermatol. 2023;50:608-614.
    PubMed     Abstract available


  333. SUZUKI R, Numata T, Hiruma J, Maeda T, et al
    Wolf's isotopic response after tinea corporis caused by Microsporum canis.
    J Dermatol. 2023;50:e159-e161.
    PubMed    


  334. KOSAKA K, Yasuda M, Kim J, Saito S, et al
    Multiple keratoacanthomas induced by treatment with dasatinib and bosutinib for chronic myeloid leukemia: A case report and literature review.
    J Dermatol. 2023;50:e171-e172.
    PubMed    


  335. TANAKA N, Nakatani S, Yahiro C, Takai T, et al
    Erythema multiforme associated with cancer radiotherapy: A single-institution case series and literature review.
    J Dermatol. 2023;50:656-663.
    PubMed     Abstract available


  336. HIRAIWA T, Yamamoto T
    Successful treatment with phototherapy for acquired reactive perforating collagenosis subsequently exacerbated following improvement of diffuse erythema induced by immune checkpoint inhibitors.
    J Dermatol. 2023;50:e164-e165.
    PubMed    


  337. FUJII K, Kirishima M, Yoshimitsu M, Hashiguchi T, et al
    Adult T-cell leukemia/lymphoma presenting with ulceration of the digits.
    J Dermatol. 2023;50:e168-e170.
    PubMed    


  338. WANG Y, Song Z, Gao Y, Yin Y, et al
    Nailfold capillary abnormalities: A predictor of psoriatic arthritis?
    J Dermatol. 2023;50:e166-e167.
    PubMed    


  339. IRAHARA M, Yamamoto-Hanada K, Sato M, Saito-Abe M, et al
    Endotoxin concentration and persistent eczema in early childhood.
    J Dermatol. 2023;50:646-655.
    PubMed     Abstract available


  340. HIGUCHI S, Noguchi H, Matsumoto T, Kashiwada-Nakamura K, et al
    Dermatophyte antigen kit in diagnosis of onychomycosis caused by Fusarium solani.
    J Dermatol. 2023;50:e162-e163.
    PubMed    


  341. MIZAWA M, Makino T, Oshima M, Hayashi M, et al
    Two cases of generalized granuloma annulare successfully treated with an excimer laser.
    J Dermatol. 2023;50:e155-e156.
    PubMed    


  342. KAWAKAMI T, Yokoyama K, Ikeda T, Nishibata Y, et al
    Similar deposition of neutrophil extracellular traps in the dermis among COVID-19-associated IgA vasculitis, post-COVID-19 vaccination IgA vasculitis, and COVID-19-unrelated IgA vasculitis.
    J Dermatol. 2023;50:e151-e152.
    PubMed    


  343. HAMAGUCHI M, Oiso N, Sato M, Kawada A, et al
    Epidermolysis bullosa acquisita with concomitant autoantibodies to alpha3 subunit of laminin 332.
    J Dermatol. 2023;50:e157-e158.
    PubMed    


  344. KWON IJ, Kim T, Yoo DS, Min S, et al
    Clinical effect of omalizumab as an adjuvant treatment to rituximab in patient with refractory bullous pemphigoid.
    J Dermatol. 2023;50:705-709.
    PubMed     Abstract available


    April 2023
  345. YAMAMOTO S, Kuriyama H, Kashiwada-Nakamura K, Kajihara I, et al
    A case of unknown primary melanoma detected with a BRAF gene mutation from a pleural fluid cell block.
    J Dermatol. 2023 Apr 23. doi: 10.1111/1346-8138.16812.
    PubMed    


  346. LU KL, Wang YH, Ting SW, Sun PL, et al
    Cutaneous infection caused by Purpureocillium lilacinum: Case reports and literature review of infections by Purpureocillium and Paecilomyces in Taiwan.
    J Dermatol. 2023 Apr 20. doi: 10.1111/1346-8138.16806.
    PubMed     Abstract available


  347. SHIMADA S, Myangat TM, Kajihara I, Sawamura S, et al
    Increased circulating exosomal Janus kinase 2 messenger RNA levels in psoriasis.
    J Dermatol. 2023 Apr 18. doi: 10.1111/1346-8138.16804.
    PubMed    


  348. MATSUYOSHI N, Oya K, Nomura T
    Skin fragility: Caution is required with the use of pain relief patches during enfortumab vedotin treatment.
    J Dermatol. 2023 Apr 18. doi: 10.1111/1346-8138.16809.
    PubMed    


  349. SANAGAWA A, Hayakawa T, Nishida E, Yamamoto A, et al
    Impact of body mass index on the severity of bexarotene-associated hypertriglyceridemia: A post hoc analysis of an open-labeled clinical study of combined bexarotene and phototherapy in Japanese patients with cutaneous T-cell lymphoma.
    J Dermatol. 2023 Apr 11. doi: 10.1111/1346-8138.16801.
    PubMed     Abstract available


  350. TAKEMOTO K, Makino T, Kagoyama K, Furukawa F, et al
    Immune thrombocytopenic purpura caused by immune checkpoint inhibitors for uveal malignant melanoma.
    J Dermatol. 2023 Apr 5. doi: 10.1111/1346-8138.16800.
    PubMed    


  351. IKUMI N, Fujita H
    Generalized pustular psoriasis occurring in a patient with multiple sclerosis during treatment with fingolimod.
    J Dermatol. 2023 Apr 5. doi: 10.1111/1346-8138.16802.
    PubMed    


  352. KANAMOTO M, Takahagi S, Aoyama S, Kido Y, et al
    The expression of prolyl isomerase Pin1 is expanded in the skin of patients with atopic dermatitis and facilitates IL-33 expression in HaCaT cells.
    J Dermatol. 2023;50:462-471.
    PubMed     Abstract available


  353. KOSANO M, Kiniwa Y, Mikoshiba A, Iwaya M, et al
    Clinical features of pagetoid spread: Analysis of perianal lesions associated with anal canal adenocarcinoma and perianal primary extramammary Paget disease.
    J Dermatol. 2023;50:546-550.
    PubMed     Abstract available


  354. CHEN YW, Chang YL, Wu CY, Chen YJ, et al
    Prevalence of acne in Taiwan: A 13-year population-based retrospective study.
    J Dermatol. 2023;50:568-570.
    PubMed    


  355. WENSINK D, Wagenmakers MAEM, Wilson JHP, Langendonk JG, et al
    Erythropoietic protoporphyria in the Netherlands: Clinical features, psychosocial impact and the effect of afamelanotide.
    J Dermatol. 2023;50:445-452.
    PubMed     Abstract available


  356. CHEN Q, Hu B, Wan L, Hu L, et al
    Three cases of refractory bullous pemphigoid in the elderly treated successfully with ultra-low-dose rituximab.
    J Dermatol. 2023;50:561-564.
    PubMed     Abstract available


  357. ISEI M, Nakata J, Deno R, Sugihara F, et al
    Langerhans cell histiocytosis associated with primary myelofibrosis presenting as disseminated maculopapular rash.
    J Dermatol. 2023;50:e133-e134.
    PubMed    


  358. CHANG YH, Yang HS, Huang HY, Lee JY, et al
    A possible role for second-hit postzygotic GJB2 mutation in porokeratotic eccrine ostial and dermal duct nevus.
    J Dermatol. 2023;50:556-560.
    PubMed     Abstract available


  359. NAKAJIMA Y, Fusumae T, Hirai I, Nakamura Y, et al
    Congenital dermatofibrosarcoma protuberans presenting as a depressed plaque: Clinical presentation and chronology.
    J Dermatol. 2023;50:e127-e128.
    PubMed    


  360. ZHANG S, Zhu QL, Xiao MS, Liu J, et al
    The value of dermoscopy and high-frequency ultrasound in staging morphea.
    J Dermatol. 2023;50:511-517.
    PubMed     Abstract available


  361. SAMUELOV L, Shehadeh W, Sarig O, Gat A, et al
    Ustekinumab therapy for Netherton syndrome.
    J Dermatol. 2023;50:494-499.
    PubMed     Abstract available


  362. TAKEUCHI S, Fukuda K, Tanaka R, Funakoshi T, et al
    Successful management of tumor necrosis factor-alpha inhibitor-induced erythema multiforme by switching to a Janus kinase inhibitor in a patient with rheumatoid arthritis and ulcerative colitis.
    J Dermatol. 2023;50:e117-e118.
    PubMed    


  363. ROH WS, Oh J, Lee MG, Kim TG, et al
    Elevated serum IgE levels are not associated with poor treatment outcome in psoriasis vulgaris.
    J Dermatol. 2023 Apr 1. doi: 10.1111/1346-8138.16795.
    PubMed     Abstract available


  364. RINDLER K, Tschandl P, Levine JP, Shaw LE, et al
    Single-cell RNA sequencing analysis of a COVID-19-associated maculopapular rash in a patient with psoriasis treated with ustekinumab.
    J Dermatol. 2023 Apr 1. doi: 10.1111/1346-8138.16793.
    PubMed     Abstract available


    March 2023
  365. TANG Z, Shen M, Man X
    Association between atopic dermatitis and hidradenitis suppurativa: A two-sample Mendelian randomization study.
    J Dermatol. 2023 Mar 29. doi: 10.1111/1346-8138.16796.
    PubMed    


  366. NINOMIYA R, Nishijima T, Aoshima M, Sakaguchi H, et al
    Sensory irritation to methylparaben is caused by its low metabolism in the skin.
    J Dermatol. 2023 Mar 22. doi: 10.1111/1346-8138.16775.
    PubMed     Abstract available


  367. KISHIMOTO M, Komine M, Kamiya K, Sugai J, et al
    Four-year drug survival of apremilast in patients with psoriasis.
    J Dermatol. 2023 Mar 20. doi: 10.1111/1346-8138.16766.
    PubMed     Abstract available


  368. SAKAMOTO K, Takatsuka I, Takemura T, Ono T, et al
    Identification of skin-infiltrating donor lymphocytes in a case of pre-engraftment syndrome.
    J Dermatol. 2023 Mar 20. doi: 10.1111/1346-8138.16785.
    PubMed    


  369. KIM YS, Park GS, Chung YJ, Lee JH, et al
    Whole-exome sequencing of secondary tumors arising from nevus sebaceous revealed additional genomic alterations besides RAS mutations.
    J Dermatol. 2023 Mar 20. doi: 10.1111/1346-8138.16784.
    PubMed     Abstract available


  370. YOKOTA N, Kondo M, Matsushima Y, Habe K, et al
    Epstein-Barr virus DNA measurement in skin tumor lesions might be a sensitive diagnostic marker of recurrence in patients with nasal-type extranodal NK/T-cell lymphoma: A case report.
    J Dermatol. 2023 Mar 20. doi: 10.1111/1346-8138.16788.
    PubMed    


  371. FUJIMURA T, Maekawa T, Kato H, Ito T, et al
    Treatment for taxane-resistant cutaneous angiosarcoma: A multicenter study of 50 Japanese cases.
    J Dermatol. 2023 Mar 20. doi: 10.1111/1346-8138.16786.
    PubMed     Abstract available


  372. HAMAGUCHI M, Ohara Y, Nakajima M, Wakasa T, et al
    Nevus anemicus with immature melanogenesis and droplets of melanocytes in a patient with nevus anemicus, nevus flammeus, and mixed vascular nevus.
    J Dermatol. 2023 Mar 20. doi: 10.1111/1346-8138.16787.
    PubMed    


  373. NAPOLITANO M, Fabbrocini G, Patruno C
    Dupilumab-associated cutaneous adverse events among adult patients with atopic dermatitis: A retrospective study.
    J Dermatol. 2023 Mar 13. doi: 10.1111/1346-8138.16764.
    PubMed     Abstract available


  374. OCHI A, Mitsui Y, Ogawa K, Nakamura S, et al
    Pyodermatitis-pyostomatitis vegetans affecting peristomal skin.
    J Dermatol. 2023 Mar 13. doi: 10.1111/1346-8138.16778.
    PubMed    


  375. HAGINO T, Saeki H, Fujimoto E, Kanda N, et al
    Efficacy and safety of baricitinib treatment for moderate to severe atopic dermatitis in real-world practice in Japan.
    J Dermatol. 2023 Mar 8. doi: 10.1111/1346-8138.16763.
    PubMed     Abstract available


  376. KAIZUKA T, Kurihara R, Harumiya M, Kimura T, et al
    Final analysis of a post-marketing surveillance study of dabrafenib and trametinib combination therapy in Japanese patients with unresectable malignant melanoma with BRAF V600 mutation.
    J Dermatol. 2023 Mar 8. doi: 10.1111/1346-8138.16759.
    PubMed     Abstract available


  377. MAEJIMA E, Oishi N, Ogawa Y, Okamoto T, et al
    Cutaneous involvement of high-grade B-cell lymphoma with MYC and BCL6 rearrangements: A case report.
    J Dermatol. 2023 Mar 8. doi: 10.1111/1346-8138.16768.
    PubMed    


  378. IMAFUKU S, Tada Y, Hippeli L, Banerjee S, et al
    Efficacy and safety of the selective TYK2 inhibitor, deucravacitinib, in Japanese patients with moderate to severe plaque psoriasis: Subgroup analysis of a randomized, double-blind, placebo-controlled, global phase 3 trial.
    J Dermatol. 2023 Mar 7. doi: 10.1111/1346-8138.16740.
    PubMed     Abstract available


  379. WANG R, Wang A, Wang M
    Two cases with bullous pemphigoid relapsed after using interleukin-17A inhibitors for psoriasis: A paradoxical reaction.
    J Dermatol. 2023 Mar 7. doi: 10.1111/1346-8138.16765.
    PubMed     Abstract available


  380. WANG L, Wang Y, Wang XE, Chen B, et al
    Causal association between atopic eczema and inflammatory bowel disease: A two-sample bidirectional Mendelian randomization study of the East Asian population.
    J Dermatol. 2023;50:327-336.
    PubMed     Abstract available


  381. IMAFUKU S
    Recent advance in management of herpes simplex in Japan.
    J Dermatol. 2023;50:299-304.
    PubMed     Abstract available


  382. KUROKAMI Y, Ueda-Hayakawa I, Fujimoto M
    Etanercept-induced erythema nodosum in a patient with rheumatoid arthritis: Case report and literature review.
    J Dermatol. 2023;50:e108-e109.
    PubMed    


  383. YASUDA M, Shang C, Yamanaka M, Amano H, et al
    Mycosis fungoides responded to dasatinib for acute lymphoblastic leukemia.
    J Dermatol. 2023;50:e106-e107.
    PubMed    


  384. KAWASHIMA M, Watanabe D, Fujio K, Komazaki H, et al
    A phase 3, randomized, double-blind, placebo-controlled study evaluating a single, patient-initiated dose of amenamevir for recurrent herpes labialis.
    J Dermatol. 2023;50:311-318.
    PubMed     Abstract available


  385. HASHIMOTO T, Okuzawa M, Yamamoto M, Okuno S, et al
    Increased touch-evoked itch (punctate hyperknesis) in postherpetic itch: Implications of reduced intraepidermal nerve fibers representing small fiber neuropathy.
    J Dermatol. 2023;50:393-396.
    PubMed     Abstract available


  386. KOBAYASHI H, Pozo FM, Sakai W, Sato K, et al
    Identification of novel mutations and reassignment of archival xeroderma pigmentosum group C cell strains from Japanese patients.
    J Dermatol. 2023;50:407-408.
    PubMed    


  387. YAMAMOTO M, Saito M, Yamamoto T
    Unilateral periorbital lupus erythematosus tumidus mimicking heliotrope rash.
    J Dermatol. 2023;50:e100-e101.
    PubMed    


  388. UESUGI-UCHIDA S, Fujisaki M, Sekine S, Takenao C, et al
    Non-episodic angioedema with eosinophilia developing after influenza vaccination: A case report.
    J Dermatol. 2023;50:e96-e97.
    PubMed    


  389. KATSUO K, Otani T, Sano H
    Apocrine adenocarcinoma of the axilla encapsulated by a fibrous capsule: A resemblance to encapsulated papillary carcinoma of the breast.
    J Dermatol. 2023;50:e102-e103.
    PubMed    


  390. LIU J, Chen Z, Hu L, Song Z, et al
    Investigation of Nagashima-type palmoplantar keratoderma in China: A cross-sectional study of 234 patients.
    J Dermatol. 2023;50:375-382.
    PubMed     Abstract available


  391. OGAWA S, Tayama J, Murota H, Kobayashi M, et al
    Association of primary focal hyperhidrosis with anxiety induced by sweating: A cross-sectional study of Japanese university students focusing on the severity of hyperhidrosis and site of sweating.
    J Dermatol. 2023;50:364-374.
    PubMed     Abstract available


  392. YAGI S, Yasuno S, Ansai O, Hayashi R, et al
    Different degree of loss-of-function among four missense mutations in the EDAR gene responsible for autosomal recessive hypohidrotic ectodermal dysplasia may be associated with the phenotypic severity.
    J Dermatol. 2023;50:349-356.
    PubMed     Abstract available


  393. KIM YS, Park GS, Bang CH, Chung YJ, et al
    Genomic landscape of multiple Bowen's disease using whole-exome sequencing.
    J Dermatol. 2023;50:397-400.
    PubMed     Abstract available


    February 2023
  394. KOMINE M, Kim H, Yi J, Zhong Y, et al
    A discrete choice experiment on oral and injection treatment preferences among moderate-to-severe psoriasis patients in Japan.
    J Dermatol. 2023 Feb 20. doi: 10.1111/1346-8138.16746.
    PubMed     Abstract available


  395. YAMASHITA C, Arase N, Fukushima K, Ueda-Hayakawa I, et al
    A case of erosive pustular dermatosis of the scalp following bullous pemphigoid in a hematopoietic stem cell transplant recipient.
    J Dermatol. 2023 Feb 16. doi: 10.1111/1346-8138.16743.
    PubMed    


  396. TERAO-HIRAYAMA K, Hasegawa A, Takei S, Katsumi T, et al
    Histiocytoid Sweet syndrome as a rare skin manifestation of relapsing polychondritis.
    J Dermatol. 2023 Feb 14. doi: 10.1111/1346-8138.16745.
    PubMed    


  397. YANASE T, Tsuruta N, Yamaguchi K, Ohata C, et al
    Survival rates of systemic interventions for psoriasis in the Western Japan Psoriasis Registry: A multicenter retrospective study.
    J Dermatol. 2023 Feb 14. doi: 10.1111/1346-8138.16737.
    PubMed     Abstract available


  398. ITAMOTO S, Yanagi T, Yabe I, Matsuno Y, et al
    Skin biopsies for diagnosing neuronal intranuclear inclusion disease: A retrospective study of 12 cases.
    J Dermatol. 2023 Feb 8. doi: 10.1111/1346-8138.16736.
    PubMed     Abstract available


  399. TANIGAWA A, Fukumoto T, Imamura S, Nakamura K, et al
    CD4/CD8 double-negative T-cell lymphoma successfully treated with a combination of bexarotene and total skin electron beam therapy.
    J Dermatol. 2023 Feb 5. doi: 10.1111/1346-8138.16739.
    PubMed    


  400. SHUKUIN R, Koizumi H, Ebata A, Imai S, et al
    Successful combination therapy of bimekizumab and granulocyte monocyte adsorption apheresis for generalized pustular psoriasis complicated with microscopic polyangiitis.
    J Dermatol. 2023 Feb 5. doi: 10.1111/1346-8138.16707.
    PubMed    


  401. TSURUTA D
    Preface to The Journal of Dermatology special issue: What's new in autoimmune bullous diseases.
    J Dermatol. 2023;50:111.
    PubMed    


  402. ISHII N
    Significance of anti-desmocollin autoantibodies in pemphigus.
    J Dermatol. 2023;50:132-139.
    PubMed     Abstract available


  403. NAKAHARA Y, Yamane M, Sunada M, Aoyama Y, et al
    SARS-CoV-2 vaccine-triggered conversion from systemic lupus erythematosus (SLE) to bullous SLE and dipeptidyl peptidase 4 inhibitors-associated bullous pemphigoid.
    J Dermatol. 2023;50:162-165.
    PubMed     Abstract available


  404. TAKAHASHI H, Iriki H, Asahina Y
    T cell autoimmunity and immune regulation to desmoglein 3, a pemphigus autoantigen.
    J Dermatol. 2023;50:112-123.
    PubMed     Abstract available


  405. JOHNSTON DGW, Hambly R, Kearney N, Tobin DJ, et al
    Cell-free DNA is elevated in the serum of patients with hidradenitis suppurativa.
    J Dermatol. 2023;50:271-273.
    PubMed    


  406. YAMAGAMI J
    B-cell targeted therapy of pemphigus.
    J Dermatol. 2023;50:124-131.
    PubMed     Abstract available


  407. HIROYASU S, Barit JJG, Hiroyasu A, Tsuruta D, et al
    Pruritogens in pemphigoid diseases: Possible therapeutic targets for a burdensome symptom.
    J Dermatol. 2023;50:150-161.
    PubMed     Abstract available


  408. MIYACHI H, Konishi T, Hashimoto Y, Matsui H, et al
    Clinical course and outcomes of pemphigus vulgaris and foliaceus: A retrospective study using a nationwide database in Japan.
    J Dermatol. 2023;50:212-221.
    PubMed     Abstract available


  409. UJIIE H
    What's new in the pathogeneses and triggering factors of bullous pemphigoid.
    J Dermatol. 2023;50:140-149.
    PubMed     Abstract available


  410. REHAN ST, Khan Z, Abbas S, Imran L, et al
    Role of topical spironolactone in the treatment of acne: A systematic review of clinical trials-Does this therapy open a path towards favorable outcomes?
    J Dermatol. 2023;50:166-174.
    PubMed     Abstract available


  411. ASAKAWA R, Ogawa Y, Maejima E, Honobe-Tabuchi A, et al
    Case of bullous pemphigoid refractory to corticosteroids by antiepileptic drug-induced CYP3A4.
    J Dermatol. 2023;50:254-257.
    PubMed     Abstract available


  412. MIYAZAKI A, Takeichi T, Tanahashi K, Taki T, et al
    Whole-exome sequencing reveals a retinitis pigmentosa-causative PRPH2 variant as a secondary finding in a patient with pseudoxanthoma elasticum.
    J Dermatol. 2023;50:e85-e86.
    PubMed    


  413. ISHIDA H, Noriki S, Mochizuki T
    Diagnostic clue for dermatophytoma using the dermatophyte test strip.
    J Dermatol. 2023;50:e87-e88.
    PubMed    


  414. MATSUOKA A, Higashi Y, Kanekura T
    Erythema nodosum at COVID-19 vaccine injection site.
    J Dermatol. 2023;50:e83-e84.
    PubMed    


  415. YAMAGAMI J, Kurihara Y, Funakoshi T, Saito Y, et al
    Rituximab therapy for intractable pemphigus: A multicenter, open-label, single-arm, prospective study of 20 Japanese patients.
    J Dermatol. 2023;50:175-182.
    PubMed     Abstract available


  416. KAWAGUCHI A, Matsuda M, Koga H, Ohata C, et al
    Anti-desmoglein 1 antibody-positive mother and antibody-negative child with Darier's disease.
    J Dermatol. 2023;50:250-253.
    PubMed     Abstract available


  417. KANEYASU H, Takahashi K, Ohta N, Okada S, et al
    Novel compound heterozygous mutations in the PLEC gene in a neonate with epidermolysis bullosa simplex with pyloric atresia.
    J Dermatol. 2023;50:239-244.
    PubMed     Abstract available


  418. CORRA A, Barei F, Genovese G, Zussino M, et al
    Five cases of new-onset pemphigus following vaccinations against coronavirus disease 2019.
    J Dermatol. 2023;50:229-233.
    PubMed     Abstract available


  419. TANAKA R, Kurihara Y, Egami S, Saito Y, et al
    Clinical severity scores as a guide for prediction of initial treatment responses in pemphigus and pemphigoid patients.
    J Dermatol. 2023;50:203-211.
    PubMed     Abstract available


  420. NORIMATSU Y, Yoshizaki A, Yamada T, Akiyama Y, et al
    Pemphigus vulgaris with advanced hypopharyngeal and gastric cancer following SARS-CoV-2 vaccination.
    J Dermatol. 2023;50:e74-e75.
    PubMed    


  421. LIU W, Sun X, Gao Y, Li H, et al
    A Chinese case of concurrent anti-laminin gamma1 pemphigoid and anti-laminin 332-type mucous membrane pemphigoid.
    J Dermatol. 2023;50:e69-e71.
    PubMed    


    January 2023
  422. HONDA KEITH Y, Otsuka A, Kogame T, Ito H, et al
    Increased type I interferon expression from T cells in lesional skin of Degos disease.
    J Dermatol. 2023 Jan 27. doi: 10.1111/1346-8138.16727.
    PubMed    


  423. LIU N, Zhang C, Hua W
    Dietary inflammatory potential and psoriasis: A cross-sectional study.
    J Dermatol. 2023 Jan 26. doi: 10.1111/1346-8138.16731.
    PubMed     Abstract available


  424. DE DECKER I, Loge T, Hoeksema H, Speeckaert MM, et al
    Dissolving microneedles for effective and painless intradermal drug delivery in various skin conditions: A systematic review.
    J Dermatol. 2023 Jan 26. doi: 10.1111/1346-8138.16732.
    PubMed     Abstract available


  425. YOSHIZAKI A, Fujii K, Kanekura T
    Neutrophilic sebaceous adenitis treated successfully with diaminodiphenyl sulfone.
    J Dermatol. 2023 Jan 26. doi: 10.1111/1346-8138.16735.
    PubMed    


  426. OHATA C, Anezaki H, Kaneko S, Okazaki F, et al
    Clinical characteristics of patients with psoriasis with family history: A multicenter observational study.
    J Dermatol. 2023 Jan 24. doi: 10.1111/1346-8138.16733.
    PubMed     Abstract available


  427. UEDA M, Kogame T, Egawa G, Kambe N, et al
    A case of Kimura disease with atopic dermatitis successfully treated with baricitinib.
    J Dermatol. 2023 Jan 20. doi: 10.1111/1346-8138.16724.
    PubMed    


  428. YUSHARYAHYA SN, Japranata VV, Jonlean R, Legiawati L, et al
    Cutaneous manifestations in elderly patients with confirmed coronavirus disease 2019 and the disease outcomes: A systematic review.
    J Dermatol. 2023 Jan 20. doi: 10.1111/1346-8138.16722.
    PubMed     Abstract available


  429. WANG WM, Jin HZ
    Biologics in pediatric psoriasis.
    J Dermatol. 2023 Jan 18. doi: 10.1111/1346-8138.16702.
    PubMed     Abstract available


  430. MURAKAMI T, Aozasa N, Fukano H, Miyamoto Y, et al
    Successful treatment of cutaneous Mycobacterium chelonae infection by switching from levofloxacin to sitafloxacin.
    J Dermatol. 2023 Jan 18. doi: 10.1111/1346-8138.16720.
    PubMed    


  431. KAMIYA S, Koizumi H, Suzuki Y, Imai S, et al
    Cutaneous manifestations of microscopic polyangiitis successfully controlled with avacopan alone.
    J Dermatol. 2023 Jan 18. doi: 10.1111/1346-8138.16726.
    PubMed    


  432. NAKASHIMA C, Kato M, Otsuka A
    Cutaneous manifestations of COVID-19 and COVID-19 vaccination.
    J Dermatol. 2023 Jan 13. doi: 10.1111/1346-8138.16651.
    PubMed     Abstract available


  433. FUJITA Y, Sugai T, Maya Y, Inamura E, et al
    Secukinumab-induced oral lichen planus in a psoriatic arthritis patient ameliorated after a switch to risankizumab.
    J Dermatol. 2023 Jan 11. doi: 10.1111/1346-8138.16719.
    PubMed     Abstract available


  434. TADA Y, Itakura A, Hosono K, Kawamura T, et al
    Psoriasis patient preferences for the use of biologics during the coronavirus era.
    J Dermatol. 2023 Jan 11. doi: 10.1111/1346-8138.16703.
    PubMed     Abstract available


  435. KISHIBE M, Koike K, Kanno K, Ishida-Yamamoto A, et al
    Autoimmunity-related neutrophilic dermatosis after coronavirus disease 2019 vaccination: A case report and literature review.
    J Dermatol. 2023 Jan 5. doi: 10.1111/1346-8138.16718.
    PubMed     Abstract available


  436. SHIMIZU A, Yamaguchi R, Kuriyama Y
    Recent advances in cutaneous HPV infection.
    J Dermatol. 2023 Jan 5. doi: 10.1111/1346-8138.16697.
    PubMed     Abstract available


  437. MALAURE C, Hoang S, Bagny K, Tauziede-Espariat A, et al
    Multifocal cutaneous phaeohyphomycosis caused by Paraconiothyrium cyclothyrioides in an immunocompromised patient: A case report.
    J Dermatol. 2023 Jan 5. doi: 10.1111/1346-8138.16706.
    PubMed    


  438. SUZUKI H, Hashimoto T, Sugiura R, Ogata H, et al
    Disseminated cutaneous hyalohyphomycosis caused by Fusarium proliferatum in a patient with aplastic anemia.
    J Dermatol. 2023 Jan 5. doi: 10.1111/1346-8138.16708.
    PubMed    


  439. ARANISHI T, Ito T, Fukuyama M, Isaka Y, et al
    Prevalence of alopecia areata in Japan: Estimates from a nationally representative sample.
    J Dermatol. 2023;50:26-36.
    PubMed     Abstract available


  440. CAMPOS-ALBERTO E, Hirose T, Napatalung L, Ohyama M, et al
    Prevalence, comorbidities, and treatment patterns of Japanese patients with alopecia areata: A descriptive study using Japan medical data center claims database.
    J Dermatol. 2023;50:37-45.
    PubMed     Abstract available


  441. MAE K, Kawakami Y, Kajita A, Takeichi T, et al
    Novel homozygous missense mutation c.1654G>T in the ALOX12B gene causing congenital ichthyosiform erythroderma.
    J Dermatol. 2023;50:e37-e38.
    PubMed    


  442. MAEDA T, Nagai K, Uehara J, Toyoshima R, et al
    Sentinel lymph node biopsy in extramammary Paget disease: A 13-year institutional experience.
    J Dermatol. 2023;50:57-63.
    PubMed     Abstract available


  443. KAGEYAMA R, Ito T, Nakazawa S, Shimauchi T, et al
    A case of telogen effluvium followed by alopecia areata after SARS-CoV-2 infection.
    J Dermatol. 2023;50:e32-e34.
    PubMed    


  444. IMURA K, Furuya K, Masuda Y, Sano Y, et al
    Nontyphoidal Salmonella subcutaneous chest wall abscess with costal osteomyelitis.
    J Dermatol. 2023;50:e35-e36.
    PubMed    


  445. KOIZUMI H, Muro Y, Imai S, Yamashita Y, et al
    A case of juvenile amyopathic dermatomyositis with anti-transcription intermediary factor 1-alpha antibody showing negative anti-TIF1-gamma ELISA results: Comment on "Case of pembrolizumab-induced dermatomyositis with anti-transcription intermediary f
    J Dermatol. 2023;50:e39-e40.
    PubMed    


  446. SANO Y, Ide K, Hasegawa T, Honda T, et al
    A case of localized pruritus on the left lower leg in a patient with spinal glioma.
    J Dermatol. 2023;50:e30-e31.
    PubMed    


  447. ARAKAWA H, Adachi T, Kobayashi Y, Inazumi T, et al
    A severe case of hidradenitis suppurativa with chronic anemia treated with adalimumab.
    J Dermatol. 2023;50:e22-e23.
    PubMed    


    December 2022
  448. YATSUZUKA K, Matsumoto T, Sakane Y, Fukaura R, et al
    The use of certolizumab pegol to successfully treat generalized pustular psoriasis combined with psoriatic uveitis.
    J Dermatol. 2022 Dec 30. doi: 10.1111/1346-8138.16704.
    PubMed    


  449. MIKAMI H, Akasaka E, Nakano H, Sawamura D, et al
    Eruptive melanocytic nevi associated with encorafenib and cetuximab combination therapy.
    J Dermatol. 2022 Dec 30. doi: 10.1111/1346-8138.16701.
    PubMed    


  450. ONITSUKA M, Farooq M, Iqbal MN, Yasuno S, et al
    A homozygous loss-of-function variant in the MPO gene is associated with generalized pustular psoriasis.
    J Dermatol. 2022 Dec 30. doi: 10.1111/1346-8138.16700.
    PubMed     Abstract available


  451. SAEKI H, Mabuchi T, Asahina A, Abe M, et al
    English version of Japanese guidance for use of biologics for psoriasis (the 2022 version).
    J Dermatol. 2022 Dec 29. doi: 10.1111/1346-8138.16691.
    PubMed     Abstract available


  452. HAN J, Stratman S, Young JN, Poplausky D, et al
    Unique protein signatures evolve during the course of a delayed-type hypersensitivity reaction in human skin.
    J Dermatol. 2022 Dec 28. doi: 10.1111/1346-8138.16688.
    PubMed     Abstract available


  453. MELIN A, Bouchereau S, Guelimi R, Bergqvist C, et al
    Safety and efficacy of high-dose clobetasol propionate 0.05% in cutaneous lichen planus.
    J Dermatol. 2022 Dec 28. doi: 10.1111/1346-8138.16689.
    PubMed     Abstract available


  454. LI J, Wen W, Mu Z, Du X, et al
    Prevalence of cutaneous manifestations in COVID-19: A meta-analysis.
    J Dermatol. 2022 Dec 20. doi: 10.1111/1346-8138.16672.
    PubMed     Abstract available


  455. SUZUKI M, Koshikawa S, Watanabe H, Inomata N, et al
    Elevated serum osteopontin levels in patients with severe cutaneous adverse drug reactions.
    J Dermatol. 2022 Dec 20. doi: 10.1111/1346-8138.16670.
    PubMed     Abstract available


  456. HONMA M, Kanai Y, Murotani K, Ito K, et al
    Effectiveness of brodalumab in improving itching and skin pain in Japanese patients with psoriasis: The ProLOGUE study.
    J Dermatol. 2022 Dec 20. doi: 10.1111/1346-8138.16682.
    PubMed     Abstract available


  457. CHEN G, Wang M, Wang P, Liang B, et al
    An intronic splice-site variant in MBTPS2 underlies ichthyosis follicularis with atrichia and photophobia syndrome.
    J Dermatol. 2022 Dec 20. doi: 10.1111/1346-8138.16684.
    PubMed     Abstract available


  458. TAKAI S, Arai E, Shojiguchi N, Nakamura Y, et al
    Application of fluorescence in situ hybridization in distinguishing acral melanoma in situ from acral junctional melanocytic nevus on the volar skin in Japanese patients.
    J Dermatol. 2022 Dec 20. doi: 10.1111/1346-8138.16681.
    PubMed     Abstract available


  459. NAKAMURA K, Ashida A, Kiniwa Y, Okuyama R, et al
    Analysis of immune-related adverse events correlated with good prognosis in melanoma treatment and fluctuating blood factors.
    J Dermatol. 2022 Dec 20. doi: 10.1111/1346-8138.16692.
    PubMed    


  460. YOKOI K, Watanabe R, Kume M, Yamane S, et al
    Melanocyte-specific CD49a(+) CD8(+) T cells in vitiligo lesion potentiate to maintain activity during systemic steroid therapy.
    J Dermatol. 2022 Dec 14. doi: 10.1111/1346-8138.16680.
    PubMed     Abstract available


  461. YAMANAKA K, Okubo Y, Yasuda I, Saito N, et al
    Efficacy and safety of risankizumab in Japanese patients with generalized pustular psoriasis or erythrodermic psoriasis: Primary analysis and 180-week follow-up results from the phase 3, multicenter IMMspire study.
    J Dermatol. 2022 Dec 13. doi: 10.1111/1346-8138.16667.
    PubMed     Abstract available


  462. KAWAKAMI T, Yokoyama K, Ikeda T, Tomizawa H, et al
    Presence of eosinophil extracellular trap cell death in the affected skin of eosinophilic granulomatosis with polyangiitis.
    J Dermatol. 2022 Dec 13. doi: 10.1111/1346-8138.16656.
    PubMed     Abstract available


  463. TAKAHASHI A, Namikawa K, Ogata D, Jinnai S, et al
    Updated analysis of nivolumab and ipilimumab combination therapy in Japanese patients with advanced melanoma.
    J Dermatol. 2022 Dec 13. doi: 10.1111/1346-8138.16669.
    PubMed     Abstract available


  464. ISHIKAWA M, Yamamoto T
    Interstitial granulomatous dermatitis in a patient with systemic lupus erythematosus presenting with rope sign.
    J Dermatol. 2022 Dec 13. doi: 10.1111/1346-8138.16674.
    PubMed    


  465. YU L, Wei L, Ma L, Li L, et al
    First report of oral atenolol for treatment of kaposiform hemangioendothelioma, a viable alternative to propranolol.
    J Dermatol. 2022 Dec 10. doi: 10.1111/1346-8138.16657.
    PubMed    


  466. ZHANG Z, Yu K, Jiang Z, Liu O, et al
    Clinical value of the prognostic nutritional index and red blood cell distribution width-to-albumin ratio for the prediction of severity of and mortality associated with Stevens-Johnson syndrome/toxic epidermal necrolysis.
    J Dermatol. 2022 Dec 7. doi: 10.1111/1346-8138.16661.
    PubMed     Abstract available


  467. YAMASAKI K, Miyachi Y
    Perspectives on rosacea patient characteristics and quality of life using baseline data from a phase 3 clinical study conducted in Japan.
    J Dermatol. 2022;49:1221-1227.
    PubMed     Abstract available


  468. WALKER AM, Bermas BL, Jacobe HT
    Morphea disease activity during pregnancy: A case series.
    J Dermatol. 2022;49:1278-1283.
    PubMed     Abstract available


  469. KIKUCHI K, Katsuyama M, Yoshikawa T, Wakeshima N, et al
    Epidemiological survey of the quantity and anatomical position of facial pigmented spots in relation to age in 454 Japanese women.
    J Dermatol. 2022;49:1245-1254.
    PubMed     Abstract available


  470. NISHIBU A, Iwanaga T, Ushigami T, Mochizuki T, et al
    A case of hidrotic ectodermal dysplasia with developing eccrine syringofibroadenoma with heterozygous mutation of GJB6 gene.
    J Dermatol. 2022;49:e451-e452.
    PubMed    


  471. HASEGAWA T, Oyama N, Kasamatsu H, Chino T, et al
    Intertriginous erythema associated with enfortumab vedotin, a nectin-4-targeting antibody-drug conjugate, in a case with metastatic urothelial cancer: Immunohistochemical evidence for molecular-targeted eruption.
    J Dermatol. 2022;49:e453-e454.
    PubMed    


  472. SAITO R, Takahagi S, Nakano F, Furutani K, et al
    A survey on subtypes and clinical characteristics of 1061 patients with urticaria in the primary care institutes in Japan.
    J Dermatol. 2022;49:1255-1262.
    PubMed     Abstract available


  473. SANCHEZ-DIAZ M, Salvador-Rodriguez L, Cuenca-Barrales C, Arias-Santiago S, et al
    Exploring the role of systemic immune-inflammation index and neutrophil-lymphocyte ratio in cardiovascular risk stratification for patients with hidradenitis suppurativa: A cross-sectional study.
    J Dermatol. 2022;49:1238-1244.
    PubMed     Abstract available


  474. KASHIWADA-NAKAMURA K, Noguchi H, Hiruma M, Tanaka M, et al
    Dermoscopic findings of sporotrichosis manifesting as a punched-out ulcer.
    J Dermatol. 2022;49:e449-e450.
    PubMed    


  475. HIRAIWA T, Yamamoto T
    Survey of the treatment outcome of patients with pustulotic arthro-osteitis associated with palmoplantar pustulosis.
    J Dermatol. 2022;49:e448.
    PubMed    


  476. YANG J, Zeng J, Lu J
    Mechanisms of ultraviolet-induced melasma formation: A review.
    J Dermatol. 2022;49:1201-1210.
    PubMed     Abstract available


  477. XU X, Pradhan S, Zhang C, Ran Y, et al
    A case of infantile tinea of vellus hair confirmed by dermoscopy and scanning electron microscopy and detection of infected source.
    J Dermatol. 2022;49:1325-1329.
    PubMed     Abstract available


  478. IKEDA T, Yokoyama K, Kawakami T
    Overlapping acute generalized exanthematous pustulosis drug reaction with eosinophilia and systemic symptoms induced by a second dose of the Moderna COVID-19 vaccine.
    J Dermatol. 2022;49:e446-e447.
    PubMed    


  479. MINAMI Y, Okamoto T, Hirotsu Y, Amemiya K, et al
    Phakomatosis pigmentovascularis type IIb with Klippel-Trenaunay syndrome: Association with GNAQ mutation in vascular endothelial cells.
    J Dermatol. 2022;49:e444-e445.
    PubMed    


  480. SEISHIMA M, Sasaki M, Sugie S
    Successful treatment of pyoderma gangrenosum using adalimumab in a patient undergoing hemodialysis.
    J Dermatol. 2022;49:e435-e436.
    PubMed    


  481. UCHIYAMA A, Kosaka K, Okada K, Motegi SI, et al
    Possible suppressive effects of tranilast on NLRP3 inflammasome activation in necrobiosis lipoidica.
    J Dermatol. 2022;49:e433-e434.
    PubMed    


  482. KINOSHITA Y, Tateishi C, Sowa-Osako J, Kusutani N, et al
    Generalized granuloma annulare with large patches on the face.
    J Dermatol. 2022;49:e426-e427.
    PubMed    


    November 2022
  483. AKATSUKA T, Toyama T, Morimura S, Komuta M, et al
    A case of primary meningeal melanocytosis treated with combination therapy with nivolumab and ipilimumab.
    J Dermatol. 2022 Nov 28. doi: 10.1111/1346-8138.16658.
    PubMed    


  484. WATANABE T, Watanabe Y, Ikeda N, Aihara M, et al
    Serum levels of C-C motif chemokine ligand 2 and interleukin-8 as possible biomarkers in patients with toxic epidermal necrolysis accompanied by acute respiratory distress syndrome.
    J Dermatol. 2022 Nov 23. doi: 10.1111/1346-8138.16647.
    PubMed     Abstract available


  485. HASUI KI, Kawakami Y, Miyake T, Hirai Y, et al
    Cutaneous toxicity with suprabasal blisters and dyskeratosis following administration of enfortumab vedotin.
    J Dermatol. 2022 Nov 22. doi: 10.1111/1346-8138.16646.
    PubMed    


  486. WATANABE T, Watanabe Y, Asai C, Asami M, et al
    Risks of malignancies among patients with psoriasis: A cohort study of 360 patients.
    J Dermatol. 2022 Nov 22. doi: 10.1111/1346-8138.16644.
    PubMed     Abstract available


  487. SAEKI H, Akiyama M, Abe M, Igarashi A, et al
    English version of Japanese guidance for the use of oral Janus kinase (JAK) inhibitors in the treatments of atopic dermatitis.
    J Dermatol. 2022 Nov 22. doi: 10.1111/1346-8138.16635.
    PubMed     Abstract available


  488. NIE XJ, Hao BZ, Zhang BL, Li YY, et al
    GATA3 ameliorates melanocyte injuries in vitiligo through SIRT3-mediated HMGB1 deacetylation.
    J Dermatol. 2022 Nov 22. doi: 10.1111/1346-8138.16634.
    PubMed     Abstract available


  489. NAKAMURA K, Ashida A, Kiniwa Y, Okuyama R, et al
    Immune status and prognosis of stage II and III primary malignant melanoma: An analysis including 77 cases of acral lentiginous melanoma.
    J Dermatol. 2022 Nov 21. doi: 10.1111/1346-8138.16650.
    PubMed    


  490. NISHIMOTO A, Ansai SI, Akaishi S, Dohi T, et al
    Keloidal dermatofibroma: Clinicopathological comparison of 52 cases with a series of 2077 other dermatofibromas.
    J Dermatol. 2022 Nov 14. doi: 10.1111/1346-8138.16638.
    PubMed     Abstract available


  491. ZHANG J, Shu J, Sun H, Zhai T, et al
    CCN1 upregulates IL-36 via AKT/NF-kappaB and ERK/CEBP beta-mediated signaling pathways in psoriasis-like models.
    J Dermatol. 2022 Nov 14. doi: 10.1111/1346-8138.16611.
    PubMed     Abstract available


  492. MARUYAMA A, Katoh N
    Subacute cutaneous lupus erythematosus successfully treated with topical delgocitinib.
    J Dermatol. 2022 Nov 14. doi: 10.1111/1346-8138.16639.
    PubMed    


  493. MIZUTANI Y, Kanai Y, Murotani K, Honma M, et al
    Treatment with brodalumab is not associated with improved sleep problems in real-life patients with plaque psoriasis: Results of the ProLOGUE study.
    J Dermatol. 2022 Nov 7. doi: 10.1111/1346-8138.16620.
    PubMed     Abstract available


  494. LIU H, Wei R, Yang Y, Zhang Z, et al
    Successful treatment with secukinumab of psoriasis-like dermatitis in a patient with holocarboxylase synthetase deficiency.
    J Dermatol. 2022 Nov 7. doi: 10.1111/1346-8138.16625.
    PubMed     Abstract available


  495. JIANG T, Liu C
    Dissecting cellulitis of the scalp with typical clinical features: A retrospective cross-sectional study in a Department of Dermatology, Beijing, China.
    J Dermatol. 2022;49:1173-1177.
    PubMed     Abstract available


  496. NOBEYAMA Y, Umezawa Y, Asahina A
    Risk of squamous cell carcinoma in immunosuppressed patients with voriconazole-related actinic keratosis.
    J Dermatol. 2022;49:1168-1172.
    PubMed     Abstract available


  497. MIYAKE R, Iwamoto K, Sakai N, Matsunae K, et al
    Uptake of Staphylococcus aureus by keratinocytes is reduced by interferon-fibronectin pathway and filaggrin expression.
    J Dermatol. 2022;49:1148-1157.
    PubMed     Abstract available


  498. LI J, Tang JY, Fu J, Zhang MW, et al
    Carvedilol ameliorates persistent erythema of erythematotelangiectatic rosacea by regulating the status of anxiety/depression.
    J Dermatol. 2022;49:1139-1147.
    PubMed     Abstract available


  499. JIANG X, Wang Z, Lin Z, Xu Z, et al
    Incompletely penetrant TRPM4-associated progressive symmetric erythrokeratodermia responses to methotrexate.
    J Dermatol. 2022;49:e422-e423.
    PubMed    


  500. HONMA M, Sugawara M, Ueno N, Honma M, et al
    Clinical characteristics of peristomal pyoderma gangrenosum: A Single Center Retrospective Observational Study.
    J Dermatol. 2022;49:1178-1182.
    PubMed     Abstract available


  501. SASAOKA Y, Kotobuki Y, Fujimoto R, Tonomura K, et al
    A case of anti-RNA polymerase III antibody-positive systemic sclerosis with generalized morphea-like lesions correlated with elevation of peripheral eosinophil counts.
    J Dermatol. 2022;49:e417-e418.
    PubMed    


  502. KIDA A, Hayashi S, Ueno Y, Kitano H, et al
    Severe clinical manifestations in an extremely low birthweight preterm baby with vascular Ehlers-Danlos syndrome.
    J Dermatol. 2022;49:e411-e412.
    PubMed    


  503. CHEN H, Zhang G, Zhang P, Long H, et al
    Case of borderline leprosy presenting with urticaria-like eruptions and limbs swelling: A lesson to be learned for dermatologists.
    J Dermatol. 2022;49:e409-e410.
    PubMed    


  504. HIRAIWA T, Yamamoto T
    Nail lesions in palmoplantar pustulosis are not significantly associated with distal interphalangeal arthritis.
    J Dermatol. 2022;49:e403-e404.
    PubMed    


  505. LEE H, Song WJ, Koh SJ, Park H, et al
    Epidemiological association between alopecia areata and celiac disease: A meta-analysis.
    J Dermatol. 2022;49:e399-e400.
    PubMed    


  506. LIU Z, Cao X, Wan C
    Stupendous skin nodules: Necrobiotic xanthogranuloma with IgA-lambda and IgG-kappa monoclonal gammopathy.
    J Dermatol. 2022 Nov 1. doi: 10.1111/1346-8138.16622.
    PubMed    


    October 2022
  507. MORITA A, Tsai TF, Yee EYW, Okubo Y, et al
    Efficacy and safety of spesolimab in Asian patients with a generalized pustular psoriasis flare: Results from the randomized, double-blind, placebo-controlled Effisayil 1 study.
    J Dermatol. 2022 Oct 25. doi: 10.1111/1346-8138.16609.
    PubMed     Abstract available


  508. KAMIYA K, Ohtsuki M
    Epidemiological survey of patients with psoriatic arthritis in the Japanese Society for Psoriasis Research from 2017 to 2020.
    J Dermatol. 2022 Oct 19. doi: 10.1111/1346-8138.16603.
    PubMed     Abstract available


  509. SHIMODA-KOMATSU Y, Mizukawa Y, Yamazaki Y, Ohyama M, et al
    Focal hypohidrosis in lesional skin in a probable case of confluent and reticulated papillomatosis: A case report with insight into the pathomechanism of recurrence.
    J Dermatol. 2022 Oct 19. doi: 10.1111/1346-8138.16616.
    PubMed     Abstract available


  510. MIYAJI Y, Yamamoto-Hanada K, Fukuie T, Narita M, et al
    Risk factors of admission in school children with severe atopic dermatitis.
    J Dermatol. 2022 Oct 18. doi: 10.1111/1346-8138.16612.
    PubMed     Abstract available


  511. YAHIRO C, Takai T, Nakatani S, Tanaka N, et al
    Skin rash associated with combined cytotoxic chemotherapy and immunotherapy for cancer: A retrospective single-center case series.
    J Dermatol. 2022 Oct 18. doi: 10.1111/1346-8138.16614.
    PubMed     Abstract available


  512. TAKANO-KAWASAKI S, Sato E, Yamaguchi K, Imafuku S, et al
    Trends in prescriptions of oral medications for psoriasis: A single-center retrospective study.
    J Dermatol. 2022 Oct 13. doi: 10.1111/1346-8138.16593.
    PubMed     Abstract available


  513. YUKI A, Takatsuka S, Abe R, Takenouchi T, et al
    Diagnostic accuracy of dermoscopy for 934 basal cell carcinomas: A single-center retrospective study.
    J Dermatol. 2022 Oct 13. doi: 10.1111/1346-8138.16607.
    PubMed     Abstract available


  514. SASAKI-SAITO N, Yamamura K, Hitaka T, Hirano Y, et al
    BRAF N581S and NRAS Q61R-mutated malignant melanoma and sensitivity to BRAF/MEK inhibitors.
    J Dermatol. 2022 Oct 11. doi: 10.1111/1346-8138.16592.
    PubMed    


  515. TAJIMA A, Yamazaki F, Huynh TNM, Ueda-Hayakawa I, et al
    A case of palisaded neutrophilic and granulomatous dermatitis associated with systemic lupus erythematosus presenting with pustules.
    J Dermatol. 2022 Oct 11. doi: 10.1111/1346-8138.16605.
    PubMed     Abstract available


  516. ISHIGURO A, Ogata D, Okuma K, Kashihara T, et al
    Malignant melanoma treatment using brachytherapy: Two case reports and 15 case series.
    J Dermatol. 2022 Oct 4. doi: 10.1111/1346-8138.16599.
    PubMed     Abstract available


  517. CHIU YJ, Weng HY, Lin YY, Lin YF, et al
    Genomic profiling with whole-exome sequencing revealed distinct mutations and novel pathways in Asian melanoma.
    J Dermatol. 2022 Oct 2. doi: 10.1111/1346-8138.16579.
    PubMed     Abstract available


  518. FAN W, Li Z, Wang Y, Zhang C, et al
    Imputation of the major histocompatibility complex region identifies major independent variants associated with bullous pemphigoid and dermatomyositis in Han Chinese.
    J Dermatol. 2022;49:998-1004.
    PubMed     Abstract available


  519. CAO Q, Zhang S, Wang J, Wang Y, et al
    Focal facial dermal dysplasias type III: Two families with Setleis syndrome in China.
    J Dermatol. 2022;49:1057-1061.
    PubMed     Abstract available


  520. BORGIA F, Li Pomi F, Alessandrello C, Vaccaro M, et al
    Coronavirus disease 2019 and pityriasis rosea: A review of the immunological connection.
    J Dermatol. 2022;49:948-956.
    PubMed     Abstract available


  521. GONZALEZ-LOPEZ MA, Ocejo-Vinals JG, Lopez-Sundh AE, Guiral S, et al
    Biomarkers of endothelial dysfunction and atherosclerosis in hidradenitis suppurativa.
    J Dermatol. 2022;49:1052-1056.
    PubMed     Abstract available


  522. OHYAMA M, Matsudo K, Fujita T
    Management of hair loss after severe acute respiratory syndrome coronavirus 2 infection: Insight into the pathophysiology with implication for better management.
    J Dermatol. 2022;49:939-947.
    PubMed     Abstract available


  523. KAMEDA E, Matsuzawa T, Togawa Y, Ikeda JI, et al
    Case of pigmented onychomatricoma: A relationship between dermoscopic and pathological findings.
    J Dermatol. 2022;49:e397-e398.
    PubMed    


  524. VERVERI A, Laidou S, Chatzidimitriou A, Gidaris D, et al
    Patient with recurrent mosaic KRAS variant: Rare oculoectodermal syndrome with severe neurologic phenotype.
    J Dermatol. 2022;49:e381-e382.
    PubMed    


  525. MIYAGAWA A, Adachi T, Arakawa H, Hamada M, et al
    A case of refractory leg ulcers caused by micro-arteriovenous fistula: Potential utility of ultrasonography in the diagnosis.
    J Dermatol. 2022;49:e389-e390.
    PubMed    


  526. MATSUKI Y, Uetake Y, Yamashita H, Yokoyama M, et al
    Case of a cellular blue nevus with multiple satellite lesions showing radial blue-white lesion: Unique dermoscopy-histopathology correlation in blue nevus with satellitosis.
    J Dermatol. 2022;49:e386-e388.
    PubMed    


    September 2022
  527. CHROMY D, Bartosik T, Brkic FF, Quint T, et al
    Dupilumab-induced skin-associated side effects in patients with chronic rhinosinusitis with nasal polyposis.
    J Dermatol. 2022 Sep 30. doi: 10.1111/1346-8138.16595.
    PubMed     Abstract available


  528. TOYODA T, Hashimoto K, Ogawa Y, Tohyama M, et al
    Immunohistological analysis of pathogenic infiltrates in the epidermis and liver of a patient with toxic epidermal necrolysis accompanied by vanishing bile duct syndrome.
    J Dermatol. 2022 Sep 29. doi: 10.1111/1346-8138.16576.
    PubMed     Abstract available


  529. KAMIYA K, Ohtsuki M
    Epidemiological survey of patients with pustular psoriasis in the Japanese Society for Psoriasis Research from 2017 to 2020.
    J Dermatol. 2022 Sep 24. doi: 10.1111/1346-8138.16583.
    PubMed     Abstract available


  530. MIYABE C, Oda T, Miyata R, Miyabe Y, et al
    Nephritis-associated plasmin receptor in the cutaneous vessels in IgA vasculitis.
    J Dermatol. 2022 Sep 24. doi: 10.1111/1346-8138.16574.
    PubMed    


  531. MORITA A, Yamaguchi Y, Tateishi C, Ikumi K, et al
    Efficacy and safety of apremilast and phototherapy versus phototherapy only in psoriasis vulgaris.
    J Dermatol. 2022 Sep 24. doi: 10.1111/1346-8138.16566.
    PubMed     Abstract available


  532. LEE ES, Kiuchi Y, Inomata N, Sueki H, et al
    Increased expression of human herpes virus 6 receptor CD134/OX40 in skin lesions of patients with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms.
    J Dermatol. 2022 Sep 19. doi: 10.1111/1346-8138.16575.
    PubMed     Abstract available


  533. TANAKA A, Niimi N, Takahashi M, Takahashi H, et al
    Prevalence of skin diseases and prognosis of atopic dermatitis in primary school children in populated areas of Japan from 2010 to 2019: The Asa Study in Hiroshima, Japan.
    J Dermatol. 2022 Sep 19. doi: 10.1111/1346-8138.16577.
    PubMed     Abstract available


  534. WATANABE A, Kamata M, Shimizu T, Uchida H, et al
    Serum levels of angiogenesis-related factors in patients with psoriasis.
    J Dermatol. 2022 Sep 19. doi: 10.1111/1346-8138.16588.
    PubMed     Abstract available


  535. HATTORI N, Koike Y, Murota H
    Skin microbiome analysis in a case of atopic dermatitis induced by an interleukin 17 inhibitor used to treat psoriasis.
    J Dermatol. 2022 Sep 19. doi: 10.1111/1346-8138.16586.
    PubMed    


  536. FENG S, Song G, Liu L, Liu W, et al
    Allergen-specific immunotherapy induces monocyte-derived dendritic cells but attenuates their maturation and cytokine production in the lesional skin of an atopic dermatitis mouse model.
    J Dermatol. 2022 Sep 19. doi: 10.1111/1346-8138.16582.
    PubMed     Abstract available


  537. HIKI K, Ogata D, Hisada I, Sakamoto T, et al
    Minimally invasive surgery combined with excision and endoscopic submucosal dissection for anorectal melanoma.
    J Dermatol. 2022 Sep 16. doi: 10.1111/1346-8138.16581.
    PubMed    


  538. LU YY, Lu CC, Tsai CY, Liu YJ, et al
    Impact of seborrheic dermatitis on osteoporosis risk: A population-based cohort study.
    J Dermatol. 2022 Sep 12. doi: 10.1111/1346-8138.16578.
    PubMed     Abstract available


  539. MIYATA A, Kimura U, Hiruma M, Tanaka M, et al
    An atypical case of cutaneous candidiasis caused by a face mask: With useful dermoscopic findings.
    J Dermatol. 2022 Sep 12. doi: 10.1111/1346-8138.16573.
    PubMed    


  540. SHIBATA Y, Fukuda T, Nobeyama Y, Asahina A, et al
    Evaluation of nonalcoholic fatty liver disease in Japanese patients with psoriasis: Chest CT imaging for screening purposes.
    J Dermatol. 2022 Sep 8. doi: 10.1111/1346-8138.16564.
    PubMed     Abstract available


  541. MINAI L, Takeichi T, Ogawa Y, Honobe-Tabuchi A, et al
    Development of pemphigus vegetans and exacerbation of pemphigus foliaceus after secukinumab loading in a patient with complicated generalized pustular psoriasis and pyoderma gangrenosum.
    J Dermatol. 2022 Sep 2. doi: 10.1111/1346-8138.16563.
    PubMed     Abstract available


  542. HIRATA Y, Shiiya C, Miyamoto J, Saito M, et al
    Congenital curved nail of the fourth toe: Report of three cases and review of the literature.
    J Dermatol. 2022;49:925-927.
    PubMed     Abstract available


  543. LEEYAPHAN C, Nanchaipruek Y, Phinyo P
    Therapeutic outcomes and prognostic factors in patients with hypertrophic herpes simplex infection treated with imiquimod: A systematic review and meta-analysis of individual patient data from case reports and case series.
    J Dermatol. 2022;49:879-886.
    PubMed     Abstract available


  544. TORII H, Kishimoto M, Tanaka M, Noguchi H, et al
    Patient perceptions of psoriatic disease in Japan: Results from the Japanese subgroup of the Understanding Psoriatic Disease Leveraging Insights for Treatment (UPLIFT) survey.
    J Dermatol. 2022;49:818-828.
    PubMed     Abstract available


  545. JAWORSKA K, Slawinska M, Wyszomirski A, Lakomy J, et al
    Dermoscopic features of eyelid margin tumors: A single-center retrospective study.
    J Dermatol. 2022;49:851-861.
    PubMed     Abstract available


  546. HUANG L, Zhang J, Chen F, Zhang X, et al
    The first case of Chinese phacomatosis pigmentokeratotica diagnosed by a missense HRAS mosaicism.
    J Dermatol. 2022;49:921-924.
    PubMed     Abstract available


  547. CHAO YC, Hong JB, Liu C, Lee MS, et al
    COL7A1 G2287R mutation with two clinical phenotypes in the same family: Bullous dermolysis of the newborn and dystrophic epidermolysis bullosa pruriginosa.
    J Dermatol. 2022;49:e313-e314.
    PubMed    


  548. MIZUMAKI K, Makino S, Ikawa Y, Maeda S, et al
    Case of pembrolizumab-induced dermatomyositis with anti-transcription intermediary factor 1-gamma antibody.
    J Dermatol. 2022;49:e311-e312.
    PubMed    


  549. TAKAMURA S, Teraki Y
    Treatment of bullous pemphigoid with dupilumab: Dupilumab exerts its effect by primarily suppressing T-helper 2 cytokines.
    J Dermatol. 2022;49:845-850.
    PubMed     Abstract available


    August 2022
  550. SUGAWARA-MIKAMI M, Kaneko H, Sasaki H, Sagawa N, et al
    Clinical features and antimicrobial treatment of skin infections caused by Panton-Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus.
    J Dermatol. 2022 Aug 26. doi: 10.1111/1346-8138.16548.
    PubMed     Abstract available


  551. XIAO Y, Gu Y, Xia D, Zhou X, et al
    Ixekizumab successfully treated refractory psoriasis concurrent bullous pemphigoid.
    J Dermatol. 2022 Aug 26. doi: 10.1111/1346-8138.16559.
    PubMed    


  552. SAEKI H, Ohya Y, Furuta J, Arakawa H, et al
    English Version of Clinical Practice Guidelines for the Management of Atopic Dermatitis 2021.
    J Dermatol. 2022 Aug 22. doi: 10.1111/1346-8138.16527.
    PubMed     Abstract available


  553. HAGINO T, Saeki H, Kanda N
    The efficacy and safety of upadacitinib treatment for moderate to severe atopic dermatitis in real-world practice in Japan.
    J Dermatol. 2022 Aug 19. doi: 10.1111/1346-8138.16549.
    PubMed     Abstract available


  554. MIAO C, Chen Y, Wang Z, Xiang X, et al
    Real-world data on the use of secukinumab and acitretin in pediatric generalized pustular psoriasis.
    J Dermatol. 2022 Aug 18. doi: 10.1111/1346-8138.16551.
    PubMed     Abstract available


  555. SEGAWA Y, Tono H, Chiba H, Sato Y, et al
    Case series of modified dermis graft for skin defects of the nasal region.
    J Dermatol. 2022 Aug 12. doi: 10.1111/1346-8138.16544.
    PubMed     Abstract available


  556. MINAGAWA A, Uhara H, Ashida A, Koga H, et al
    Clinical history analysis of Japanese melanoma cases and characteristics of melanoma with childhood onset.
    J Dermatol. 2022 Aug 10. doi: 10.1111/1346-8138.16545.
    PubMed     Abstract available


  557. TADA Y, Kim H, Spanopoulos D, Habiro K, et al
    Treatment patterns, healthcare resource utilization, and costs in patients with moderate-to-severe psoriasis treated with systemic therapy in Japan: A retrospective claims database study.
    J Dermatol. 2022 Aug 10. doi: 10.1111/1346-8138.16543.
    PubMed     Abstract available


  558. TANAKA A, Miyauchi T, Kitamura S, Iwata H, et al
    Carotenoderma due to lycopenemia: A case report and evaluation of lycopene deposition in the skin.
    J Dermatol. 2022 Aug 8. doi: 10.1111/1346-8138.16537.
    PubMed     Abstract available


  559. KIM M, Kim M, Kim JW, Kim BR, et al
    Clinical characteristics of pustulotic arthro-osteitis in Korea.
    J Dermatol. 2022;49:762-768.
    PubMed     Abstract available


  560. LIN YC, Tu WT, Hou PC, Huang HY, et al
    Autosomal dominant epidermolysis bullosa simplex exacerbated by hyperkeratotic scabies.
    J Dermatol. 2022;49:e283-e284.
    PubMed    


  561. CHEN CL, Wu CY, Lyu YS, Chou YJ, et al
    Association between bullous pemphigoid and risk of venous thromboembolism: A nationwide population-based cohort study.
    J Dermatol. 2022;49:753-761.
    PubMed     Abstract available


  562. HSU TC, Yu PH, Chang YH, Guevara BEK, et al
    Novel compound heterozygous indel ZMPSTE24 mutations in a Taiwanese male infant with restrictive dermopathy.
    J Dermatol. 2022;49:e280-e282.
    PubMed    


  563. SHIRAHAMA T, Hamada T, Abe T, Arakawa M, et al
    Dermoscopic furrow ink test of the palmar lesion in loricrin keratoderma.
    J Dermatol. 2022;49:783-786.
    PubMed     Abstract available


  564. MATSUOKA A, Fujii K, Kanekura T
    Clear cell syringoma: Disappearance of clear cells after improvement in diabetes mellitus by pituitary adenoma resection.
    J Dermatol. 2022;49:e268-e269.
    PubMed    


  565. MITSUISHI T, Miyata K, Ando A, Sano K, et al
    Author reply to "Onycholysis associated with Kawasaki disease: A comment on characteristic nail lesions in Kawasaki disease: Case series and literature review".
    J Dermatol. 2022;49:e293-e294.
    PubMed    


  566. MIYAZAKI A, Takeichi T, Takeuchi S, Taki T, et al
    Extremely mild dominant dystrophic epidermolysis bullosa: Genotype information from whole-exome sequencing of salivary gDNA predicts disease severity.
    J Dermatol. 2022;49:e276-e277.
    PubMed    


  567. TANAKA A, Yanagi T, Seo T, Mai S, et al
    Ecthyma gangrenosum caused by Streptococcus pyogenes: Report of a case and review of the literature.
    J Dermatol. 2022;49:e266-e267.
    PubMed    


  568. MIYAZAKI A, Taki T, Takeichi T, Kono M, et al
    Darier disease successfully treated with a topical agent containing vitamin A (retinyl palmitate), vitamin E, and urea.
    J Dermatol. 2022;49:779-782.
    PubMed     Abstract available


  569. KAMEDA E, Togawa Y, Maru Y, Matsue H, et al
    Ungual seborrheic keratosis with longitudinal melanonychia: A case report.
    J Dermatol. 2022;49:775-778.
    PubMed     Abstract available


  570. YAMASHITA A, Fukui T, Akasaka E, Nakajima K, et al
    A mild case of acute generalized exanthematous pustulosis caused by gemcitabine.
    J Dermatol. 2022;49:e261-e263.
    PubMed    


  571. HIRANO Y, Kitamura S, Seo T, Yoshimoto N, et al
    Multiple actinic keratosis on the face associated with pirfenidone-induced photosensitivity.
    J Dermatol. 2022;49:e253-e254.
    PubMed    


  572. OTANI A, Iio K, Hataya H
    Onycholysis associated with Kawasaki disease: A comment on "Characteristic nail lesions in Kawasaki disease: Case series and literature review".
    J Dermatol. 2022;49:e291-e292.
    PubMed    


    July 2022
  573. MELSON GJ, Hong SG, Brem CE
    Melanocytic matricoma with atypical features: A case of malignant melanocytic matricoma?
    J Dermatol. 2022 Jul 30. doi: 10.1111/1346-8138.16536.
    PubMed     Abstract available


  574. FUJISHIMA C, Tahara J, Munemoto S, Hioki C, et al
    Cutaneous nontuberculous mycobacterial infections in Japan: Review of the Japanese literature.
    J Dermatol. 2022 Jul 29. doi: 10.1111/1346-8138.16531.
    PubMed     Abstract available


  575. SHEN M, Xiao H, Zhu W, Lu Y, et al
    Comparing willingness-to-pay and time-trade-off as the measures of burden of psoriasis: A pooled analysis of community, hospital, and web-based samples in China.
    J Dermatol. 2022 Jul 29. doi: 10.1111/1346-8138.16522.
    PubMed     Abstract available


  576. FUKADA N, Suzuki T, Aoyama K, Kinjo A, et al
    Bullous pemphigoid during the treatment of psoriasis vulgaris with risankizumab.
    J Dermatol. 2022 Jul 29. doi: 10.1111/1346-8138.16534.
    PubMed    


  577. YAMAZAKI N, Shimizu A, Ozaki M, Hamada M, et al
    Real-world safety and effectiveness of pembrolizumab in Japanese patients with radically unresectable melanoma: An all-case postmarketing surveillance in Japan.
    J Dermatol. 2022 Jul 27. doi: 10.1111/1346-8138.16518.
    PubMed     Abstract available


  578. MAAS EJ, Wallingford CK, McGuire JJ, Rutjes C, et al
    Amelanotic/hypopigmented melanoma in a sibship with oculocutaneous albinism.
    J Dermatol. 2022 Jul 27. doi: 10.1111/1346-8138.16528.
    PubMed     Abstract available


  579. MATSUOKA A, Fujii K, Higashi Y, Yoshimitsu M, et al
    Subcutaneous panniculitis-like T-cell lymphoma associated with methotrexate treatment.
    J Dermatol. 2022 Jul 26. doi: 10.1111/1346-8138.16524.
    PubMed    


  580. HAYAMA K, Fujita H, Terui T
    Current trend in the treatment of generalized pustular psoriasis in Japan: Results from a questionnaire-based epidemiological study.
    J Dermatol. 2022 Jul 25. doi: 10.1111/1346-8138.16530.
    PubMed    


  581. KAWAKAMI T, Nakade I, Tamura Y, Ito F, et al
    Typical cutaneous small-vessel vasculitis induced by combined injection of antiphosphatidylserine/prothrombin complex antibody and anti-LAMP-2 antibody in normal rats.
    J Dermatol. 2022 Jul 25. doi: 10.1111/1346-8138.16523.
    PubMed     Abstract available


  582. SAKAMOTO K, Baba T, Mori H, Misawa J, et al
    T cell-rich perivascular inflammation in a case of cutaneous variant intravascular large B-cell lymphoma.
    J Dermatol. 2022 Jul 25. doi: 10.1111/1346-8138.16529.
    PubMed    


  583. SAEKI H, Kanai Y, Murotani K, Ito K, et al
    Work productivity in real-life employed patients with plaque psoriasis: Results from the ProLOGUE study.
    J Dermatol. 2022 Jul 20. doi: 10.1111/1346-8138.16517.
    PubMed     Abstract available


  584. JO SJ, Park CJ, Bang CH, Jeong KH, et al
    Calcipotriol/betamethasone aerosol foam (Enstilum) for the topical treatment of psoriasis vulgaris in routine practice in Korea: A prospective, noninterventional, multicenter study of treatment outcomes and patient satisfaction.
    J Dermatol. 2022 Jul 18. doi: 10.1111/1346-8138.16519.
    PubMed     Abstract available


  585. KISHIBE M, Takeda K, Honma M, Makino Y, et al
    Effectiveness of anti-interleukin-17-receptor antibody for hydroxychloroquine-induced generalized pustular psoriasis in a patient with systemic lupus erythematosus.
    J Dermatol. 2022 Jul 15. doi: 10.1111/1346-8138.16514.
    PubMed    


  586. KOGA H, Tsutsumi M, Teye K, Ishii N, et al
    Subcorneal pustular dermatosis-type IgA pemphigus associated with multiple myeloma: A case report and literature review.
    J Dermatol. 2022 Jul 15. doi: 10.1111/1346-8138.16516.
    PubMed     Abstract available


  587. MIZUNO Y, Shibata S, Miyagaki T, Ito Y, et al
    Serum cell-free DNA as a new biomarker in cutaneous T-cell lymphoma.
    J Dermatol. 2022 Jul 12. doi: 10.1111/1346-8138.16520.
    PubMed     Abstract available


  588. IMAI H, Hashimoto S, Ninomiya R, Luo J, et al
    Pharmacokinetics of lanoconazole in human skin after repeated topical application.
    J Dermatol. 2022 Jul 10. doi: 10.1111/1346-8138.16515.
    PubMed     Abstract available


  589. TACHIBANA K, Ohkawa Y, Kanto N, Maeda K, et al
    The expression of keratan sulfate in malignant melanoma enhances the adhesion and invasion activity of melanoma cells.
    J Dermatol. 2022 Jul 10. doi: 10.1111/1346-8138.16506.
    PubMed     Abstract available


  590. MORITA A, Nishikawa K, Yamada F, Yamanaka K, et al
    Safety, efficacy, and drug survival of the infliximab biosimilar CT-P13 in post-marketing surveillance of Japanese patients with psoriasis.
    J Dermatol. 2022 Jul 7. doi: 10.1111/1346-8138.16508.
    PubMed     Abstract available


  591. TSUNODA K, Watabe D, Amano H
    Exacerbation of psoriasis following vaccination with the Pfizer-BioNTech BTN162b2 mRNA COVID-19 vaccine during risankizumab treatment.
    J Dermatol. 2022 Jul 7. doi: 10.1111/1346-8138.16505.
    PubMed    


  592. MARTIN A, Gouveia BM, Rawson R, Guitera P, et al
    Complex management of lentigo maligna in the setting of chrysiasis, argyriasis, and tattoo using in vivo reflectance confocal microscopy.
    J Dermatol. 2022;49:703-709.
    PubMed     Abstract available


  593. SUGIYAMA S, Yamamoto T, Aoyama Y
    Clinical features of dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid in Japan: A nationwide retrospective observational study.
    J Dermatol. 2022;49:697-702.
    PubMed     Abstract available


  594. IKEDA T, Yokoyama K, Kawakami T
    Heliotrope-like manifestation of adult-onset Still disease with macrophage activation syndrome: A case-based review.
    J Dermatol. 2022;49:736-740.
    PubMed     Abstract available


  595. KAWAKAMI T, Yokoyama K, Ikeda T, Nishibata Y, et al
    Presence of neutrophil extracellular traps in superficial venous thrombosis of Behcet's disease.
    J Dermatol. 2022;49:741-745.
    PubMed     Abstract available


  596. MOCHIZUKI T, Yamada S, Hironaga M, Futatsuya T, et al
    Change in dominant genotype of Microsporum canis, a causative fungus of zoonotic dermatophytosis, in Japan over the past 40 years.
    J Dermatol. 2022;49:682-690.
    PubMed     Abstract available


  597. IWANAGA A, Murota H
    Author reply to comment on "Clinical practice guidelines for pseudoxanthoma elasticum (2017)": The importance of mutation analysis.
    J Dermatol. 2022;49:e250.
    PubMed    


  598. ANDO Y, Ohshima Y, Yanagishita T, Watanabe H, et al
    Clinical utility of botulinum toxin type A local injection therapy for head and forehead hyperhidrosis.
    J Dermatol. 2022;49:719-723.
    PubMed     Abstract available


  599. KITAO R, Oda Y, Washio K, Tai Y, et al
    Lower efficacy of omalizumab in older adults with chronic spontaneous urticaria.
    J Dermatol. 2022;49:729-731.
    PubMed     Abstract available


  600. LI Q, Terry SF, Uitto J
    Comment on "Clinical practice guidelines for pseudoxanthoma elasticum (2017)": The importance of mutation analysis.
    J Dermatol. 2022;49:e248-e249.
    PubMed    


  601. XU M, Yan J
    2940-nm multifractional erbium:yttrium-aluminum-garnet laser for the treatment of dissecting cellulitis of the scalp: Case reports and literature review.
    J Dermatol. 2022;49:e230-e231.
    PubMed    


  602. KAWAMURA T, Mai Y, Narahira A, Matsuno Y, et al
    Regression of acquired reactive perforating collagenosis after dipeptidyl peptidase-4 inhibitor cessation.
    J Dermatol. 2022;49:e238-e240.
    PubMed    


  603. HAYASHI M, Wataya-Kaneda M, Koguchi-Yoshioka H, Arase N, et al
    Familial Michelin tire baby syndrome.
    J Dermatol. 2022;49:e219-e220.
    PubMed    


  604. IINUMA S, Hayashi K, Tsuda T, Nakano S, et al
    Hidradenitis suppurativa associated with immunoglobulin A-dominant infection-related glomerulonephritis.
    J Dermatol. 2022;49:e224-e225.
    PubMed    


  605. CHULAROJANAMONTRI L, Tuchinda P, Rujitharanawong C, Hunnangkul S, et al
    New-onset and exacerbated skin diseases after COVID-19 infection: A systematic review.
    J Dermatol. 2022 Jul 1. doi: 10.1111/1346-8138.16501.
    PubMed    


    June 2022
  606. JIAO J, Zhao X, Wang Y, Liang N, et al
    Normal mesenchymal stem cells can improve the abnormal function of T cells in psoriasis via upregulating transforming growth factor-beta receptor.
    J Dermatol. 2022 Jun 29. doi: 10.1111/1346-8138.16490.
    PubMed     Abstract available


  607. UMEDA Y, Teramoto Y, Asami Y, Matsuya T, et al
    Comparison of surgical morbidities between LigaSure and conventional techniques in inguinal or ilioinguinal lymph node dissection for skin cancer: A single center retrospective study.
    J Dermatol. 2022 Jun 27. doi: 10.1111/1346-8138.16502.
    PubMed     Abstract available


  608. HORII M, Fushida N, Ikeda T, Oishi K, et al
    Cytokine-producing B-cell balance associates with skin fibrosis in patients with systemic sclerosis.
    J Dermatol. 2022 Jun 25. doi: 10.1111/1346-8138.16495.
    PubMed     Abstract available


  609. LIM SH, Koh SB, Lee WS, Lee S, et al
    Rapidly increasing incidence and prevalence of lichen planopilaris in an Asian population: A Korean nationwide population-based study.
    J Dermatol. 2022 Jun 21. doi: 10.1111/1346-8138.16498.
    PubMed    


  610. PRUESSMANN JN, Langan EA, Rupp J, Marquardt J, et al
    Challenge of hepatitis B testing following intravenous immunoglobulin therapy in patients with autoimmune skin diseases.
    J Dermatol. 2022 Jun 21. doi: 10.1111/1346-8138.16500.
    PubMed     Abstract available


  611. QIN H, Lu J, Yi X, Ding Y, et al
    Secukinumab treatment for a psoriasis patient co-infected with HIV and latent tuberculosis: A case report.
    J Dermatol. 2022 Jun 21. doi: 10.1111/1346-8138.16494.
    PubMed    


  612. MITSUI Y, Shobatake C, Ogawa K, Hirai T, et al
    Usefulness of ultrasonography in the preoperative diagnosis of mixed tumor of the skin (chondroid syringoma): A case series with nine patients.
    J Dermatol. 2022 Jun 19. doi: 10.1111/1346-8138.16497.
    PubMed    


  613. CHI MH, Chung WH, Hui RC, Chen CB, et al
    Clinical features and outcomes in children with Stevens-Johnson syndrome and toxic epidermal necrolysis.
    J Dermatol. 2022 Jun 17. doi: 10.1111/1346-8138.16476.
    PubMed     Abstract available


  614. TANAKA M, Miyagaki T, Sato N, Akita T, et al
    Epidermotropic cutaneous T-cell lymphoma with follicular helper T-cell phenotype limited to one anatomical region.
    J Dermatol. 2022 Jun 17. doi: 10.1111/1346-8138.16492.
    PubMed    


  615. KATOH N, Saeki H, Kataoka Y, Etoh T, et al
    Evaluation of standard treatments for managing adult Japanese patients with inadequately controlled moderate-to-severe atopic dermatitis: Two-year data from the ADDRESS-J disease registry.
    J Dermatol. 2022 Jun 17. doi: 10.1111/1346-8138.16485.
    PubMed     Abstract available


  616. NOMOTO Y, Fujii K, Nakamura D, Gushi A, et al
    Epstein-Barr virus-positive primary cutaneous Hodgkin lymphoma.
    J Dermatol. 2022 Jun 16. doi: 10.1111/1346-8138.16489.
    PubMed    


  617. CHIANG CP, Hung CT, Chen YH, Chen CY, et al
    Stevens-Johnson syndrome and toxic epidermal necrolysis associated with increased risk of developing psychiatric disorders: A retrospective population-based cohort study in Taiwan.
    J Dermatol. 2022 Jun 10. doi: 10.1111/1346-8138.16487.
    PubMed     Abstract available


  618. SAITO S, Tanaka R, Ono N, Umegaki-Arao N, et al
    Palmar whitish change after water exposure in a familial mild case of loricrin keratoderma (loricrin ichthyosis).
    J Dermatol. 2022 Jun 3. doi: 10.1111/1346-8138.16481.
    PubMed    


  619. FUJIMOTO T, Okatsu H, Miyama H
    Two-week prospective observational study of 5% sofpironium bromide gel in Japanese patients with primary axillary hyperhidrosis.
    J Dermatol. 2022;49:594-599.
    PubMed     Abstract available


  620. YANG L, Zhou N, Alamgir M, Wang Z, et al
    Risk factors of long-term alopecia after pulsed-dye laser treatment for infantile scalp hemangiomas: A retrospective study.
    J Dermatol. 2022;49:661-665.
    PubMed     Abstract available


  621. EDSON-HEREDIA E, Aranishi T, Isaka Y, Anderson P, et al
    Patient and physician perspectives on alopecia areata: A real-world assessment of severity and burden in Japan.
    J Dermatol. 2022;49:575-583.
    PubMed     Abstract available


  622. ITO T, Kamei K, Yuasa A, Matsumoto F, et al
    Health-related quality of life in patients with alopecia areata: Results of a Japanese survey with norm-based comparisons.
    J Dermatol. 2022;49:584-593.
    PubMed     Abstract available


  623. YANAGIDA N, Takahagi S, Aoyama Y, Tanaka A, et al
    Anhidrosis accompanied by cholinergic urticaria-like rash and dermal pain in a patient with Sjogren's syndrome.
    J Dermatol. 2022;49:666-670.
    PubMed     Abstract available


  624. MIYAZAKI S, Nakano H, Mizuno M, Ozaki S, et al
    Two novel mutations in the ATP2C1 gene found in Japanese patients with Hailey-Hailey disease.
    J Dermatol. 2022;49:656-660.
    PubMed     Abstract available


  625. SUZUKI H, Namiki T, Enzan N, Tanaka A, et al
    Novel mutation in the UROS gene causing congenital erythropoietic porphyria in an elderly Japanese female.
    J Dermatol. 2022;49:e215-e216.
    PubMed    


  626. HOSOMI S, Fujimoto K, Fujiwara Y
    Curly hair caused by selenium deficiency in an adult woman.
    J Dermatol. 2022;49:e197-e198.
    PubMed    


    May 2022
  627. WANG WY, Yu S, Hu SC
    Subacute cutaneous lupus erythematosus following ChAdOx1 nCoV-19 vaccination.
    J Dermatol. 2022 May 27. doi: 10.1111/1346-8138.16473.
    PubMed    


  628. KOO T, Baek G, Jue MS
    Risk of tuberculosis infection and serial changes in interferon-gamma release assays in elderly patients with psoriasis receiving biologic therapy.
    J Dermatol. 2022 May 26. doi: 10.1111/1346-8138.16471.
    PubMed     Abstract available


  629. SALAVA A, Salo V, Remitz A
    Keratosis pilaris and filaggrin loss-of-function mutations in patients with atopic dermatitis - Results of a Finnish cross-sectional study.
    J Dermatol. 2022 May 26. doi: 10.1111/1346-8138.16477.
    PubMed     Abstract available


  630. UHARA H, Tsuchida T, Kiyohara Y, Akamatsu A, et al
    Safety and effectiveness of nivolumab in Japanese patients with malignant melanoma: Final analysis of a post-marketing surveillance.
    J Dermatol. 2022 May 23. doi: 10.1111/1346-8138.16432.
    PubMed     Abstract available


  631. CANU D, Doutre MS
    Regression of sarcoidosis skin lesions after receiving the Moderna anti-coronavirus disease 2019 vaccine.
    J Dermatol. 2022 May 19. doi: 10.1111/1346-8138.16438.
    PubMed    


  632. YOSHIOKA A, Kunisada M, Fukuda H, Kubo A, et al
    Autoimmune progesterone dermatitis treated with dienogest: A case report.
    J Dermatol. 2022 May 19. doi: 10.1111/1346-8138.16445.
    PubMed    


  633. ARAKAWA N, Watabe D, Tanji T, Amano H, et al
    Childhood granulomatous periorificial dermatitis showing a good response to doxycycline.
    J Dermatol. 2022 May 17. doi: 10.1111/1346-8138.16437.
    PubMed    


  634. GOTO H, Kondo M, Iida S, Matsushima Y, et al
    Psoriasis-like skin lesions occurring at remote sites after topical imiquimod.
    J Dermatol. 2022 May 15. doi: 10.1111/1346-8138.16443.
    PubMed    


  635. MORITZ S, Penney D, Weidinger S, Gabbert T, et al
    A randomized controlled trial on a novel behavioral treatment for individuals with skin picking and other body-focused repetitive behaviors.
    J Dermatol. 2022 May 15. doi: 10.1111/1346-8138.16435.
    PubMed    


  636. GRACA A, Martins AM, Ribeiro HM, Marques Marto J, et al
    Indirect consequences of coronavirus disease 2019: Skin lesions caused by the frequent hand sanitation and use of personal protective equipment and strategies for their prevention.
    J Dermatol. 2022 May 13. doi: 10.1111/1346-8138.16431.
    PubMed     Abstract available


  637. TACHIBANA K, Kawakami Y, Tokuda M, Sato S, et al
    Flare-up of generalized pustular psoriasis following Pfizer-BioNTech BNT162b2 mRNA COVID-19 vaccine: Two cases without mutations of IL36RN and CARD14 genes.
    J Dermatol. 2022 May 13. doi: 10.1111/1346-8138.16442.
    PubMed    


  638. KITAJIMA Y, Yamashina M, Hanamoto M, Shijimaya T, et al
    Primary cutaneous anaplastic large cell lymphoma with DUSP22-IRF4 rearrangement demonstrating a biphasic histopathologic pattern and a complete natural regression.
    J Dermatol. 2022 May 13. doi: 10.1111/1346-8138.16424.
    PubMed    


  639. KASE M, Fujita Y, Ota A, Shimizu S, et al
    Loss of epidermal Langerhans cells in psoriasiform lesions of de novo induced or worsened pre-existing psoriasis following uses of immune checkpoint inhibitors.
    J Dermatol. 2022 May 12. doi: 10.1111/1346-8138.16427.
    PubMed     Abstract available


  640. NOMOTO Y, Higashi Y, Uchida Y, Fujii K, et al
    Disseminated cutaneous sporotrichosis with intravascular granuloma.
    J Dermatol. 2022 May 10. doi: 10.1111/1346-8138.16429.
    PubMed    


  641. TAMAI M, Sakamoto R, Goto N, Morimura O, et al
    Cutaneous manifestations of coronavirus disease 2019 patients in Japan.
    J Dermatol. 2022 May 10. doi: 10.1111/1346-8138.16433.
    PubMed     Abstract available


  642. SASAKI R, Asano Y, Fujimura T
    A pediatric case of corticosteroid-resistant erosive pustular dermatosis of scalp-like alopecia treated successfully with oral indomethacin, doxycycline, and topical tacrolimus.
    J Dermatol. 2022 May 10. doi: 10.1111/1346-8138.16425.
    PubMed    


  643. KAMIMURA A, Nakamura Y, Takenouchi T, Matsushita S, et al
    Concordance in judgment of clinical borders of basal cell carcinomas in Japanese patients: A preliminary study of JCOG2005 (J-BASE-MARGIN).
    J Dermatol. 2022 May 5. doi: 10.1111/1346-8138.16422.
    PubMed     Abstract available


  644. JUNG JM, Yang HJ, Lee WJ, Won CH, et al
    Association between psoriasis and alopecia areata: A systematic review and meta-analysis.
    J Dermatol. 2022 May 5. doi: 10.1111/1346-8138.16420.
    PubMed     Abstract available


  645. MATSUDATE Y
    Case of allergic contact dermatitis due to nickel contained in stainless steel skull pins.
    J Dermatol. 2022 May 3. doi: 10.1111/1346-8138.16421.
    PubMed    


  646. SAWAMURA S, Kajihara I, Sakamoto R, Otsuka-Maeda S, et al
    Elevation of circulating interleukin-23 DNA levels in patients with psoriasis.
    J Dermatol. 2022 May 2. doi: 10.1111/1346-8138.16418.
    PubMed    


  647. WANG L, Xing H
    Primary localized cutaneous amyloidosis presenting only as hypopigmented patches: A case report.
    J Dermatol. 2022 May 2. doi: 10.1111/1346-8138.16378.
    PubMed    


  648. OHN J, Choi YG, Yun J, Jo SJ, et al
    Identifying patients with deteriorating generalized pustular psoriasis: Development of a prediction model.
    J Dermatol. 2022 May 2. doi: 10.1111/1346-8138.16383.
    PubMed     Abstract available


  649. TAKAMIYAGI S, Iriki H, Asahina Y, Furuichi Y, et al
    Severe graft-versus-host disease-like enterocolitis accompanied with cytomegalovirus-reactivation in drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms.
    J Dermatol. 2022 May 2. doi: 10.1111/1346-8138.16415.
    PubMed     Abstract available


  650. YAMASAKI K, Yamanaka K, Zhao Y, Iwano S, et al
    Adalimumab in Japanese patients with active ulcers of pyoderma gangrenosum: Final analysis of a 52-week phase 3 open-label study.
    J Dermatol. 2022;49:479-487.
    PubMed     Abstract available


  651. LIU T, Li J, Deng Z, Chen M, et al
    Increased serum levels of CCL3, CXCL8, CXCL9, and CXCL10 in rosacea patients and their correlation with disease severity.
    J Dermatol. 2022;49:525-533.
    PubMed     Abstract available


  652. XIAO T, Liu Y, Wang T, Ren J, et al
    Two novel mutations of SERPINB7 in eight cases of Nagashima-type palmoplantar keratosis in the Chinese population.
    J Dermatol. 2022;49:539-544.
    PubMed     Abstract available


  653. WADA-IRIMADA M, Yamamoto H, Terui H, Omori-Shimada R, et al
    Characterization of rosacea patients in Tohoku area of Japan: Retrospective study of 340 rosacea cases.
    J Dermatol. 2022;49:519-524.
    PubMed     Abstract available


  654. MATSUBARA A, Tsuchida N, Sakurai M, Maeda A, et al
    A case of VEXAS syndrome with Sweet's disease and pulmonary involvement.
    J Dermatol. 2022;49:e177-e178.
    PubMed    


  655. MUNEMOTO S, Tsuchihara K, Fujishima C, Hioki C, et al
    Novel mutation of the ferrochelatase gene in a Japanese boy with erythropoietic protoporphyria.
    J Dermatol. 2022;49:e179-e180.
    PubMed    


  656. HOSHINA D, Orita A
    Sweet syndrome after severe acute respiratory syndrome coronavirus 2 mRNA vaccine: A case report and literature review.
    J Dermatol. 2022;49:e175-e176.
    PubMed    


  657. HSU CH, Tu WT, Chen PC, Yu-Yun Lee J, et al
    Novel compound heterozygous ITGB4 mutations underlie lethal junctional epidermolysis bullosa with pyloric atresia and aplasia cutis congenita.
    J Dermatol. 2022;49:e154-e156.
    PubMed    


  658. SASAKI H, Fujishima C, Hioki C, Yoshida H, et al
    A case of paraneoplastic pemphigus associated with other iatrogenic immunodeficiency-associated lymphoproliferative disorders.
    J Dermatol. 2022;49:e165-e166.
    PubMed    


  659. WADA S, Namiki T, Miura K
    Mononuclear variant of adult xanthogranuloma associated with B-cell acute lymphocytic leukemia.
    J Dermatol. 2022;49:e161-e162.
    PubMed    


  660. TANAKA A, Kitamura S, Yanagi T, Seo T, et al
    Case of penile Bowen's disease on postoperative lymphedema associated with human papilloma virus type 52.
    J Dermatol. 2022;49:e163-e164.
    PubMed    


  661. KITAYAMA S, Makino T, Mizawa M, Shimizu T, et al
    Newborn twins with neonatal pemphigoid gestationis.
    J Dermatol. 2022;49:e157-e158.
    PubMed    


    April 2022
  662. OTA M, Nobeyama Y, Asahina A
    Case of hypothyroidism-diagnostic unclassified cutaneous mucinosis showing a plaque on the flank region.
    J Dermatol. 2022 Apr 28. doi: 10.1111/1346-8138.16414.
    PubMed    


  663. WAKI Y, Nobeyama Y, Katsumata F, Asahina A, et al
    Successful treatment with dacarbazine against a parathyroid hormone-related protein-producing melanoma causing hypercalcemia after immune checkpoint inhibitor failure.
    J Dermatol. 2022 Apr 27. doi: 10.1111/1346-8138.16411.
    PubMed     Abstract available


  664. BOMZE D, Sprecher E, Geller S
    Severe cutaneous adverse reactions associated with systemic ivermectin: A pharmacovigilance analysis.
    J Dermatol. 2022 Apr 27. doi: 10.1111/1346-8138.16398.
    PubMed     Abstract available


  665. YU R, Chen S, Pan Y, Ma C, et al
    Combined use of cyclosporine in the treatment of Stevens-Johnson syndrome/toxic epidermal necrolysis.
    J Dermatol. 2022 Apr 19. doi: 10.1111/1346-8138.16369.
    PubMed     Abstract available


  666. SHU J, Yamamoto Y, Aoyama K, Togawa Y, et al
    Assessment of malignant melanoma lesions using violet-light dermoscopy: A case report.
    J Dermatol. 2022 Apr 17. doi: 10.1111/1346-8138.16389.
    PubMed     Abstract available


  667. YAMANAKA K, Sato K, Masaki T, Nakano E, et al
    Basal cell carcinoma derived from epidermal cyst of the knee of a patient with xeroderma pigmentosum group C.
    J Dermatol. 2022 Apr 12. doi: 10.1111/1346-8138.16375.
    PubMed    


  668. CHAROENPIPATSIN N, Chularojanamontri L, Rujitharanawong C, Tuchinda P, et al
    Rituximab-induced psoriasis in a patient with pemphigus foliaceous: A case report and literature review.
    J Dermatol. 2022 Apr 5. doi: 10.1111/1346-8138.16367.
    PubMed    


  669. WATANABE H, Ashida M, Satomi N, Koike Y, et al
    Histopathological analysis of skin reactions after coronavirus disease 2019 vaccination: Increment in number of infiltrated plasmacytoid dendritic cell.
    J Dermatol. 2022 Apr 4. doi: 10.1111/1346-8138.16374.
    PubMed     Abstract available


  670. OKA Y, Fukumoto T, Imamura S, Horita N, et al
    Atypical Gianotti-Crosti syndrome like skin lesions following vaccination.
    J Dermatol. 2022 Apr 4. doi: 10.1111/1346-8138.16385.
    PubMed    


  671. NAKAJIMA K, Suzuki H, Yamamoto M, Yamamoto T, et al
    A familial case of periodontal Ehlers-Danlos syndrome lacking skin extensibility and joint hypermobility with a missense mutation in C1R.
    J Dermatol. 2022 Apr 1. doi: 10.1111/1346-8138.16372.
    PubMed     Abstract available


  672. KURIHARA K, Fujiyama T, Tokura Y, Honda T, et al
    Possible involvement of interleukin-22-producing CD103(+) CD8(+) T cells in the epidermal hyperplasia of atopic dermatitis.
    J Dermatol. 2022 Apr 1. doi: 10.1111/1346-8138.16382.
    PubMed    


  673. HAYASHI N, Hayama K, Takahashi K, Kurokawa I, et al
    Real-world safety and effectiveness of adalimumab in patients with hidradenitis suppurativa: 12-week interim analysis of post-marketing surveillance in Japan.
    J Dermatol. 2022;49:411-421.
    PubMed     Abstract available


  674. WANG Y, Wang J, Li Y, Pan C, et al
    AQP5 pathogenic variants induce palmoplantar keratoderma Bothnia type in two Chinese families.
    J Dermatol. 2022;49:463-468.
    PubMed     Abstract available


  675. CORDERO-RAMOS J, Barros-Tornay R, Toledo-Pastrana T, Ferrandiz L, et al
    Effectiveness and safety of topical 15% resorcinol in the management of mild-to-moderate hidradenitis suppurativa: A cohort study.
    J Dermatol. 2022;49:459-462.
    PubMed     Abstract available


  676. NAKAI Y, Ashida H, Kajita A, Yokoyama E, et al
    Impetigo herpetiformis successfully treated with brodalumab.
    J Dermatol. 2022;49:e149-e150.
    PubMed    


  677. ZHOU X, Cheng L, Wang Y, Gou H, et al
    Effect of NUDT15 polymorphisms on early hematological safety of low-dose azathioprine in Chinese patients with pemphigus vulgaris: A prospective cohort study.
    J Dermatol. 2022;49:402-410.
    PubMed     Abstract available


  678. KOREKAWA A, Nakajima K, Nakano H, Sawamura D, et al
    Clarithromycin for the treatment of pyoderma gangrenosum associated with myelodysplastic syndrome.
    J Dermatol. 2022;49:e131-e132.
    PubMed    


  679. MIZAWA M, Makino T, Furukawa F, Torai R, et al
    Efficacy of Q-switched ruby laser treatment for pigmented fungiform papillae of the tongue.
    J Dermatol. 2022;49:e133-e134.
    PubMed    


  680. HATORI Y, Kawakita H, Ito M, Kobayashi K, et al
    Subungual arteriovenous hemangioma mimicking subungual malignant tumor.
    J Dermatol. 2022;49:e127-e128.
    PubMed    


    March 2022
  681. TAKEI S, Hashimoto W, Tasaki K, Hashimoto T, et al
    Cutaneous infection caused by the Scedosporium apiospermum complex.
    J Dermatol. 2022 Mar 30. doi: 10.1111/1346-8138.16381.
    PubMed    


  682. SASAKI H, Kato J, Horimoto K, Sato S, et al
    Delayed-onset abscopal effect after palliative radiotherapy for acral melanoma treated with anti-PD-1 therapy.
    J Dermatol. 2022 Mar 30. doi: 10.1111/1346-8138.16380.
    PubMed    


  683. ZENG J, Wang D, Luo J, Li L, et al
    Mannan-binding lectin exacerbates the severity of psoriasis by promoting plasmacytoid dendritic cell differentiation via the signal transducer and activator of transcription 3-interferon regulatory factor 8 axis.
    J Dermatol. 2022 Mar 29. doi: 10.1111/1346-8138.16323.
    PubMed     Abstract available


  684. UCHIDA H, Kamata M, Egawa S, Nagata M, et al
    Impact of the COVID-19 pandemic on biologic treatment in psoriasis patients: A single-center retrospective study in Japan.
    J Dermatol. 2022 Mar 23. doi: 10.1111/1346-8138.16362.
    PubMed     Abstract available


  685. CHENG AY, Lan J, Lee CH
    Impaired Wnt/beta-catenin and protein patched homolog 1 signaling in extraocular sebaceous carcinoma: A clinical and histopathological study.
    J Dermatol. 2022 Mar 22. doi: 10.1111/1346-8138.16351.
    PubMed     Abstract available


  686. CUI R, Chen M, Li X, Wang Q, et al
    Assessment of four screening tools and retrieval of key questions to detect undiagnosed psoriatic arthritis in Chinese patients with psoriasis: A multicenter study.
    J Dermatol. 2022 Mar 22. doi: 10.1111/1346-8138.16355.
    PubMed     Abstract available


  687. SEO T, Miyauchi T, Kawakami T, Ujiie H, et al
    Human figure-shaped contact dermatitis due to the illustration on the inner surface of compression sleeves.
    J Dermatol. 2022 Mar 22. doi: 10.1111/1346-8138.16363.
    PubMed    


  688. KAN T, Tanaka A, Kanamoto M, Morioke S, et al
    Longitudinal prevalence of atopic dermatitis among freshmen at Hiroshima University between 2002 and 2019.
    J Dermatol. 2022 Mar 22. doi: 10.1111/1346-8138.16366.
    PubMed     Abstract available


  689. MAENO M, Tamagawa-Mineoka R, Arakawa Y, Masuda K, et al
    Facial discoid lupus erythematosus during dupilumab treatment for atopic dermatitis.
    J Dermatol. 2022 Mar 18. doi: 10.1111/1346-8138.16356.
    PubMed    


  690. MAKINO T, Kataoka K, Kitayama S, Mizawa M, et al
    Successful treatment with excimer laser for cutaneous lesion of sarcoidosis.
    J Dermatol. 2022 Mar 18. doi: 10.1111/1346-8138.16357.
    PubMed    


  691. CHAIYABUTR C, Jiamton S, Silpa-Archa N, Wongpraparut C, et al
    Retrospective study of psoriasis in people living with HIV: Thailand's experience.
    J Dermatol. 2022 Mar 15. doi: 10.1111/1346-8138.16352.
    PubMed     Abstract available


  692. ISHIDA T, Saito R, Takahagi S, Tanaka A, et al
    Case of presenile diffuse sebaceous hyperplasia treated with adapalene gel.
    J Dermatol. 2022 Mar 8. doi: 10.1111/1346-8138.16349.
    PubMed    


  693. MATSUSHIMA Y, Mizutani K, Iida S, Ichishi M, et al
    Severe skin inflammation leads to salivary gland atrophy and dysfunction.
    J Dermatol. 2022 Mar 7. doi: 10.1111/1346-8138.16334.
    PubMed     Abstract available


  694. ITO Y, Takeichi T, Nakagawa K, Tanahashi K, et al
    Case of ichthyosis with confetti caused by KRT10 mutation, complicated with multiple malignant melanomas.
    J Dermatol. 2022 Mar 6. doi: 10.1111/1346-8138.16348.
    PubMed    


  695. UCHIYAMA A, Fujiwara C, Inoue Y, Motegi SI, et al
    Real-world effectiveness and safety of baricitinib in Japanese patients with atopic dermatitis: A single-center retrospective study.
    J Dermatol. 2022 Mar 6. doi: 10.1111/1346-8138.16350.
    PubMed    


  696. UEHARA A, Endo Y, Kosaka K, Oka A, et al
    Case of recurrent cutaneous eosinophilic vasculitis with subcutaneous nodules in the early stage of the disease.
    J Dermatol. 2022 Mar 3. doi: 10.1111/1346-8138.16342.
    PubMed    


  697. KOREKAWA A, Nakajima K, Fukushi K, Nakano H, et al
    Three cases of drug-induced hypersensitivity syndrome associated with mRNA-based coronavirus disease 2019 vaccines.
    J Dermatol. 2022 Mar 3. doi: 10.1111/1346-8138.16347.
    PubMed     Abstract available


  698. LEE E, Lee S, Tashiro Y, Ogihara M, et al
    Sequential screening of biomarkers in a case of drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms occurring with virus reactivation and autoimmune disease.
    J Dermatol. 2022 Mar 3. doi: 10.1111/1346-8138.16341.
    PubMed    


  699. IWANAGA A, Utani A, Koike Y, Okubo Y, et al
    Clinical Practice Guidelines for Pseudoxanthoma Elasticum Drafting Committee: Clinical Practice Guidelines for Pseudoxanthoma Elasticum Drafting Committee: Clinical Practice Guidelines for Pseudoxanthoma Elasticum Drafting Committee.
    J Dermatol. 2022;49:e91-e98.
    PubMed     Abstract available


  700. SAEKI H, Tsunemi Y, Arai S, Ichiyama S, et al
    English version of guidelines for the management of asteatosis 2021 in Japan.
    J Dermatol. 2022;49:e77-e90.
    PubMed     Abstract available


  701. MIYACHI Y, Yamasaki K, Fujita T, Fujii C, et al
    Metronidazole gel (0.75%) in Japanese patients with rosacea: A randomized, vehicle-controlled, phase 3 study.
    J Dermatol. 2022;49:330-340.
    PubMed     Abstract available


  702. OTA M, Nobeyama Y, Fukuda T, Asahina A, et al
    Relationship between iodine-enhanced dual energy-computed tomographic findings and ultrasonographic findings for psoriatic arthritis.
    J Dermatol. 2022;49:368-373.
    PubMed     Abstract available


  703. KONO T, Miyachi Y, Kawashima M
    Reply to Comment on "Clinical significance of the water retention and barrier function-improving capabilities of ceramide-containing formulations: A qualitative review".
    J Dermatol. 2022;49:e124.
    PubMed    


  704. HIRANO Y, Iwata H, Tsujuwaki M, Mai S, et al
    Super-resolution imaging detects BP180 autoantigen in immunoglobulin M pemphigoid.
    J Dermatol. 2022;49:374-378.
    PubMed     Abstract available


  705. KANEDA E, Tonomura K, Kotobuki Y, Ueda-Hayakawa I, et al
    Case of anti-Mi-2 antibody-positive dermatomyositis with predictable onset before the development of muscle symptoms.
    J Dermatol. 2022;49:e104-e105.
    PubMed    


  706. IWASAWA O, Kamiya K, Komine M, Ohtsuki M, et al
    Case of atypical erythema multiforme following coronavirus disease 2019 vaccination.
    J Dermatol. 2022;49:e113-e114.
    PubMed    


  707. IWASAWA O, Kamiya K, Okada H, Komine M, et al
    A case of erythroderma with elevated serum immunoglobulin E and thymus and activation-regulated chemokine levels following coronavirus disease 2019 vaccination.
    J Dermatol. 2022;49:e117-e118.
    PubMed    


  708. KANATANI Y, Shinkuma S, Matsumoto Y, Mitsui Y, et al
    Recurrence of impetigo herpetiformis carrying compound heterozygous mutations in IL36RN after remission with secukinumab.
    J Dermatol. 2022;49:e108-e110.
    PubMed    


  709. HIROYASU S, Hiroyasu A, Mine M, Kotobuki Y, et al
    Case of pemphigoid nodularis with immunoglobulin (Ig)G deposition accompanied by postinflammatory hypopigmentation without IgG deposition on the same forearm.
    J Dermatol. 2022;49:e99-e101.
    PubMed    


  710. KURIYAMA Y, Shimizu A, Kanai S, Yokoyama Y, et al
    Focal palmoplantar keratoderma in a patient with the KRT6B mutation.
    J Dermatol. 2022;49:e111-e112.
    PubMed    


  711. HOSOKAWA Y, Kamiya T, Sugita S, Hida T, et al
    Primary cutaneous diffuse large B-cell lymphoma, leg type, of the face that appeared on pre-existing T-cell pseudolymphoma clinically resembling actinic reticuloid.
    J Dermatol. 2022 Mar 1. doi: 10.1111/1346-8138.16331.
    PubMed    


    February 2022
  712. OKUNE M, Okiyama N, Fukuzono M, Sasaki K, et al
    Development of systemic lupus erythematosus after dupilumab treatment in a case of atopic dermatitis.
    J Dermatol. 2022 Feb 27. doi: 10.1111/1346-8138.16322.
    PubMed     Abstract available


  713. NOGUCHI H, Matsumoto T, Kimura U, Hiruma M, et al
    Empiric antifungal therapy in patients with cutaneous and subcutaneous phaeohyphomycosis.
    J Dermatol. 2022 Feb 25. doi: 10.1111/1346-8138.16312.
    PubMed     Abstract available


  714. AKATSUKA T, Sakai Y, Toyama T, Morimura S, et al
    Cutaneous reactions after coronavirus disease 2019 vaccination: Summary of 20 Japanese cases.
    J Dermatol. 2022 Feb 25. doi: 10.1111/1346-8138.16335.
    PubMed    


  715. TSUCHIYA M, Hashimoto R, Arai K, Yoshida K, et al
    Psoriasiform dermatitis in a girl with ulcerative colitis receiving vedolizumab.
    J Dermatol. 2022 Feb 23. doi: 10.1111/1346-8138.16318.
    PubMed    


  716. OZAKI S, Ichiyama S, Ito M, Hoashi T, et al
    Real-world blood examination screening data before initiation of biologics for psoriasis patients.
    J Dermatol. 2022 Feb 22. doi: 10.1111/1346-8138.16333.
    PubMed     Abstract available


  717. HAYASHI D, Nakai K, Sowa-Osako J, Ohsawa M, et al
    Deranged integrin expression in the epidermis of pemphigoid nodularis and prurigo nodularis: Are they the same hyperproliferative state?
    J Dermatol. 2022 Feb 21. doi: 10.1111/1346-8138.16330.
    PubMed    


  718. UCHIDA S, Kawai K, Tsutsui Y, Yamazaki M, et al
    Felty syndrome in a patient with undiagnosed rheumatoid arthritis presenting with multiple cutaneous abscesses.
    J Dermatol. 2022 Feb 21. doi: 10.1111/1346-8138.16332.
    PubMed    


  719. KISHIMOTO M, Komine M, Kamiya K, Sugai J, et al
    Case of psoriasis with hepatitis B virus infection during tumor necrosis factor inhibitor treatment successfully treated with ixekizumab and tenofovir alafenamide fumarate.
    J Dermatol. 2022 Feb 20. doi: 10.1111/1346-8138.16320.
    PubMed    


  720. KAWAKAMI T
    Surgical procedures and innovative approaches for vitiligo regenerative treatment and melanocytorrhagy.
    J Dermatol. 2022 Feb 17. doi: 10.1111/1346-8138.16316.
    PubMed     Abstract available


  721. NAKAZAWA S, Phadungsakswasdi P, Kageyama H, Fukuchi K, et al
    Decreased serum level of suprabasin in patients with nickel allergy.
    J Dermatol. 2022 Feb 17. doi: 10.1111/1346-8138.16315.
    PubMed    


  722. NISHIOKA K, Koizumi A, Takita Y
    Seven cases of contact dermatitis due to stearyl alcohol contained in topical medications.
    J Dermatol. 2022 Feb 16. doi: 10.1111/1346-8138.16325.
    PubMed     Abstract available


  723. MITSUISHI T, Miyata K, Ando A, Sano K, et al
    Characteristic nail lesions in Kawasaki disease: Case series and literature review.
    J Dermatol. 2022;49:232-238.
    PubMed     Abstract available


  724. NAGAI-SANGAWA M, Fukunaga A, Takeuchi C, Nishiyama S, et al
    Beneficial screening of Fabry disease in patients with hypohidrosis.
    J Dermatol. 2022;49:308-312.
    PubMed     Abstract available


  725. MOCHIZUKI H, Anzawa K, Mochizuki T
    Genotyping of intraspecies polymorphisms of Sporothrix globosa using partial sequence of mitochondrial DNA.
    J Dermatol. 2022;49:263-271.
    PubMed     Abstract available


  726. MIYACHI M, Imamura-Ichigatani T, Ihara H, Ohga Y, et al
    Herpes simplex virus DNA testing by a loop-mediated isothermal amplification method for accurate clinical diagnosis and detection of mucosal viral shedding.
    J Dermatol. 2022;49:282-288.
    PubMed     Abstract available


  727. ZHOU S, Gu L, Shi Z, Gu L, et al
    A novel nomogram based on a retrospective study of 346 patients to predict the recurrence risk of condyloma acuminatum after 5-aminolevulinic acid photodynamic therapy.
    J Dermatol. 2022;49:272-281.
    PubMed     Abstract available


  728. NAKANISHI T, Kokubu H, Fujimoto N, Tanaka T, et al
    Detection rate of pustules in palmoplantar pustulosis with dermoscopy.
    J Dermatol. 2022;49:299-302.
    PubMed     Abstract available


  729. SHINTANI Y, Nishida E, Furuhashi T, Muramatsu S, et al
    Efficacy of bath-psoralen and ultraviolet A therapy for mycosis fungoides - retrospective analysis of 62 cases.
    J Dermatol. 2022;49:239-245.
    PubMed     Abstract available


  730. KAWAI K
    Preface to Journal of Dermatology special issue: Cutaneous lymphoma.
    J Dermatol. 2022;49:201.
    PubMed    


  731. CHAO JP, Lin JY, Chiang CY, Hsieh TS, et al
    Assessment of melanin distribution in epidermolysis bullosa simplex with mottled pigmentation: A case report.
    J Dermatol. 2022;49:e63-e64.
    PubMed    


  732. HARADA K, Hagiwara T
    Gardner-Diamond syndrome complicated with chronic urticaria successfully treated with antihistamine.
    J Dermatol. 2022;49:e75-e76.
    PubMed    


  733. SHIRATORI M, Ozawa T, Tsuruta D
    Syndactyly repair in Kindler syndrome.
    J Dermatol. 2022;49:e65-e66.
    PubMed    


  734. YAMADA A, Kawase M, Matsumoto T, Demitsu T, et al
    Papular acantholytic dyskeratosis in a male patient localized to the anogenital area mimicking condyloma acuminatum.
    J Dermatol. 2022;49:e57-e58.
    PubMed    


  735. FUJII S, Nobeyama Y, Mizuno S, Asahina A, et al
    A case of desmoplastic trichoepithelioma accompanied by pseudolymphoma.
    J Dermatol. 2022;49:e55-e56.
    PubMed    


  736. TSUTSUI Y, Kawai K
    Papular CD30(+) T-cell pseudolymphoma induced by S-1.
    J Dermatol. 2022;49:e48-e49.
    PubMed    


    January 2022
  737. WANG Q, Lu W, Luo Y, Tan M, et al
    Relationship between patient acceptable symptom state and disease scores in psoriasis.
    J Dermatol. 2022 Jan 25. doi: 10.1111/1346-8138.16299.
    PubMed     Abstract available


  738. PEH D, Wan Ahmad Kammal WSL, Beh PJ, Yong ACH, et al
    Correlation of whole blood hydroxychloroquine concentration with cutaneous lupus erythematosus and factors associated with it: First multicenter, cross-sectional analysis in Malaysia.
    J Dermatol. 2022 Jan 24. doi: 10.1111/1346-8138.16292.
    PubMed     Abstract available


  739. MUNEKATA Y, Kitamura S, Yanagi T, Shimano M, et al
    Dermoscopic features of aneurysmal dermatofibroma: A case report and review of the literature.
    J Dermatol. 2022 Jan 17. doi: 10.1111/1346-8138.16306.
    PubMed    


  740. KAWANO N, Shiratori T, Kawada A
    Case of molluscum contagiosum of an aged female in association with the use of upadacitinib.
    J Dermatol. 2022 Jan 17. doi: 10.1111/1346-8138.16307.
    PubMed    


  741. HATTORI N, Koike Y, Murota H
    Treatment with an interleukin-17 inhibitor resulted in complete remission of psoriasis and flare-up of atopic dermatitis.
    J Dermatol. 2022 Jan 17. doi: 10.1111/1346-8138.16308.
    PubMed    


  742. ENDO Y, Kim J, Uchiyama A, Yasuda M, et al
    Spontaneous pneumomediastinum developed after steroid pulse therapy in diffuse cutaneous systemic sclerosis patient: A case report.
    J Dermatol. 2022 Jan 11. doi: 10.1111/1346-8138.16305.
    PubMed    


  743. ZHAO L, Wang C, Zhang Y, Li J, et al
    Whole-exome sequencing identified a novel pathogenic mutation of the CYP4F22 gene in a Chinese patient with autosomal recessive congenital ichthyosis and in vitro study of the mutant CYP4F22 protein.
    J Dermatol. 2022 Jan 11. doi: 10.1111/1346-8138.16300.
    PubMed     Abstract available


  744. OHUCHI K, Amagai R, Tamabuchi E, Kambayashi Y, et al
    Fulminant type 1 diabetes mellitus triggered by coronavirus disease 2019 vaccination in an advanced melanoma patient given adjuvant nivolumab therapy.
    J Dermatol. 2022 Jan 10. doi: 10.1111/1346-8138.16304.
    PubMed    


  745. UCHIYAMA M
    Primary cicatricial alopecia: Recent advances in evaluation and diagnosis based on trichoscopic and histopathological observation, including overlapping and specific features.
    J Dermatol. 2022;49:37-54.
    PubMed     Abstract available


  746. WANG J, Yu L, Zhang S, Wang C, et al
    Successful treatment of Netherton syndrome with dupilumab: A case report and review of the literature.
    J Dermatol. 2022;49:165-167.
    PubMed     Abstract available


  747. KINOSHITA-ISE M, Sachdeva M
    Update on trichoscopy: Integration of the terminology by systematic approach and a proposal of a diagnostic flowchart.
    J Dermatol. 2022;49:4-18.
    PubMed     Abstract available


  748. KITAJIMA Y, Kume N, Tajima A, Tanizaki H, et al
    Spindle cell squamous cell carcinoma exhibiting a metaplasia to atypical fibroxanthoma.
    J Dermatol. 2022;49:e44-e45.
    PubMed    


  749. SLAWINSKA M, Biernat W, Lange M, Nowicki RJ, et al
    Dermoscopy of Nanta nevus: A study of two cases.
    J Dermatol. 2022;49:e5-e6.
    PubMed    


  750. NAKAMURA M, Morita A
    Immune activity in Merkel cell carcinoma.
    J Dermatol. 2022;49:68-74.
    PubMed     Abstract available


  751. OHTSUKA T, Odagaki A, Akatsuka T
    Case of systemic sclerosis overlapping with neuromyelitis optica.
    J Dermatol. 2022;49:e40-e41.
    PubMed    


  752. NOGUCHI H, Matsumoto T, Kimura U, Hiruma M, et al
    Textbook case of onychomycosis caused by Scopulariopsis brevicaulis.
    J Dermatol. 2022;49:e38-e39.
    PubMed    


  753. LIM JW, Lee JH, Kim HJ
    Use of hydroxychloroquine in dermatology: A multicenter retrospective study in Korea.
    J Dermatol. 2022;49:173-178.
    PubMed     Abstract available


  754. FUKUYAMA M, Ito T, Ohyama M
    Alopecia areata: Current understanding of the pathophysiology and update on therapeutic approaches, featuring the Japanese Dermatological Association guidelines.
    J Dermatol. 2022;49:19-36.
    PubMed     Abstract available


  755. NIEBEL D, Wilhelmi J, De Vos L, Ziob J, et al
    Annular plaques mimicking Rowell's syndrome in the course of coronavirus disease 2019 mRNA vaccines: An overlooked phenomenon?
    J Dermatol. 2022;49:151-156.
    PubMed     Abstract available


  756. HAYASHI R, Shimomura Y
    Update of recent findings in genetic hair disorders.
    J Dermatol. 2022;49:55-67.
    PubMed     Abstract available


  757. KIRATIKANON S, Phinyo P, Rujiwetpongstorn R, Patumanond J, et al
    Adult-onset immunodeficiency due to anti-interferon-gamma autoantibody-associated Sweet syndrome: A distinctive entity.
    J Dermatol. 2022;49:133-141.
    PubMed     Abstract available


  758. EBATA S, Yoshizaki A, Fukasawa T, Yoshizaki-Ogawa A, et al
    Percentage of residual B cells after 2 weeks of rituximab treatment predicts the improvement of systemic sclerosis-associated interstitial lung disease.
    J Dermatol. 2022;49:179-183.
    PubMed     Abstract available


  759. MIYAKE T, Natsuga K, Umayahara T, Naito S, et al
    Case of inherited epidermolysis bullosa simplex with KLHL24 gene mutation in Japan.
    J Dermatol. 2022;49:e24-e25.
    PubMed    


  760. YOKOZEKI H, Fujimoto T, Wanatabe S, Ogawa S, et al
    Topical glycopyrronium tosylate in Japanese patients with primary axillary hyperhidrosis: A randomized, double-blind, vehicle-controlled study.
    J Dermatol. 2022;49:86-94.
    PubMed     Abstract available


  761. OHATA M, Oda Y, Washio K, Fukunaga A, et al
    Efficacy of additional treatment for chronic spontaneous urticaria refractory to treatment - A single-center retrospective real-world study.
    J Dermatol. 2022;49:e7-e8.
    PubMed    


  762. TSUNEMI Y, Nakahigashi H
    Clinical study on the effects of the applied volume of moisturizer in patients with asteatosis.
    J Dermatol. 2022;49:75-85.
    PubMed     Abstract available


  763. KINOSHITA-ISE M, Fukuyama M, Ohyama M
    Distinctive age distribution and hair loss pattern putatively highlighting uniqueness of Japanese cases of fibrosing alopecia in a pattern distribution.
    J Dermatol. 2022;49:106-117.
    PubMed     Abstract available


  764. SAITO-SASAKI N, Sawada Y, Sato S, Sugino H, et al
    Possible beneficial impact of surgical deroofing procedure to cover the disadvantage of adalimumab treatment for hidradenitis suppurativa.
    J Dermatol. 2022;49:e3-e4.
    PubMed    


  765. ORITA A, Kitamura S, Maeda T, Yanagi T, et al
    Hidradenitis suppurativa successfully treated with two-stage surgery under disease control with adalimumab.
    J Dermatol. 2022;49:e1-e2.
    PubMed    


  766. SOGLIA S, Maione V, Bugatti M, Vermi W, et al
    Adalimumab for interleukin-1beta-mediated chronic non-scarring scalp folliculitis: Case report and literature review.
    J Dermatol. 2022;49:157-160.
    PubMed     Abstract available


    December 2021
  767. BABA A, Kanekura T, Tsubouchi H
    Lichenoid drug eruption after coronavirus disease 2019 vaccination.
    J Dermatol. 2021 Dec 27. doi: 10.1111/1346-8138.16294.
    PubMed    


  768. IKUMI K, Torii K, Sagawa Y, Kanayama Y, et al
    Phosphodiesterase 4 inhibitor apremilast improves insulin resistance in psoriasis patients.
    J Dermatol. 2021 Dec 27. doi: 10.1111/1346-8138.16286.
    PubMed    


  769. YONEKURA K
    Current treatment strategies and emerging therapies for cutaneous lymphoma.
    J Dermatol. 2021 Dec 27. doi: 10.1111/1346-8138.16289.
    PubMed     Abstract available


  770. WU R, Li X, Li S, Tang G, et al
    Decreased microRNA-126 expression in psoriatic CD4(+) T cells promotes T-helper 17 cell differentiation and the formation of dermatitis in imiquimod-induced psoriasis-like mice.
    J Dermatol. 2021 Dec 21. doi: 10.1111/1346-8138.16272.
    PubMed     Abstract available


  771. FUJII K
    Pathogenesis of cutaneous T cell lymphoma: Involvement of Staphylococcus aureus.
    J Dermatol. 2021 Dec 19. doi: 10.1111/1346-8138.16288.
    PubMed     Abstract available


  772. MIYAZAKI M, Ohkawa N, Miyabayashi K, Shoji H, et al
    Case of harlequin ichthyosis in preterm infant with a compound heterozygous ABCA12 missense mutation.
    J Dermatol. 2021 Dec 13. doi: 10.1111/1346-8138.16277.
    PubMed    


  773. INAZAWA-TERADA M, Namiki T, Omigawa C, Fujimoto T, et al
    An epidemiological survey of anhidrotic/hypohidrotic ectodermal dysplasia in Japan: High prevalence of allergic diseases.
    J Dermatol. 2021 Dec 13. doi: 10.1111/1346-8138.16278.
    PubMed     Abstract available


  774. COHEN-BARAK E, Mwassi B, Zagairy F, Danial-Farran N, et al
    Parental mosaic cutaneous-gonadal GJB2 mutation: From epidermal nevus to inherited ichthyosis-deafness syndrome.
    J Dermatol. 2021 Dec 9. doi: 10.1111/1346-8138.16268.
    PubMed     Abstract available


  775. SEO T, Kitamura S, Yanagi T, Ujiie H, et al
    Efficacy of a combination of paclitaxel and radiation therapy against cutaneous angiosarcoma: A single-institution retrospective study of 21 cases.
    J Dermatol. 2021 Dec 8. doi: 10.1111/1346-8138.16273.
    PubMed     Abstract available


  776. HIRANO Y, Kosumi H, Miyazawa H, Yanagi T, et al
    Toxic epidermal necrolysis induced by tirabrutinib.
    J Dermatol. 2021 Dec 5. doi: 10.1111/1346-8138.16274.
    PubMed    


  777. YATSUZUKA K, Murakami M, Kuroo Y, Fukui M, et al
    Flare-up of generalized pustular psoriasis combined with systemic capillary leak syndrome after coronavirus disease 2019 mRNA vaccination.
    J Dermatol. 2021 Dec 3. doi: 10.1111/1346-8138.16271.
    PubMed     Abstract available


  778. CHENG CY
    Risk of incident cataract in patients with psoriasis: A population-based cohort study.
    J Dermatol. 2021 Dec 3. doi: 10.1111/1346-8138.16261.
    PubMed     Abstract available


  779. CHUNG KB, Choi S, Bang D, Kim DY, et al
    Skin manifestation as an explaining factor of heterogeneity in Behcet's disease: A focused analysis in full-blown conditions.
    J Dermatol. 2021 Dec 3. doi: 10.1111/1346-8138.16250.
    PubMed     Abstract available


  780. YATSUZUKA K, Murakami M, Yoshida S, Utsunomiya R, et al
    Successful treatment of psoriasis vulgaris with apremilast in a patient with decompensated cirrhosis.
    J Dermatol. 2021 Dec 1. doi: 10.1111/1346-8138.16266.
    PubMed    


  781. ROGGENKAMP D, Sammain A, Furstenau M, Kausch M, et al
    Thiamidol((R)) in moderate-to-severe melasma: 24-week, randomized, double-blind, vehicle-controlled clinical study with subsequent regression phase.
    J Dermatol. 2021;48:1871-1876.
    PubMed     Abstract available


  782. ICHIKI N, Tawada C, Kato Z, Nakano H, et al
    Novel nonsense mutation in the SLC39A4 gene in a Japanese boy with mild acrodermatitis enteropathica.
    J Dermatol. 2021;48:e602-e603.
    PubMed    


  783. KONO T, Miyachi Y, Kawashima M
    Clinical significance of the water retention and barrier function-improving capabilities of ceramide-containing formulations: A qualitative review.
    J Dermatol. 2021;48:1807-1816.
    PubMed     Abstract available


  784. IKUMI N, Terui T, Fujita H
    Peripheral arthritis presenting pencil-in-cup deformity in a patient with palmoplantar pustulosis.
    J Dermatol. 2021;48:e612-e613.
    PubMed    


  785. YOTO A, Makino T, Mizawa M, Matsui Y, et al
    Two cases of Hailey-Hailey disease effectively treated with apremilast and a review of reported cases.
    J Dermatol. 2021;48:1945-1948.
    PubMed     Abstract available


  786. NOGUCHI H, Matsumoto T, Kimura U, Hiruma M, et al
    Ungual hyalohyphomycosis caused by Penicillium citrinum successfully treated with fosravuconazole.
    J Dermatol. 2021;48:e608-e609.
    PubMed    


  787. SAKAI H, Minami-Hori M, Shimamura T, Kanno K, et al
    Kawasaki disease in adolescence and adulthood: Report of four cases.
    J Dermatol. 2021;48:1940-1944.
    PubMed     Abstract available


  788. NAKAMURA K, Kosano M, Sakai Y, Saito N, et al
    Case of bullous pemphigoid following coronavirus disease 2019 vaccination.
    J Dermatol. 2021;48:e606-e607.
    PubMed    


  789. HASEGAWA A, Hayashi R, Shimomura Y, Hirashima M, et al
    Only plantar lesion of punctate palmoplantar keratoderma with a novel missense mutation in the AAGAB gene: Two Japanese familial case reports and review of reported mutations.
    J Dermatol. 2021;48:1926-1930.
    PubMed     Abstract available


  790. CHEN Y, Li Z, Song D, Wang S, et al
    Novel deletion of the POFUT1 gene associated with multiple seborrheic keratosis Dowling-Degos disease.
    J Dermatol. 2021;48:e591-e593.
    PubMed    


  791. WANG YA, Lee JY, Yang CC
    Sustainable effect of ultra-low dose rituximab for mild-to-moderate pemphigus vulgaris: A case report.
    J Dermatol. 2021;48:e583-e584.
    PubMed    


  792. OKUNO S, Hashimoto T, Satoh T
    Case of neuropathic itch-associated prurigo nodules on the bilateral upper arms after unilateral herpes zoster in a patient with cervical herniated discs: Successful treatment with mirogabalin.
    J Dermatol. 2021;48:e585-e586.
    PubMed    


  793. SHIBATA K, Kunisada M, Miyai S, Kawamori S, et al
    Incontinentia pigmenti in a female infant with somatic mosaicism due to the IKBKG variant.
    J Dermatol. 2021;48:e577-e578.
    PubMed    


  794. TAKENAKA M, Murota H, Nishimoto K
    Chronological evaluation of treatment effect for tinea unguium with efinaconazole: Possibility of an early estimation of treatment effects.
    J Dermatol. 2021;48:1923-1925.
    PubMed     Abstract available


  795. OKUBO Y, Morishima H, Zheng R, Terui T, et al
    Sustained efficacy and safety of guselkumab in patients with palmoplantar pustulosis through 1.5 years in a randomized phase 3 study.
    J Dermatol. 2021;48:1838-1853.
    PubMed     Abstract available


  796. SHIDO K, Kojima K, Yoshida-Akai S, Kikuchi K, et al
    Ehlers-Danlos syndrome type IV with a novel COL3A1 exon 14 skipping variation confirmed by Tohoku Medical Megabank Organization genomic database.
    J Dermatol. 2021;48:1918-1922.
    PubMed     Abstract available


    November 2021
  797. MIYAGAWA A, Adachi T, Kobayashi Y, Takamiyagi S, et al
    Plasmapheresis as a promising treatment option in apalutamide-associated toxic epidermal necrolysis.
    J Dermatol. 2021 Nov 26. doi: 10.1111/1346-8138.16248.
    PubMed    


  798. ASAKURA M, Yoshida K, Ishii M, Fujita H, et al
    Case of oral glycogenic acanthosis clinically resembling lichen planus.
    J Dermatol. 2021 Nov 26. doi: 10.1111/1346-8138.16259.
    PubMed    


  799. YONEKURA K, Ichiki M, Takeda K, Uchiyama N, et al
    Successful treatment of tumor stage mycosis fungoides with total skin helical tomotherapy.
    J Dermatol. 2021 Nov 21. doi: 10.1111/1346-8138.16246.
    PubMed     Abstract available


  800. HOLSKEN S, Krefting F, Schneider L, Benson S, et al
    A brief screening tool for depression in psoriasis patients: The Two Questions Test in clinical practice.
    J Dermatol. 2021 Nov 21. doi: 10.1111/1346-8138.16241.
    PubMed     Abstract available


  801. KASHIWADA-NAKAMURA K, Myangat TM, Kajihara I, Kanemaru H, et al
    Circulating Janus kinase family DNA levels in psoriasis: elevated JAK2 DNA copy number in cell-free DNA.
    J Dermatol. 2021 Nov 19. doi: 10.1111/1346-8138.16245.
    PubMed    


  802. SUNAGAWA K, Fukumoto T, Hamada T
    Invasive fusariosis presenting as multiple cutaneous nodules on the trunk and extremities.
    J Dermatol. 2021 Nov 16. doi: 10.1111/1346-8138.16239.
    PubMed    


  803. MYANGAT TM, Wada S, Sawamura S, Kajihara I, et al
    Microsatellite instability analysis using Promega panel in cutaneous squamous cell carcinoma.
    J Dermatol. 2021 Nov 14. doi: 10.1111/1346-8138.16238.
    PubMed    


  804. MAI S, Yanagi T, Shimano M, Nishie W, et al
    Case of hereditary leiomyomatosis and renal cell cancer showing multiple cutaneous leiomyomas harboring a recurrent nonsense mutation in the fumarate hydratase gene.
    J Dermatol. 2021 Nov 9. doi: 10.1111/1346-8138.16223.
    PubMed    


  805. HASHIZUME H, Ishikawa Y, Ajima S
    Is steroid pulse therapy a suitable treatment for drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms? A systematic review of case reports in patients treated with corticosteroids in Japan.
    J Dermatol. 2021 Nov 9. doi: 10.1111/1346-8138.16230.
    PubMed     Abstract available


  806. GOODERHAM MJ, Lynde C, Turchin I, Avadisian M, et al
    Real-world, long-term treatment patterns of commonly used biologics in Canadian patients with moderate-to-severe chronic plaque psoriasis.
    J Dermatol. 2021 Nov 7. doi: 10.1111/1346-8138.16214.
    PubMed     Abstract available


  807. FUJII K, Kanekura T
    Surgical excision: An option for a resectable lesion of cutaneous type adult T-cell leukemia/lymphoma.
    J Dermatol. 2021 Nov 7. doi: 10.1111/1346-8138.16221.
    PubMed    


  808. SAITO S, Endo Y, Nishio M, Uchiyama A, et al
    Anti-polymyositis/Scl antibody-positive overlap syndrome of diffuse cutaneous systemic sclerosis, dermatomyositis, systemic lupus erythematosus, and antiphospholipid syndrome.
    J Dermatol. 2021 Nov 3. doi: 10.1111/1346-8138.16219.
    PubMed     Abstract available


  809. YAMADA M, Nakano H, Ogita A, Saeki H, et al
    The second Japanese case of porphyria cutanea tarda with a novel genetic mutation in UROD.
    J Dermatol. 2021;48:1802-1803.
    PubMed    


  810. TOUBI E, Vadasz Z
    Predictive features associated with chronic spontaneous urticaria recurrence.
    J Dermatol. 2021;48:1786-1788.
    PubMed     Abstract available


  811. WU RW, Lin TK
    Oxford-AstraZeneca COVID-19 vaccine-induced acute localized exanthematous pustulosis.
    J Dermatol. 2021;48:e562-e563.
    PubMed    


  812. MAURELLI M, Bellinato F, Girolomoni G
    Adrenergic urticaria successfully treated with omalizumab.
    J Dermatol. 2021;48:e541-e542.
    PubMed    


  813. ONISHI Y, Arakawa Y, Tamagawa-Mineoka R, Ohshita A, et al
    Occurrence of palmoplantar pustulosis during atezolizumab therapy for non-small cell lung cancer.
    J Dermatol. 2021;48:e570-e571.
    PubMed    


  814. ZHOU X, Wang M, Wang S, Jiang X, et al
    Identification of novel compound heterozygous ITGB4 mutations in a Chinese woman with junctional epidermolysis bullosa without pylori atresia but profound urinary symptoms: A case report and review of the literature.
    J Dermatol. 2021;48:1780-1785.
    PubMed     Abstract available


  815. CHEN TL, Yip HT, Wang JH, Chang CH, et al
    Risk of chronic spontaneous urticaria in reproductive-aged women with abnormal uterine bleeding: A population-based cohort study.
    J Dermatol. 2021;48:1754-1762.
    PubMed     Abstract available


  816. USHIDA M, Arita T, Matsui M, Kanehisa F, et al
    Case of epidermodysplasia verruciformis with a novel mutation of TMC8.
    J Dermatol. 2021;48:e568-e569.
    PubMed    


  817. EGAWA K
    Familial occurrence of follicular keratosis of the chin.
    J Dermatol. 2021;48:1793-1796.
    PubMed     Abstract available


  818. ZHU R, Liu Y, Yan J, Tian Y, et al
    Overexpression of trefoil factor 1 and trefoil factor 3 in primary extramammary Paget's disease and implication of a novel therapeutic target.
    J Dermatol. 2021;48:e549-e550.
    PubMed    


  819. LEE SY, Lee KH, Ishii N, Hashimoto T, et al
    Rare case of bullous pemphigoid occurring on atrophic centers of disseminated superficial porokeratosis lesions.
    J Dermatol. 2021;48:e530-e531.
    PubMed    


  820. IKUMI N, Hayama K, Terui T, Kitamura N, et al
    Retrospective study of the differences in the management for pustulotic arthro-osteitis in patients with palmoplantar pustulosis between dermatologists and rheumatologists.
    J Dermatol. 2021;48:e551-e553.
    PubMed    


  821. OKU A, Nakai K, Ikenaga T, Sato K, et al
    Case of afatinib-induced severe purpuric drug eruption with gastrointestinal bleeding.
    J Dermatol. 2021;48:e534-e535.
    PubMed    


  822. KONDO N, Sakai Y, Kakutani R, Netsu T, et al
    Clinical characteristics and treatment status of pustulotic arthro-osteitis: A single-center study involving 51 cases.
    J Dermatol. 2021;48:1724-1730.
    PubMed     Abstract available


  823. HUANG Y, Yang J, Sun L, Zhang L, et al
    Efficacy of influential factors in hemoporfin-mediated photodynamic therapy for facial port-wine stains.
    J Dermatol. 2021;48:1700-1708.
    PubMed     Abstract available


  824. KAWAI T, Hayashi R, Yokoyama R, Abe R, et al
    Case of transient neonatal hyperpigmentation of the proximal nail fold.
    J Dermatol. 2021;48:e528-e529.
    PubMed    


  825. OHATA C, Tsuruta N, Yonekura K, Higashi Y, et al
    Clinical characteristics of Japanese pustular psoriasis: A multicenter observational study.
    J Dermatol. 2021 Nov 1. doi: 10.1111/1346-8138.16217.
    PubMed     Abstract available


    October 2021
  826. SONG WJ, Lim Y, Jo SJ
    De novo guttate psoriasis following coronavirus disease 2019 vaccination.
    J Dermatol. 2021 Oct 28. doi: 10.1111/1346-8138.16203.
    PubMed    


  827. SHIMODA-KOMATSU Y, Ida Y, Noda A, Oda M, et al
    Histological assessment of granuloma formation for the management of cutaneous Mycobacterium chelonae infection.
    J Dermatol. 2021 Oct 24. doi: 10.1111/1346-8138.16208.
    PubMed    


  828. SATO A, Takemori C, Fukumoto T, Aoyama N, et al
    Cutaneous leukocytoclastic vasculitis induced by thiamazole.
    J Dermatol. 2021 Oct 22. doi: 10.1111/1346-8138.16205.
    PubMed    


  829. LEE SJ, Lee A, Ishii N, Hashimoto T, et al
    Clinical outcome and B-cell kinetics in intercellular immunoglobulin A dermatosis treated with rituximab.
    J Dermatol. 2021 Oct 21. doi: 10.1111/1346-8138.16194.
    PubMed    


  830. BOCH K, Langan EA, Zillikens D, Ludwig RJ, et al
    Retrospective analysis of the clinical characteristics and patient-reported outcomes in vulval lichen planus: Results from a single-center study.
    J Dermatol. 2021 Oct 19. doi: 10.1111/1346-8138.16191.
    PubMed     Abstract available


  831. HAMADA T, Morita A, Suga H, Boki H, et al
    Safety and efficacy of bexarotene for Japanese patients with cutaneous T-cell lymphoma: Real-world experience from post-marketing surveillance.
    J Dermatol. 2021 Oct 18. doi: 10.1111/1346-8138.16201.
    PubMed     Abstract available


  832. LIU C, Gu L, Ding J, Meng Q, et al
    Autophagy in skin barrier and immune-related skin diseases.
    J Dermatol. 2021 Oct 16. doi: 10.1111/1346-8138.16185.
    PubMed     Abstract available


  833. CHAISUWANNARAK K, Chularojanamontri L, Junsuwan N, Eimpunth S, et al
    Cutaneous manifestations and dermoscopic findings are important clues to the diagnosis of Talaromyces marneffei in HIV patients with immune reconstitution inflammatory syndrome: A case report and literature review.
    J Dermatol. 2021 Oct 15. doi: 10.1111/1346-8138.16197.
    PubMed     Abstract available


  834. HUANG Y, Liu J, Zhang X, Li Y, et al
    Patients with senile pruritus have a distinct skin microbiota and epidermal barrier in comparison with healthy controls.
    J Dermatol. 2021 Oct 11. doi: 10.1111/1346-8138.16153.
    PubMed     Abstract available


  835. LU L, Yu Y, Zhang J, Fan X, et al
    Incidental amelioration of bullous pemphigoid during ixekizumab treatment for psoriasis.
    J Dermatol. 2021 Oct 11. doi: 10.1111/1346-8138.16189.
    PubMed    


  836. MIYAHARA H, Okiyama N, Okune M, Konishi R, et al
    Case of anti-nuclear matrix protein 2 antibody-positive juvenile dermatomyositis preceded by linear cutaneous lupus erythematosus on the face.
    J Dermatol. 2021 Oct 8. doi: 10.1111/1346-8138.16192.
    PubMed    


  837. GOTO T, Kogure A, Kuwano Y
    Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms with skin eruptions mimicking acute generalized exanthematous pustulosis.
    J Dermatol. 2021 Oct 8. doi: 10.1111/1346-8138.16190.
    PubMed    


  838. KONISHI R, Tanaka R, Inoue S, Ichimura Y, et al
    Evaluation of apremilast, an oral phosphodiesterase 4 inhibitor, for refractory cutaneous dermatomyositis: A phase 1b clinical trial.
    J Dermatol. 2021 Oct 3. doi: 10.1111/1346-8138.16179.
    PubMed     Abstract available


  839. RAIKER R, Pakhchanian H, Pham J, Phan K, et al
    Coronavirus disease 2019 complications in patients with hidradenitis suppurativa: A multicenter analysis.
    J Dermatol. 2021;48:1619-1621.
    PubMed    


  840. YAMAMOTO T, Aoyama Y
    Role of pro-inflammatory cytokines in the pathophysiology of herpes simplex virus superinfection in Darier's disease.
    J Dermatol. 2021;48:1607-1611.
    PubMed     Abstract available


  841. KAGE P, Simon JC, Treudler R
    Case of atopic eczema treated with dupilumab throughout conception, pregnancy, and lactation.
    J Dermatol. 2021;48:E484-E485.
    PubMed    


  842. DAINICHI T, Kaku Y, Izumi M, Kataoka K, et al
    Anti-BP230-type papular non-bullous pemphigoid with granular immunoglobulin G deposition at the papillary dermis.
    J Dermatol. 2021;48:E517-E519.
    PubMed    


  843. YAMAMURA K, Matsushita S, Shimaoka S, Kitazono M, et al
    Anorectal function preserving surgery with endoscopic submucosal dissection in patients with perianal extramammary Paget's disease.
    J Dermatol. 2021;48:E520-E521.
    PubMed    


  844. IWABUCHI C, Hino H, Shimada K, Kaneko H, et al
    Recurrent furunculosis by Panton-Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus USA300 clone in Tokyo: A report of two cases.
    J Dermatol. 2021;48:E522-E523.
    PubMed    


  845. KURIYAMA Y, Shimizu A, Oka H, Sato M, et al
    Erythema nodosum-like eruption in coronavirus disease 2019: A case report and literature review of Asian countries.
    J Dermatol. 2021;48:1588-1592.
    PubMed     Abstract available


  846. LIU KL, Tsai TL, Tsai WC, Tsai SF, et al
    Prenatal heavy metal exposure, total immunoglobulin E, trajectory, and atopic diseases: A 15-year follow-up study of a Taiwanese birth cohort.
    J Dermatol. 2021;48:1542-1549.
    PubMed     Abstract available


  847. KIM JW, Kim M, Kim M, Kim BR, et al
    Atypical presentation of herpes simplex virus infection in an immunocompromised patient.
    J Dermatol. 2021;48:E512-E513.
    PubMed    


  848. SUEZAWA M, Dainichi T, Kaku Y, Izumi M, et al
    Dipeptidyl peptidase 4 inhibitor-associated mucous membrane pemphigoid.
    J Dermatol. 2021;48:1584-1587.
    PubMed     Abstract available


  849. LEECHAROEN W, Thanomkitti K, Thuangtong R, Varothai S, et al
    Use of facial care products and frontal fibrosing alopecia: Coincidence or true association?
    J Dermatol. 2021;48:1557-1563.
    PubMed     Abstract available


  850. ARAKAWA H, Tanese K, Tanaka R, Murakami K, et al
    Efficacy of hydroxychloroquine for treating annular erythema associated with Sjogren's syndrome.
    J Dermatol. 2021;48:1526-1532.
    PubMed     Abstract available


  851. MUROTA H, Fujimoto T, Oshima Y, Tamada Y, et al
    Cost-of-illness study for axillary hyperhidrosis in Japan.
    J Dermatol. 2021;48:1482-1490.
    PubMed     Abstract available


  852. KOMATSU H, Umegaki-Arao N, Futei Y, Iwabuchi E, et al
    Two cases of acquired lymphangioma: Dermoscopic-histopathologic correlation between irregular vessels on lacunae.
    J Dermatol. 2021;48:E506-E507.
    PubMed    


  853. DIAS DE OLIVEIRA NF, Miyamoto D, Maruta CW, Aoki V, et al
    Recurrent erythema multiforme: A therapeutic proposal for a chronic disease.
    J Dermatol. 2021;48:1569-1573.
    PubMed     Abstract available


  854. ASANO N, Yasuno S, Hayashi R, Shimomura Y, et al
    Characterization of EDARADD gene mutations responsible for hypohidrotic ectodermal dysplasia.
    J Dermatol. 2021;48:1533-1541.
    PubMed     Abstract available


  855. WATANABE S, Iozumi K, Abe M, Ito Y, et al
    Clinical effectiveness of efinaconazole 10% solution for treatment of onychomycosis with longitudinal spikes.
    J Dermatol. 2021;48:1474-1481.
    PubMed     Abstract available


  856. GOTO M, Izumi K, Hatano Y
    Case of bullous pemphigoid positive for full-length BP180 ELISA accompanied by immunological reconstitution due to antiretroviral therapy for human immunodeficiency virus infection.
    J Dermatol. 2021;48:E490-E491.
    PubMed    


  857. MORI A, Shinkuma S, Mitsui Y, Ogawa K, et al
    Acral persistent papular mucinosis: A case report and summary of 24 Japanese cases.
    J Dermatol. 2021;48:1574-1578.
    PubMed     Abstract available


  858. ZHANG Y, Qin W, Wang H, Lin Z, et al
    Novel pathogenic variants in the RECQL4 gene causing Rothmund-Thomson syndrome in three Chinese patients.
    J Dermatol. 2021;48:1511-1517.
    PubMed     Abstract available


    September 2021
  859. HUANG HL, Xu HM, Liu YD, Shou DW, et al
    Fecal microbiota transplantation as a novel approach for the treatment of atopic dermatitis.
    J Dermatol. 2021 Sep 27. doi: 10.1111/1346-8138.16169.
    PubMed    


  860. KIDO-NAKAHARA M, Yokote G, Yoshida M, Furue M, et al
    Atopic Dermatitis Control Tool (ADCT): A useful tool for self-evaluation in patients with atopic dermatitis.
    J Dermatol. 2021 Sep 27. doi: 10.1111/1346-8138.16176.
    PubMed    


  861. ADACHI M, Adachi T, Yokota M, Ichimura C, et al
    A case of vancomycin-induced linear IgA bullous dermatosis with toxic epidermal necrolysis-like symptoms: Palmoplantar eruptions as a possible risk marker.
    J Dermatol. 2021 Sep 24. doi: 10.1111/1346-8138.16173.
    PubMed    


    June 2021
  862. OSADA A, Arimitsu T, Nakazaki H, Kin T, et al
    Severe drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms in a 1-month-old infant with trisomy 21.
    J Dermatol. 2021 Jun 28. doi: 10.1111/1346-8138.16042.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Dermatology is free of charge.